MAJOR DEPRESSION AND INSULIN RESISTANCE AMONG NONDIABETIC U.S. ADULTS AGED 20-39 YEARS: THE ROLES OF GENDER AND RACE/ETHNICITY by Shen, Qiuhua
 
 
MAJOR DEPRESSION AND INSULIN RESISTANCE AMONG NONDIABETIC 
U.S. ADULTS AGED 20-39 YEARS: THE ROLES OF GENDER AND 
RACE/ETHNICITY 
BY 
 
QIUHUA SHEN 
 
Submitted to the graduate degree program in School of Nursing and the Graduate 
Faculty of the University of Kansas in partial fulfillment of the requirements for the 
degree of Doctor of Philosophy. 
 
 
 
 
 
 
__________________________ 
Chairperson: Carol Smith 
 
__________________________ 
Co-chair: Sandra Bergquist-Beringer 
 
__________________________ 
Kelly Bosak 
 
__________________________ 
Ubolrat Piamjariyakul 
 
__________________________ 
John Keighley 
 
__________________________ 
Hung-Wen (Henry) Yeh 
 
 
Date Defended: April 11, 2011 
 
 
ii 
 
The Dissertation Committee for QIUHUA SHEN certified that this is the 
approved version of the following dissertation: 
 
 
MAJOR DEPRESSION AND INSULIN RESISTANCE AMONG 
NONDIABETIC U.S. ADULTS AGED 20-39 YEARS: THE ROLES OF GENDER 
AND RACE/ETHNICITY 
 
 
 
 
 
______________________________ 
Chairperson: Carol Smith 
 
______________________________ 
Co-chair: Sandra Bergquist-Beringer 
 
 
Date Approved: ________________ 
 
iii 
 
ABSTRACT 
The relationship between depression and insulin resistance has been evaluated in 
previous studies but with conflicting results. No study was found that investigates the 
role of race/ethnicity in the relationship between depression and insulin resistance. 
The purpose of this study was to: 1) determine the prevalence of major depression 
and insulin resistance among nondiabetic young adults aged 20-39 years in the United 
States, 2) examine the relationship between major depression and insulin resistance 
among nondiabetic young adults aged 20-39 years in the United States, and 3) 
determine whether this relationship varies by gender, race/ethnicity, or measure of 
depression.  
Analyses of cross-sectional data from the National Health and Nutrition 
Examination Survey (NHANES) 1999-2008 were performed. The study sample 
consisted of 1,054 (46.5%) men and 1,211 (53.5%) women who were nondiabetic and 
aged 20-39 years (N = 2,265). Major depression was measured by the Composite 
International Diagnostic Interview in NHANES 1999-2004 and by the Patient Health 
Questionnaire-9 in NHANES 2005-2008. Insulin resistance was measured by the 
homeostasis model assessment for insulin resistance. 
The prevalence of major depression and insulin resistance among nondiabetic 
U.S. adults aged 20-39 years in the study was 3.7% (n = 84; weighted % = 3.8) and 
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25.7% (n = 582; weighted % = 22.7) respectively. No significant association was 
found between major depression and insulin resistance in bivariate logistic regression 
analysis. However, a significant interaction effect between gender and major 
depression was observed. For men, major depression was negatively associated with 
insulin resistance after adjusting for age, race/ethnicity, systolic blood pressure, 
triglyceride level, high-sensitivity C-reactive protein, obesity, leisure time physical 
activity, smoking, and alcohol consumption. In contrast, no significant association 
between major depression and insulin resistance among women was found. There was 
no significant interaction between race/ethnicity and major depression. No significant 
variations in the relationship between major depression and insulin resistance by 
measure of depression were revealed. Study findings provide support for a significant 
positive relationship between insulin resistance and 1) systolic blood pressure, 2) 
triglyceride level, 3) and obesity as measured by body mass index or waist 
circumference among nondiabetic young adults aged 20-39 years.   
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 CHAPTER I INTRODUCTION 
Insulin Resistance and Depression 
 Insulin resistance is causally linked to the development of type 2 diabetes 
(Fonseca, 2007). Clinical abnormalities, such as hypertension, elevated triglyceride 
and low-density-lipoprotein cholesterol (LDL-C), or decreased 
high-density-lipoprotein cholesterol (HDL-C), that are associated with insulin 
resistance and its accompanying hyperinsulinemia also contribute to an increased risk 
for cardiovascular disease (Reaven, 2005a; Saely et al., 2005). Given advances in 
modernization and current sedentary lifestyles, the prevalence of insulin resistance 
has significantly increased (Lloyd-Jones et al., 2010). The adverse effects of insulin 
resistance are latent but detrimental (Jellinger, 2007; Lebovitz, 2006; Reaven, 1988). 
Without intervention, insulin resistance can progress to type 2 diabetes and 
accompanying negative sequelae, such as hypertension, dyslipidemia and other 
cardiovascular disease.  
According to the 2007 National Diabetes Fact Sheet, 7.8% of the United States 
population, or about 23.6 million people have diabetes. Approximately 90-95% of 
those affected have type 2 diabetes. Another estimated 57 million people have 
prediabetes; a condition when blood glucose levels are higher than normal but do not 
meet the diagnostic criteria of diabetes that includes impaired fasting glucose [IFG] 
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and impaired glucose tolerance [IGT]. About 1.6 million new cases of diabetes 
are diagnosed in adults aged 20 years and older every year (CDC, 2008).  
The costs associated with diabetes are high. In 2007, the estimated total national 
cost of diabetes in the United States was approximately $174 billion (CDC, 2008; 
National Institute of Diabetes and Digestive and Kidney Diseases, 2008). According 
to current national diabetes cost statistics, this $174 billion included $116 billion 
direct costs related to medical expenditures and $58 billion indirect costs associated 
with increased absenteeism, reduced productivity and lost productive capacity 
(American Diabetes Association, 2008b; CDC, 2008; National Institute of Diabetes 
and Digestive and Kidney Diseases, 2008). The average medical expenditures of 
individuals with diagnosed diabetes is $11,744 per year (American Diabetes 
Association, 2008b).  
The rate of diabetes related complications also is increasing. It is reported that the 
death rate of heart disease among people with diabetes is two to four times higher 
than those without diabetes (Lloyd-Jones, et al., 2010). In addition, diabetes is the 
leading cause of new cases of blindness and kidney failure. More than 60% of 
nontraumatic lower-limb amputations occur in diabetic patients. According to the 
latest available data, diabetes was the seventh leading cause of death listed on United 
States death certificates in 2006, which contributed to a total of 233,619 deaths in 
2005 (CDC, 2008). 
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 Depression also is a major cause of morbidity and mortality in the United 
States. It has substantial negative impact on patients‟ quality of life, physical and 
mental well-being, and social functioning, which can lead to increased disability and 
reduced work productivity (Halfin, 2007). The economic burden of depression on 
society and individuals is enormous. In 2000, the estimated total cost of depression in 
the United States was $83.1 billion (Greenberg et al., 2003; Wade & Haring, 2010). 
This included $26.1 billion (31%) (equivalent to $32 billion in 2008) for direct 
medical costs, $51.5 billion (62%) (equivalent to $63 billion in 2008) for indirect 
costs, and $5.4 billion (7%) for suicide-related mortality costs (Greenberg, et al., 2003; 
Wade & Haring, 2010). In Sweden, the total cost of depression for 2005 was 3.5 
billion Euros, including 500 million Euros (16%) of direct medical costs, 3 billion 
Euros (86%) of indirect costs and 100 million Euros of drug cost (3%) (Sobocki, 
Lekander, Borgstrom, Strom, & Runeson, 2007). At the individual level, it was 
reported that patients with depression had 50-100% higher medical expenditures than 
comparable patients without depression (Halfin, 2007). Moreover, workers with 
depression were on short term disability an average of 1.5 to 3.2 days longer in a 
one-month period than those without depression, translating into an average salary 
loss of $182 to $395 person/month (Kessler et al., 1999).  
Studies have found an increased prevalence of depression among patients with 
diabetes, and other chronic diseases such as asthma, cancer, cardiovascular disease, 
and obesity (Chapman, Perry, & Strine, 2005). It was reported that about 50% of 
patients with asthma experienced clinically significant depressive symptoms (Di 
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Marco, Santus, & Centanni, 2010; Mancuso, Peterson, & Charlson, 2000). 
Moreover, depression may play an important role in the etiology and pathogenesis of 
these chronic diseases. The overall relative risk for developing coronary heart disease 
among patients with depression was 1.64 (95% confidence interval [CI] = 1.29-2.08) 
based on a meta-analysis (Rugulies, 2002). Similar findings were observed in a recent 
prospective cohort study among 23,282 Finnish adults aged 20-54 years (Nabi et al., 
2010). A positive bidirectional association between depression and type 2 diabetes 
also has been well established. Results from two meta-analyses demonstrated that 
individuals with depression had a 37% increased risk of developing type 2 diabetes 
(Knol et al., 2006) and patients with type 2 diabetes had a 24% increased risk of 
developing depression (Nouwen et al., 2010). Women with diabetes had significantly 
higher prevalence of depression than men (23.8% vs 12.8%) (Ali, Stone, Peters, 
Davies, & Khunti, 2006). Although insulin resistance is the underlying mechanism for 
type 2 diabetes, the relationship between depression and insulin resistance is far less 
studied and remains unclear with conflicting results reported from previous studies.   
Prevalence of Insulin Resistance 
 Insulin resistance can be present in apparently healthy appearing persons. The 
reported prevalence of insulin resistance in the general population ranges from 21.5% 
(Do, Lohsoonthorn, Jiamjarasrangsi, Lertmaharit, & Williams, 2010) to 59% 
(Petersen et al., 2006) and varies by racial/ethnic groups. Among adults aged 20 years 
and older with euglycemia, the reported prevalence of insulin resistance was 32.2% 
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(Ioannou, Bryson, & Boyko, 2007). The prevalence of insulin resistance was 
even higher among patients with metabolic syndrome and chronic diseases. In a 
recent study conducted among 1,453 U.S. eighth-grade students, those with highest 
quintiles (20%) of the homeostasis model assessment for insulin resistance 
(HOMA-IR), a surrogate of insulin resistance, were almost 200 times more likely to 
have metabolic syndrome than those with the lowest quintile of HOMA-IR (Jago et 
al., 2008). An estimated 40.2% of women with polycystic ovary syndrome (PCOS) 
had insulin resistance (Vrbikova et al., 2007). About 50% of patients with primary 
hypertension were insulin resistant, regardless of their treatment status (treated or 
untreated) (Lima, Abbasi, Lamendola, & Reaven, 2009). Overall, the variations in 
reported prevalence rates may result from the methods used to measure insulin 
resistance and the cutoff value to define insulin resistance.   
Prevalence of Depression 
Depression is a mood disorder. As defined by the Diagnostic and Statistical 
Manual of Mental Disorders, 4
th
 edition (DSM-IV) (American Psychiatric 
Association, 1994), depression can be further classified as major depressive disorder 
(MDD), also known as major depression, dysthymic disorder, and depressive disorder 
not otherwise specified (NOS), or minor depression. Their definition and clinical 
diagnostic criteria are discussed in detail in a later section. 
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Estimates of the prevalence of depression in the United States vary across 
studies, depending on the operational definition of depression (clinical diagnosis of 
depression or depressive symptoms), measurements (structured clinical diagnostic 
interview or self-report depression questionnaire/inventory), and studied populations 
(general population or diseased populations). The prevalence of lifetime depression in 
the general population ranges from 15.7% to 16.2%. A more detailed discussion on 
prevalence of depression across age, gender, and race/ethnic groups can be found in 
Chapter II of this dissertation.  
Statement of the Problem 
 A limited number of studies have been conducted to examine the relationship 
between depression and insulin resistance. Based on the fact that depression is highly 
prevalent among patients with type 2 diabetes and insulin resistance precedes 
development of type 2 diabetes, it was hypothesized that depression and insulin 
resistance are positively associated. However, the relationship between depression 
and insulin resistance remains unclear as the limited number of studies conducted 
report mixed results. A detailed discussion of these previous studies is included in 
Chapter II of this dissertation. Moreover, all these studies were conducted in Europe, 
Australia, or Asia and most were limited to middle- and older-aged adults. Only two 
studies explored the relationship between depression and insulin resistance in young 
males and only one study compared this relationship in young males and females. 
Study methodologies further limit the generalizability of their results. No known 
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study was found that investigates the relationship between depression and 
insulin resistance by race/ethnicity.  
Significance 
 Investigation of the relationship between depression and insulin resistance among 
young adults is essential to understanding how insulin resistance may be influenced 
by depression among what is generally considered a healthy population. With 
identification of persons who are at risk of developing insulin resistance in primary 
care clinics, preventive interventions can be developed to intervene at an early stage. 
Knowing the impact of depression on young adults‟ health will encourage health care 
professionals to recognize depression in the clinical settings and provide appropriate 
treatment. Prompt intervention may help delay or prevent the progression of insulin 
resistance to type 2 diabetes. Improving the state of insulin resistance at an early age 
can not only delay the onset of type 2 diabetes, but also may decrease the morbidity 
and mortality rate of chronic diseases associated with insulin resistance later in life as 
well as health care costs. 
Purpose 
 The purpose of this study, using data from the National Health and Nutrition 
Examination Survey (NHANES), was to: 1) determine the prevalence of major 
depression and insulin resistance among nondiabetic young adults aged 20-39 years 
in the United States, 2) examine the relationship between major depression and 
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insulin resistance among nondiabetic young adults aged 20-39 years in the 
United States, and 3) determine whether the relationship between major depression 
and insulin resistance varies by gender, race/ethnicity, and measure of depression.  
Assumptions  
 The study was based on the following assumptions: 
1. The clinical guidelines on metabolic syndrome from the National Cholesterol 
Education Program Adult Treatment Panel III (NCEP ATP III) (NCEP ATP III, 
2002) and World Health Organization (WHO) (Alberti & Zimmet, 1998) provide 
evidence based support for factors closely associated with insulin resistance.   
2. The phenomenon of insulin resistance was measureable by established methods 
such as the homeostasis model assessment for insulin resistance. 
3. Physiological variables included in this study were measureable by suitable 
laboratory equipment and assays.  
4. Behavioral or demographic variables in this study were measurable through 
self-report.  
5. Participants selected in NHANES 1999-2008 to represent the U.S. civilian, 
non-institutionalized population actually represented the U.S. civilian, 
non-institutionalized population.  
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6. The depression instruments of the Composite International Diagnostic 
Interview (CIDI) and the Patient Health Questinnaire-9 (PHQ-9) measured major 
depression in the same way, using the diagnostic criteria established by the 
American Psychiatric Association’s Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV). However, this assumption was examined in the analyses.  
Conceptual Schema  
A conceptual schema was constructed to provide a theoretical basis for the study. 
The clinical guidelines from NCEP ATP III (NCEP ATP III, 2002) and WHO (Alberti 
& Zimmet, 1998) on metabolic syndrome provided the basis for selecting covariates 
for the study. Figure 1 demonstrates the factors that are associated with insulin 
resistance supported by these two scientific bodies and review of the literature in 
Chapter II of this dissertation. Factors associated with insulin resistance were 
categorized as demographic, physiological, and lifestyle factors. The relationship 
between depression, as a psychological factor, and insulin resistance and whether this 
relationship varied by gender and race/ethnicity were examined in the study. Factors 
that are italicized in the conceptual schema were not tested. These factors and their 
relationship with insulin resistance are discussed in detail in Chapter II.  
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DEMOGRAPHIC FACTORS: 
Age 
Gender 
Race/Ethnicity 
PSYCHOLOGICAL FACTORS: 
Depression 
PHYSIOLOGICAL FACTORS: 
Systolic blood pressure 
Triglycerides level 
C-Reactive protein 
Free fatty acids 
TNF- α 
IL-1 
IL-6 
 
LIFESTYLE FACTORS: 
Smoking 
Alcohol consumption 
Physical inactivity 
Obesity 
 
                
 
 
Figure 1. Conceptual schema of factors thought to be associated with insulin 
resistance.  
(Synthesized from NCEP ATP III. (2002). Third report of the expert panel on 
detection, evaluation, and treatment of high blood cholesterol in adults (ATP III final 
report). Retrieved from http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3_rpt.htm) 
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Research Questions 
The following were the research questions that were explored in this study: 
1. What is the overall prevalence of major depression among nondiabetic U.S. adults 
aged 20-39 years? 
2. What is the overall prevalence of insulin resistance among nondiabetic U.S. adults 
aged 20-39 years? 
3. What is the relationship between major depression and insulin resistance among 
nondiabetic U.S. adults aged 20-39 years? 
a) What is the unadjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years? 
b) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by gender, 
adjusting for age, race/ethnicity, systolic blood pressure, triglyceride, 
high-sensitivity C-reactive protein (hs-CRP), obesity (body mass index [BMI] 
or waist circumference), physical activity, smoking status, and alcohol 
consumption? 
b1) Is there an interaction between gender and major depression in the 
relationship with insulin resistance among nondiabetic U.S. adults aged 
20-39 years? 
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b2) If the interaction between gender and major depression is 
significant, what is the adjusted relationship between major depression 
and insulin resistance among nondiabetic U.S. adults aged 20-39 years 
by gender, adjusting for age, race/ethnicity, systolic blood pressure, 
triglyceride, hs-CRP, obesity (BMI or waist circumference), physical 
activity, smoking status, and alcohol consumption? 
b3) If the interaction between gender and major depression is not significant, 
what is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years, adjusting for 
age, gender, race/ethnicity, systolic blood pressure, triglyceride, hs-CRP, 
obesity (BMI or waist circumference), physical activity, smoking status, 
and alcohol consumption? 
c) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by race/ethnicity, 
adjusting for age, gender, systolic blood pressure, triglyceride, hs-CRP, 
obesity (BMI or waist circumference), physical activity, smoking status, and 
alcohol consumption? 
c1) Is there an interaction between race/ethnicity (non-Hispanic White, 
non-Hispanic Black, Mexican American, and other) and major depression 
in the association with insulin resistance among nondiabetic U.S. adults 
aged 20-39 years? 
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c2) If the interaction between race/ethnicity and major depression is 
significant, what is the adjusted relationship between major depression 
and insulin resistance among nondiabetic U.S. adults aged 20-39 years 
by race/ethnicity, adjusting for age, gender, systolic blood pressure, 
triglyceride, hs-CRP, obesity (BMI or waist circumference), physical 
activity, smoking status, and alcohol consumption? 
c3) If the interaction between race/ethnicity and major depression is not 
significant, what is the adjusted relationship between major depression 
and insulin resistance among nondiabetic U.S. adults aged 20-39 years, 
adjusting for age, gender, race/ethnicity, systolic blood pressure, 
triglyceride, hs-CRP, obesity (BMI or WC), physical activity, smoking 
status, and alcohol consumption? 
4. What is the relationship between major depression and insulin resistance by types 
of depression measure among nondiabetic U.S. adults aged 20-39 years? 
a) What is the unadjusted relationship between major depression and 
insulin resistance among nondiabetic U.S. adults aged 20-39 years by 
types of depression measure? 
b) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by types of 
depression measure, adjusting for age, gender, race/ethnicity, systolic 
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blood pressure, triglyceride, hs-CRP, obesity (BMI or waist 
circumference), physical activity, smoking status, and alcohol 
consumption? 
 Definitions of Terms 
 The definitions of the terms used in this study are provided below. The 
operational definitions of the terms also are specified. 
Nondiabetic U.S. adults aged 20-39 years 
 Conceptual definition. Nondiabetic U.S. adults aged 20-39 years are defined as 
U.S. adults aged 20-39 years who do not have diabetes.  
Operational definition. Operationally, this was defined as: 1) U.S. adults aged 
20-39 years who participated in the NHANES 1999-2008, 2) who denied having 
diabetes, and 3) had a fasting glucose < 126 mg/dl at the time of NHANES 
participation.  
Insulin Resistance 
 Conceptual definition. Insulin resistance occurs, when a higher than normal 
amount of insulin is required to maintain euglycemia. Clinically, insulin resistance is 
defined as “the inability of a known quantity of exogenous or endogenous insulin to 
increase glucose uptake and utilization in an individual as much as it does in a normal 
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population” (Lebovitz, 2001, p. S136). Although insulin has various actions, it 
is its effect on glucose uptake and utilization that defines insulin resistance. This is 
the basis for all the techniques that apply the relationship between insulin supply and 
glucose uptake and utilization to quantify insulin resistance. Insulin exerts its actions 
by binding to insulin receptors on cellular membrane and induces a conformational 
change in the receptors that triggers two major cascades of protein-protein 
interactions. Any factor that intervenes in the process can impair insulin action, 
particularly glucose uptake.  
 Operational definition. Insulin resistance was measured by the homeostasis 
model assessment for insulin resistance (HOMA-IR) in this study. It was 
operationally defined as a HOMA-IR score ≥ 75 percentile of HOMA-IR scores in 
the nondiabetic population aged ≥ 20 years. Study subjects whose HOMA-IR scores 
were above the top 25% were defined as insulin resistant individuals. The rest were 
defined as non-insulin resistant. The HOMA-IR is discussed in detail in the Chapter 
III of this dissertation. 
Depression 
 Conceptual definition. Depression is a mood disorder that is defined as recurrent 
disturbances or alterations in mood that cause psychological distress and behavioral 
impairment.  
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 Operational definition. The operational definition of depression for this 
study was a diagnosis of major depression by the World Health Organization (WHO) 
Composite International Diagnostic Interview (CIDI) in the NHANES 1999-2004 or a 
diagnosis of major depression by the Patient Health Questionnaire-9 (PHQ-9) in the 
NHANES 2005-2008. 
Prevalence 
 Conceptual definition. Prevalence of a disease is defined as the total number of 
cases of the disease in the population at a given time and is calculated by dividing the 
total number of cases with the disease by the total number of individuals in the 
population.  
Operational definition. In this study, the prevalence of insulin resistance was 
defined as the proportion of the total number of nondiabetic young adults aged 20-39 
years who had insulin resistance. The prevalence of depression was defined as the 
proportion of the total number of nondiabetic young adults aged 20-39 years who had 
major depression.  
Interaction 
 Conceptual definition. An interaction exists when an independent variable 
interacts with the independent variable of interest and affects the strength and/or 
direction of the association between the independent variable of interest and an 
 17 
outcome variable. In other words, the association of the independent variable 
of interest with the outcome variable depends on the level of another independent 
variable (Bennett, 2000).  
 Operational definition. In this study, interaction was defined as an interaction 
term (gender*depression or race/ethnicity*depression) with a p-value ≤ .05 in the 
multivariate logistic regression analyses. 
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CHAPTER II REVIEW OF THE LITERATURE 
 Insulin resistance is a significant risk factor for many diseases, especially for type 
2 diabetes and cardiovascular disease. Estimates of the incidence and prevalence of 
insulin resistance have increased dramatically over the last two decades. Research has 
examined a number of factors, including depression that are associated with insulin 
resistance; however, the relationship between depression and insulin resistance 
remains unclear. This chapter reviews and summarizes the major studies on insulin 
resistance and depression to provide a conceptual basis for the study. Specifically, this 
chapter discusses the literature related to the pathogenesis of insulin resistance, 
factors associated with insulin resistance, and the negative impact of insulin 
resistance on health. The definition of depression and its classification and prevalence, 
the relationship between depression and insulin resistance, and the possible 
pathophysiological mechanisms underlying this relationship also are addressed.  
Insulin Resistance 
Insulin resistance is defined as attenuated insulin-stimulated glucose uptake with 
a normal quantity of insulin that is sufficient to produce normal glucose uptake in a 
normal healthy individual (Lebovitz, 2001). The concept of insulin resistance was 
first introduced by Himsworth (1936) about 70 years ago, when he observed that 
many patients with diabetes are “insulin insensitive”. With the development of 
advanced techniques to measure insulin activity, the phenomenon of insulin resistance 
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has gained substantial attention. Insulin resistance has become an increasingly 
common abnormality (Lebovitz, 2001), which exists not only in patients with 
impaired glucose tolerance and type 2 diabetes, but also in at least 25% of normal 
population with euglycemia (Reaven, 1988, 2005b). According to Ioannou, Bryson, 
and Boyko (2007), the prevalence of insulin resistance is 32.2% among 
normoglycemic persons and 31.1% among persons with impaired fasting glucose or 
undiagnosed diabetes in the United States. To better understand insulin resistance, 
normal insulin action is briefly reviewed.  
Normal Insulin Action 
 Insulin plays a critical role in many metabolic processes including the regulation 
of glucose uptake and controlling gene transcription and cell proliferation (White & 
Myers, 2001). The main metabolic effects of insulin are to: 1) stimulate glucose 
uptake in insulin-sensitive cells such as skeletal muscle cells, adipocytes, and the liver; 
and 2) suppress hepatic glucose production and increase very-low-density lipoprotein 
(VLDL) (Yki-Jarvinen, 2003). During glucose homeostasis, insulin binds to the 
insulin receptors on the membranes of insulin-sensitive cells to activate tyrosine 
kinase, which stimulates a cascade of protein kinases to move glucose transporters 4 
(GLUT 4) positioned in the membrane vesicles within the cytosol of cells to the cell 
surface. The presence of GLUT 4 on the cell membrane allows the transport of 
glucose into the cells (Barrett, 2005). Other metabolic effects of insulin include 
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inhibition of the release of free fatty acids from adipose tissue and facilitation 
of protein synthesis from amino acid (Eckel, Grundy, & Zimmet, 2005).  
 Insulin is considered to have anti-atherogenic effects (Yki-Jarvinen, 2003). 
Montagnani, Ravichandran, Chen, Esposito, and Quon (2002) found that insulin can 
increase the production of nitric oxide (NO) in endothelial cells of blood vessels. NO 
stimulates vasodilation. Insulin also can inhibit type-1 plasminogen activator inhibitor 
(PAI-1) (Juhan-Vague, Alessi, & Vague, 1996) and platelet aggregation (Trovati & 
Anfossi, 1998). In addition, insulin is thought to be a growth factor that stimulates 
vascular cell proliferation and synthesis of matrix proteins (Feener & King, 1997; 
McFarlane, Banerji, & Sowers, 2001).     
Pathogenesis of Insulin Resistance  
 Interference with insulin‟s normal action can occur at any point along the 
complex signaling pathway. Accordingly, there are multiple possible mechanisms that 
can account for the development of insulin resistance. Insulin resistance occurs when 
its action on glucose uptake is impaired. Specifically, significantly lower glucose 
transport across the entire physiological range of insulin concentrations is 
characteristic of insulin resistance. The resulting higher circulating levels of glucose 
stimulate pancreatic beta cells to produce more insulin and a larger fraction of the 
insulin receptors must be occupied in order to maintain euglycemia (Barrett, 2005). 
Therefore, compensatory hyperinsulinemia is commonly present in insulin resistant 
individuals.  
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 Although it is still controversial, some researchers proposed that excessive 
free fatty acids are implicated in the pathogenesis of insulin resistance (Eckel, et al., 
2005). Free fatty acids also are believed to induce insulin resistance in muscles by 
impairing the insulin-signaling pathway, thus the movement of GLUT 4 to the cell 
membrane for glucose uptake (Boden & Laakso, 2004). The study conducted by 
Boden et al. (1991) showed that insulin resistance appeared two to four hours after an 
acute increase in plasma free fatty acid concentration and disappeared after plasma 
free fatty acid levels returned to normal among nondiabetic men. Similar results were 
found in nondiabetic women (Homko, Cheung, & Boden, 2003). However, it is 
known that one action of insulin is to suppress adipose tissue lipolysis and promote 
hepatic uptake of free fatty acids, then suppress the level of free fatty acids. Insulin 
resistance in liver tissue may interfere with hepatic uptake of free fatty acids thus 
contribute to elevated plasma free fatty acid levels (Boden & Laakso, 2004). This 
seemingly conflicting information makes it difficult to differentiate the direction of 
the relationship between insulin resistance and excessive free fatty acids. It is known 
that they are highly correlated with each other. In addition, excessive free fatty acids  
increase the level of oxidative stress (Ceriello, 2000). The reactive oxygen species 
generated by increased oxidative stress also may contribute to the pathogenesis of 
insulin resistance (Itani, Ruderman, Schmieder, & Boden, 2002). Other proposed 
mechanisms include genetic abnormalities in the insulin signaling pathways and fetal 
malnutrition (Lebovitz, 2001). Further discussion on factors associated with insulin 
resistance and their potential roles in the pathogenesis of insulin resistance follows. 
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Factors Associated With Insulin Resistance 
 Clinical guidelines NCEP ATP III (NCEP ATP III, 2002) and WHO (Alberti & 
Zimmet, 1998) identify factors associated with insulin resistance, which were 
delineated in research on metabolic syndrome, including hypertension, dyslipidemia, 
and obesity. These two scientific bodies provided the basis for selecting covariates for 
this study. Other covariates were identified through a review of the literature on the 
topic and include age, gender, race/ethnicity, C-reactive protein (CRP), physical 
inactivity, smoking, and alcohol consumption.   
Age. The prevalence of impaired glucose tolerance and type 2 diabetes increases 
with age. Compared to young people, elderly adults also are more subject to insulin 
resistance. Fujita et al (2009) found an aged-related defect in muscle protein 
anabolism among healthy older adults that resulted from age-related insulin resistance 
as evidenced by the fact that muscle protein synthesis and anabolic signaling 
increased under supraphysiological hyperinsulinemia. However, the pathogenesis 
underlying this increasing age-associated insulin resistance is not fully understood 
and studies investigating the relationship between insulin resistance and age report 
inconsistent results. In some studies, insulin sensitivity was found to be lower among 
older adults than in younger people, while other studies found no significant 
association between insulin resistance and age, after controlling for body fat 
distribution or weight. For example, Karakelides, Irving, Short, O‟Brien and Nair 
(2010) compared insulin sensitivity and skeletal muscle mitochondrial ATP 
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production rates (MAPRs) across 12 young lean, 12 young obese, 12 elderly 
lean, and 12 elderly obese adults. They found that obesity had significant effect in 
reducing insulin sensitivity, independent of age; while age had no independent effect 
on insulin sensitivity. In addition, the elderly participants had lower muscle MAPRs 
than the young participants, independent of obesity and insulin sensitivity. They 
concluded that aged-related reductions in insulin sensitivity were likely due to an 
aged-related increase in adiposity rather than a consequence of advanced 
chronological age. Similar findings were observed by Sakurai et al. (2010) among 
812 Japanese elderly with type 2 diabetes aged 65 or above and by Qiao et al. (2005) 
in a large European population-based study with 6,314 men and 6,393 women aged 
30-88 years. Although increased insulin resistance may not directly result from age 
per se, age is usually considered as an important factor to control for in studies 
involving insulin resistance.  
Gender. Studies have shown that gender is closely related to insulin resistance 
with females being more insulin resistant than males from birth throughout adulthood. 
This phenomenon can be attributed to intrinsic genetic and hormonal differences 
between females and males (Wilkin & Murphy, 2006). At birth, girls were found to 
have significantly higher concentration of insulin and/or its precursor peptides (i.e., 
proinsulin and split proinsulin) and were lighter weight than boys (Ibanez et al., 2008; 
Shields et al., 2007). Insulin plays a major role in fetal growth; however, a higher 
concentration of insulin is associated with smaller body weight among girls, 
indicating girls are insulin resistant in uterus and at birth. This observation was 
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persistent among 357 children aged 10-14 years undergoing puberty (Moran et 
al., 1999).  
Race/Ethnicity. Genetic differences plus environmental factors exert their effects 
on insulin resistance through the role of race/ethnicity. Research found that the 
etiologies and prevalence of insulin resistance vary among different racial/ethnic 
groups. The Caucasian population is the most studied group followed by African and 
Hispanic groups. Other ethnic groups such as Asian are less well studied. Lovejoy, de 
la Bretonne, Klemperer, and Tulley (1996) observed that African American women (n 
= 37) had a lower insulin sensitivity index measured by the minimal model than 
Caucasian women (n = 22) matched for age, BMI, and waist to hip ratio (WHR), 
even though they had smaller visceral fat area measured by computed tomographic 
scan (CT). In the later study by Karim, Wang, Hale, and Elbein (2005), African 
American men and women, when compared with Caucasians, were found to have 
significant genetic variants in the beta-cell specific transcription factor insulin 
promoter factor 1 gene that is important for the development of pancreas and 
maintenance of beta-cell mass. These genetic variants may increase African 
Americans‟ risk of developing insulin resistance and type 2 diabetes. In a recent 
review by Reimann, Schutte, and Schwarz (2007), other factors such as central 
obesity, variations in adipokines secretion, glucose metabolism, and urbanization also 
may contribute to the ethnic differences in insulin resistance.  
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 Hispanics are another racial/ethnic group with a higher prevalence of 
diagnosed diabetes than non-Hispanic Whites among people aged 20 years or older 
(10.4% vs 6.6%), after adjusting for population age differences (American Diabetes 
Association, 2008a). Results may be related to their insulin resistance state. For 
example, healthy and nondiabetic Mexican American women (n = 14) were found to 
be more insulin resistant and hyperinsulinemic than non-Hispanic Whites (n = 19) 
with matched age and BMI (Aguirre, Jones, Pei, Villa, & Reaven, 1997).    
 Type 2 diabetes is reported highly prevalent among American Indians, compared 
to the U.S. general population. In a cross-sectional study involving 4,549 American 
Indians aged 45-74 years recruited from Arizona, Oklahoma, and South and North 
Dakota, the age-adjusted rate of type 2 diabetes ranged from 33% in South and North 
Dakota men to 72% in Arizona women (Lee et al., 1995). A diabetes-specific 
quantitative trait loci for body weight on chromosome 1 has been identified among 
American Indians (Franceschini et al., 2008). These genes could influence 
distribution of body fat, thus may explain the high susceptibility to obesity, insulin 
resistance and type 2 diabetes among the American Indians.  
Hypertension. A positive relationship between insulin resistance and hypertension 
has been established in previous studies. Patients with untreated hypertension were 
found to be hyperinsulinemic (Ferrannini et al., 1987; Zavaroni et al., 1992). The 
co-existence of glucose intolerance and hyperinsulinemia among these patients with 
hypertension strongly suggests that insulin-stimulated glucose uptake is impaired and 
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insulin resistance is present in this group of patients. At least one-half of 
patients with hypertension are estimated to be insulin resistant (Lima, et al., 2009).   
 Several possible mechanisms have been proposed to explain the role of insulin 
resistance in hypertension (Manrique, Lastra, Gardner, & Sowers, 2009). Studies have 
found that there is a strong positive relationship between insulin resistance and 
increased activity of the renin angiotensin aldosterone system (RAAS) and the 
sympathetic nervous system, independent of any change in plasma glucose 
concentration (Christensen et al., 1980; Grassi et al., 2005; Lembo et al., 1992; Rowe 
et al., 1981). Moreover, vasodilation induced by NO is impaired because of 
endothelial dysfunction in an insulin resistant state that is associated elevation of free 
fatty acids (Montagnani, et al., 2002; Tripathy et al., 2003). In addition, insulin can 
act on the proximal tubule of the kidneys to increase sodium retention, thus induce 
hypertension in hyperinsulinemia (Sarafidis & Bakris, 2007; Song et al., 2006).  
Dyslipidemia. Dyslipidemia, the most common complication of type 2 diabetes, 
also is implicated in insulin resistance (Avramoglu, Basciano, & Adeli, 2006; 
Palaniappan et al., 2007). Petersen et al. (2007) investigated the role of insulin 
resistance in promoting atherogenic dyslipidemia among 24 young and healthy adults 
(12 were insulin resistant and 12 were non-insulin resistant). They found that net 
hepatic triglyceride synthesis increased significantly in insulin resistant subjects 
accompanied by a 20% decrease in high-density lipoprotein cholesterol (HDL-C) 
level, when compared to non-insulin resistant individuals. Findings may be explained 
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by excessive plasma free fatty acids associated with insulin resistance that 
results in an increased production of glucose, triglycerides, and an increased secretion 
of very-low-density lipoprotein (VLDL) (Jellinger, 2007).  
 C-reactive protein. C-reactive protein (CRP) is a biomarker for systemic 
inflammation and is found to be positively associated with insulin resistance among 
different populations, such as 2,514 nondiabetic U.S. adults aged 20 years and older 
(Meng et al., 2007), 1,525 Peruvian adults with a mean age of 39 years (Gelaye et al., 
2010), 1,624 nondiabetic Japanese aged 40-69 years (Nakanishi, Shiraishi, & Wada, 
2005), and 574 middle aged nondiabetic Taiwanese (Chou et al., 2010). CRP may 
cause insulin resistance by impairing the insulin signaling pathway (D'Alessandris, 
Lauro, Presta, & Sesti, 2007; Xu, Morita, Ikeda, Miki, & Yamori, 2007). There also is 
increasing evidence showing that elevated CRP levels, particularly, high sensitivity 
CRP (hs-CRP,) (i.e., hs-CRP > 3.0 mg/L), is an independent and significant risk factor 
for type 2 diabetes and cardiovascular disease such as myocardial infarction and 
ischemic stroke (Devaraj, Singh, & Jialal, 2009; Jeppesen et al., 2008; Ridker, 2007; 
Rifai & Ridker, 2001). Different from standard CRP test, hs-CRP is measured by 
high-sensitivity assay that can detect a range of 0.02-10 mg/L concentrations of CRP. 
According to a scientific statement from the Centers for Disease Control and 
Prevention (CDC) and American Heart Association (AHA), plasma levels of hs-CRP 
are categorized as low (< 1.0 mg/L), moderate (1.0 to 3.0 mg/L), and high (> 3.0 
mg/L), indicating low, average, or high relative cardiovascular risk respectively 
(Pearson et al., 2003).  
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Obesity. Numerous studies have shown that obesity is the most significant 
risk factor for insulin resistance. However, the operational definition of obesity varies 
across studies. Body mass index (BMI) is widely used to identify persons with weight 
problems and is calculated by dividing an individual‟s body weight in kilograms by 
the square of height in meters (kg/m
2
). According to the WHO, a BMI < 18.5 is 
defined as underweight, a BMI of between 18.5 and 24.9 is defined as normal weight, 
while a BMI from 25 to 29.9 is defined as overweight and a BMI ≥ 30 is defined as 
obesity (WHO, 2000). Although it is popular and convenient to use, many researchers 
have identified the limitations of using BMI in studies on insulin resistance. BMI is 
based on weight and height and does not consider the distribution of fat, muscle and 
bone mass. Research also has shown that BMI may overestimate fat tissues for those 
with more lean body mass and underestimate adiposity on those with less lean body 
mass. For example, Romero-Corral et al. (2008) evaluated the accuracy of BMI in 
diagnosing obesity, using cross-sectional nationally representative data (N = 13,601) 
from the Third National Health and Nutrition Examination Survey (NHANES III). 
They found that the prevalence of obesity defined by BMI ≥ 30 kg/m
2
 was 19.1% and 
24.7% for men and women respectively, while the rate of obesity defined by body fat 
percent (BF% > 25% for men and > 35% for women) was much higher for both men 
(43.9%) and women (53.3%).  
Because of these limitations, other measures such as waist circumference were 
recommended and have become more popular in research and clinical settings. Waist 
circumference is the distance around the abdomen between the lower rib cage and 
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hips and is measured by placing a tape around the waist at the upper point of 
the iliac crest with minimal inspiration. Increased waist circumference is a strong 
indication for central obesity, which is defined as >35 inches (88 cm) for women 
and > 40 inches (102 cm) for men (NCEP ATP III, 2002). Waist circumference also 
has been identified as a better predictor for multiple health risks (e.g., type 2 diabetes 
and cardiovascular disease) than BMI (Han, Sattar, & Lean, 2006).  
Researchers continue to investigate the relationship between BMI and insulin 
resistance. In a cross-sectional study conducted among a cohort of 1,194 female twins 
aged 18-74 years, Skidmore et al. (2008) investigated the relationship of birth weight, 
adult BMI, and change in size between birth and adulthood to insulin resistance, 
using linear regression analyses. There was no significant association between birth 
weight and insulin resistance, but a significant positive relationship between adult 
BMI and insulin resistance was found (a 26% increase in insulin resistance per SD 
increase in BMI with a confidence interval [CI] of 22.6-29.5%). Farin, Abbasi, and 
Reaven (2006) conducted a study among 330 healthy nondiabetic adults (191 women 
and 139 men with mean age of 50 years) to compare the effectiveness of waist 
circumference and BMI in identifying insulin-resistant individuals. They found that 
BMI and waist circumference correlated well with each other (r = .78, p < .001) and 
with the steady-state plasma glucose (SSPG) concentration in the insulin-suppression 
test, which is a direct measure of the ability of insulin to mediate glucose disposal at a 
given load (r = .58, p < .001 for BMI; r = .57, p < .001 for waist circumference). 
Participants who were abdominally obese (waist circumference > 88cm for women 
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and > 102 cm for men) had significantly higher SSPG concentrations than 
those with a normal waist circumference within the overweight BMI category. When 
stratified by waist circumference, subjects in the overweight BMI category had 
greater SSPG concentrations than subjects who had a normal BMI within normal 
waist circumference category. For those who were abdominally obese, participants 
with BMI ≥ 30 had higher SSPG concentrations than those with overweight BMI. The 
authors concluded that both waist circumference and BMI accounted for about 30% 
variations in the SSPG concentrations but did not find evidence to suggest that waist 
circumference was superior to BMI for identifying insulin resistance. Therefore, no 
matter which obesity index is used, it is clear that obesity contributes to insulin 
resistance.   
 Central obesity is a main component of metabolic syndrome. The role of central 
obesity in the development of insulin resistance is through various adipokines 
secreted by adipose tissue, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, 
resistin, leptin, and adiponectin (Boden & Laakso, 2004). Adiponectin is one of the 
adipokines that have anti-inflammatory effect and is likely to improve insulin 
sensitivity by stimulating fatty acid oxidation and decreasing plasma triglycerides 
(Boden & Laakso, 2004). Among 783 young men aged 20-29 years, it was found that 
with increased subcutaneous adipose tissue, the level of adiponectin decreases 
accompanying a higher HOMA-IR level, an indication of insulin resistance 
(Frederiksen et al., 2009). The reduced release of adiponectin in obesity may 
contribute to insulin resistance and the development of type 2 diabetes. Although the 
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mechanism by which obesity leads to decreased adiponectin level is unclear, 
Boden & Laakso (2004) proposed that adiponectin is inhibited by hyperinsulinemia 
and enhanced TNF-α caused by obesity-induced insulin resistance. Excess free fatty 
acids in obesity also can induce insulin resistance by impairing the insulin-signaling 
pathway (Boden & Laakso, 2004; Homko, et al., 2003).  
Physical inactivity. The beneficial effects of exercise in preventing chronic 
diseases are well known. Alternatively, lack of exercise or physical inactivity itself 
may contribute to the development of chronic diseases, although this relationship is 
mediated by the interaction between genetically controlled biochemical processes and 
a myriad of bio-cultural influences-lifestyle factors, including nutrition, exercise, and 
exposure to noxious substances (Booth, Laye, Lees, Rector, & Thyfault, 2008). 
Physical inactivity refers to not engaging in any regular pattern of physical activity 
beyond daily functioning (CDC, 2010c). Research has focused on the underlying 
mechanisms exerted by physical inactivity on the development of insulin resistance. A 
reduction in skeletal muscle insulin sensitivity (Kump & Booth, 2005) and a rapid 
expansion of intra-abdominal fat storage are the two major biological consequences 
of the shift from high physical activity to a sedentary condition (Booth, et al., 2008). 
It was hypothesized that decreased utilization of energy-producing substrates by 
skeletal muscle from physical inactivity signals a reduced need for additional uptake 
of glucose, which diminishes insulin sensitivity for glucose uptake.  
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Smoking. Studies have found that smoking contributes to greater 
accumulation of visceral fat and greater insulin resistance and that smoking is 
associated with increased risk of metabolic syndrome and type 2 diabetes (Chiolero, 
Faeh, Paccaud, & Cornuz, 2008). Cross-sectional studies show that smokers have 
higher waist-to-hip ratio (WHR), an indicator of central obesity, than nonsmokers in a 
review by Chiolero et al. (2008). This can be attributed to the increased cortisol level, 
an imbalance between male (testosterone) and female sex hormones (estrogen) in 
female smokers and a decrease in testosterone in male smokers. The combined effect 
of weight gain and increased WHR associated with smoking can lead to insulin 
resistance.  
 The relationship between smoking and insulin resistance has been investigated in 
previous studies. Male smokers with impaired glucose tolerance (IGT) or diabetes 
were found to be more insulin resistant than non-smokers with IGT or diabetes (Ko, 
Tong, So, Cockram, & Chan, 2007). This significant association was consistent with 
findings from studies among Japanese patients with type 2 diabetes (Anan et al., 
2006), college students (Bergman et al., 2009), and aboriginal people in rural British 
Columbia, Canada (Daniel & Cargo, 2004). Anan et al. (2006) also observed that 
insulin levels were higher among smokers than nonsmokers. Interestingly, Daniel and 
Cargo (2004) found that current smokers had the highest β cell function, followed by 
non-smokers and former smokers. In contrast, no significant association between 
active smoking and insulin sensitivity was found in a study by Henkin et al. (1999) 
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among 1,481 participants aged 40-69 years or among participants with normal 
glucose tolerance (Ko, et al., 2007). 
 Smoking may exert its detrimental effects on health through the influence of 
nicotine and carbon monoxide (Campbell, Moffatt, & Stamford, 2008). Nicotine 
binds to various receptors, causing the release of acetylcholine, norepinephrine, 
dopamine, serotonin, and vasopressin. These neurotransmitters promote sympathetic 
stimulation and vasoconstriction of the arteries, thus increase heart rate and blood 
pressure (Campbell, et al., 2008). In addition, decreased insulin action might be 
explained by increased insulin receptor substrate (IRS)-1 Ser
636
 phosphorylation that 
can inhibit insulin signaling among smokers when compared to nonsmokers 
(Bergman, et al., 2009).   
Alcohol consumption. Moderate alcohol consumption has been associated with 
lower risk for both cardiovascular disease and type 2 diabetes. However, the exact 
mechanism by which alcohol consumption improves insulin sensitivity is not known 
and conflicting results have been reported. A study by Kim, Abbasi, Lamendola, and 
Reaven (2009) showed that 8 weeks of moderate alcohol consumption (30g of alcohol 
per day) had minimal impact on enhancing insulin sensitivity in 20 nondiabetic but 
insulin-resistant individuals with a mean age of 54 years. Although the SSPG 
concentrations decreased by approximately 8% in the total group, it was not 
statistically significant. There were no statistically significant changes in fasting 
plasma glucose, insulin and surprisingly, triglyceride concentrations after 8-weeks of 
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moderate alcohol consumption in this study. Findings contradict those from a 
meta-analysis that identified moderate alcohol consumption (30g per day) can 
increase level of triglycerides by 5.9% from baseline (Rimm, Williams, Fosher, 
Criqui, & Stampfer, 1999). Heavy drinking is usually associated with increased 
triglyceride levels (Brinton, 2010; Foerster et al., 2009).   
 In contrast, Hong, Smith, Harvey, and Nunez (2009) examined the effects of 
alcohol consumption on insulin sensitivity in the controlled animal study on male 
mice with three different body weight phenotypes and found that alcohol did not 
affect glucose tolerance test (GTT) in any of the body weight phenotypes; however, 
alcohol consumption promoted insulin sensitivity in mice consuming both the low fat 
and high fat diets. They concluded that alcohol consumption increased insulin 
sensitivity without affecting body fat levels in male mice. Similarly, improved insulin 
sensitivity was observed among 36 postmenopausal women after 6 weeks of 
consumption of 250 ml white wine (~ 25g alcohol per day), along with an increase in 
HDL levels, a decrease in LDL levels and a decrease in fasting triacylglycerol 
(Joosten, Beulens, Kersten, & Hendriks, 2008). The proposed hypothesis suggests 
that alcohol has effects on: (1) inhibiting gluconeogenesis; (2) decreasing 
inflammation; (3) increasing the production of factors that improve insulin sensitivity 
(i.e., adiponectin); and (4) increasing the production of insulin by the pancreas (Hong, 
et al., 2009).  
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Impact of Insulin Resistance on Health 
Insulin resistance is not considered a disease, but it is not a benign state (Reaven, 
2005b). Many studies have been conducted during the last two decades to investigate 
the role of insulin resistance and hyperinsulinemia in the pathogenesis of metabolic, 
endocrine, and cardiovascular diseases (Avramoglu, et al., 2006; Despres et al., 1996; 
Fontbonne et al., 1991; Hsueh & Law, 1998). These studies provide solid evidence for 
a strong association between insulin resistance and many clinical diseases or 
abnormalities such as type 2 diabetes, hypertension, dyslipidemia, hyperuricemia, 
metabolic syndrome, and cardiovascular diseases (Lebovitz, 2001; Stern, 1997). 
When beta cells are able to secret higher levels of insulin to compensate insulin 
resistance, euglycemia is maintained. When beta cells fail to maintain 
hyperinsulinemia, type 2 diabetes develops with significant hyperglycemia. The 
relative risk of developing type 2 diabetes in 8 years among individuals with insulin 
resistance is increased as much as 13 fold compared to those without insulin 
resistance (Stern, 1997). Insulin resistance can induce hypertension by the possible 
mechanisms of activating sympathetic nervous system (Grassi, et al., 2005; Lembo, et 
al., 1992), reducing the production of NO (Montagnani, et al., 2002), and increasing 
sodium retention in the renal system (Sarafidis & Bakris, 2007; Song, et al., 2006). 
Insulin resistance also is associated with hyperuricemia (Bonora et al., 2008). The 
elevated free fatty acids concomitant with insulin resistance can lead to increased 
production of triglycerides, LDL-C, VLDL and decreased HDL-C (Jellinger, 2007). 
In addition, hypercoagulability among patients with insulin resistance results from 
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impaired fibrinolysis that is due to increased concentration of plasminogen 
activator inhibitor 1 (PAI-1) associated with hyperinsulinemia (Meigs et al., 2000). 
Insulin resistance is proposed as a fundamental component of the metabolic syndrome 
(Reaven, 2005b) and a risk factor for cardiovascular disease (Fonseca, Desouza, 
Asnani, & Jialal, 2004). Detailed discussion of the adverse impact of insulin 
resistance on health can be found in an unpublished review (Shen, 2008).  
Depression 
Definition of Depression 
 As mentioned previously in Chapter I, depression is a type of mood disorder. 
According to the Diagnostic and Statistical Manual of Mental Disorders, 4
th
 edition 
(DSM-IV) (American Psychiatric Association, 1994), mood disorders are defined as 
recurrent disturbances or alterations in mood that cause psychological distress and 
behavioral impairment. The diagnosis of depression is based on subjective experience 
of mood and the presence of a certain number of other depressive symptoms 
including psychological and physical, which can be evaluated by a structured or 
standardized clinical interview (Davidson, Rieckmann, & Rapp, 2005). The presence 
of depressive symptoms also can be measured by self-reported depression 
questionnaires or inventory.  
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Classification of Depression  
Depression or depressive disorder is one of the five categories of mood disorders. 
The other four categories are bipolar disorders, mood disorder caused by a general 
medical condition, substance – induced mood disorder, and mood disorder not 
otherwise specified (NOS) (American Psychiatric Association, 1994). The three 
sub-categories of depressive disorders include major depressive disorder (MDD), 
single or recurrent episodes; dysthymic disorder; and depressive disorder NOS. MDD 
also is known as major depression and is defined as one or more major depressive 
episodes. The DSM-IV diagnostic criteria for MDD are: 1) either a depressed mood 
or a loss of interest in nearly all activities that must be present for at least 2 weeks; 
and 2) four of seven additional symptoms that must be present for at least 2 weeks 
including significant appetite/weight change, insomnia or hypersomnia, psychomotor 
agitation or retardation, fatigue or loss of energy, excessive guilt or feelings of 
worthlessness, diminished ability to think or concentrate or indecisiveness, and 
suicidal ideation. In contrast, dysthymic disorder is a milder but more chronic form of 
MDD in that the depressed mood is present for most days for at least 2 years plus two 
of seven additional symptoms. Depressive disorder NOS includes disorders with 
depressive features that do not meet all the criteria of MDD or dysthymic disorder. 
Prevalence of Depression 
Estimates of the prevalence of depression in the United States vary across studies, 
depending on the definition of depression, measure of depression (structured clinical 
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diagnostic interview or self-report depressive symptom inventory), and studied 
populations (general population or patient population). The prevalence of lifetime 
depression (defined as depression at any point along individuals‟ lifetime) in general 
population ranges from 15.7% to 16.2%. Kessler et al. (2003) examined nationally 
representative data on household residents aged 18 years or older available from 
National Comorbidity Survey Replication (NCS-R) and found the prevalence of 
lifetime MDD measured by the WHO Composite International Diagnostic Interview 
(CIDI) was 16.2% and the prevalence of 12-month MDD measured by the CIDI was 
6.6%. In a recent study by Strine et al. (2008), the authors analyzed data on 217,379 
participants in 38 states, the District of Columbia, Puerto Rico, and the U.S. Virgin 
Islands from the 2006 Behavioral Risk Factor Surveillance Survey (BRFSS) and 
reported that the overall prevalence of current depressive symptoms, when measured 
by the eight-item Patient Health Questionnaire [PHQ-8] and defined as PHQ-8 ≥ 10, 
was 8.7% (ranges from 5.3% [Alaska] - 13.7% [West Virginia], by state and territory). 
These authors also found that the prevalence of a lifetime diagnosis of depression, 
when measured by a question “Has a doctor ever told you that you have a depressive 
disorder (including depression, major depression, dysthymia, or minor depression)?”, 
was 15.7% (ranges from 6.8 % [the U.S. Virgin Islands] - 21.3 % [Oregon], by state 
and territory). The prevalence rate of depression measured by the PHQ-9 was 7% 
among adults aged 20 and above (Pratt & Brody, 2010). A higher rate of depression 
was reported among special patient populations, such as Asian women with breast 
 39 
cancer (26%) (Chen et al., 2009), those with type 1 diabetes (32.1%) 
(Gendelman et al., 2009), and individuals with type 2 diabetes (56%) (Kahn et al., 
2008). 
Prevalence of depression across age. The prevalence of depression varies across 
the adult life-span and has been found to be higher among young adults and decrease 
as people age. For example, one study reported that the prevalence rate of a diagnosed 
current DSM-IV mental disorder was about 23.8% among young adults aged 20 - 24 
years in Finland (Aalto-Setala, Marttunen, Tuulio-Henriksson, Poikolainen, & 
Lonnqvist, 2001). Moreover, depressive disorders were the most prevalent among all 
other mental disorders with an overall rate of 10.8% (7.4% in males and 12.7% in 
females). Similarly , Gwynn et al. (2008) evaluated the 12-month prevalence of MDD 
among a representative sample of 1,817 community-based New York City adults. 
MDD was diagnosed by the WHO‟s CIDI. They found that the overall 12-month 
prevalence of MDD was 8%. Adults aged 20 - 39 years had highest prevalence of 
MDD (9%) in this study, compared to adults aged 40 - 59 years (7%) or those aged 60 
years and above (5%). This age-related decrease in prevalence of depression may be 
explained by decreased emotional responsiveness, increased emotional control, and 
developed resistance to repeatedly exposed adverse or stressful life events as people 
are getting older (Jorm, 2000). In comparison, the overall 12-month prevalence of 
MDD was 6.7% among U.S. adults aged 18 or above (Kessler, Chiu, Demler, 
Merikangas, & Walters, 2005). MDD was measured by WHO World Mental Health 
(WMH) Survey version of the CIDI (WMH-CIDI) in this study. In contrast, a higher 
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prevalence rate (11.19%) of any type of depression was reported among 851 
Americans aged 71 years or older (Steffens, Fisher, Langa, Potter, & Plassman, 2009) 
Depression was measured by the CIDI short form.  
Prevalence of depression across gender. Females have a higher prevalence rate of 
depression than males. This might be explained by gender differences in genetic 
predisposition, hormonal, and responses to adverse life events (CDC, 2010b). In the 
community-based study of New York adults (Gwynn, et al., 2008), the prevalence of 
depression among females was 9%, which was significantly higher than the rate of 
depression in men (6%). McGuire et al. (2008) estimated the prevalence of depression 
in 14,425 older U.S. women aged 65 and older, using data from 2006 Behavioral Risk 
Factor Surveillance Survey (BRFSS). The reported prevalence of current depression 
and lifetime diagnosis of depression was 5.9% and 12.3% respectively. In contrast, no 
significant differences in prevalence rate of depression were found between American 
men (10.2%) and women (11.4%) aged 71 and above (Steffens, et al., 2009). 
Prevalence of depression across race/ethnicity. The prevalence of depression 
varies across race/ethnicity, as do the relative differences between groups. Some 
studies found that racial/ethnic minorities had significantly higher rates of depression 
than Whites, some studies reported Whites had higher rate of depression, while others 
reported no racial/ethnic differences in depression rates. Among community-based 
New York adults aged 20 years and older, black Americans were found to have the 
highest prevalence of MDD (9%), followed by Whites (8%), Hispanics (7%) and 
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Asian (5%) (Gwynn, et al., 2008). Similarly, McKnight-Eily et al. (2009) 
reported a much higher prevalence of current depressive symptoms (13.8%) and 
lifetime diagnosis of a depressive disorder (14.9%) among African American women 
aged 18 to 64 years. In contrast, among a group of Americans aged 71 year or older, 
non-Hispanic White American (11.7%) and Hispanics (12.5%) were reported to have 
the highest prevalence rate of depression, followed by African Americans (4.1%) 
(Steffens, et al., 2009). In a recent meta-analysis by Mendelson et al. (2008), the 
authors compared the prevalence of MDD and depressive symptoms among Latinos 
with non-Latino Whites in the U.S. and found Latinos reported more depressive 
symptoms than non-Latino Whites, but findings were not clinically significant. No 
significant group differences in the lifetime prevalence of MDD were found between 
Latinos and non-Latino Whites. A higher prevalence rates of depressive disorders 
(16.2%) and MDD (9.2%) were found among 513 Chinese patients aged 18 years or 
above hospitalized in general hospitals (Zhong et al., 2010).  
The Relationship between Depression and Insulin Resistance 
Research has established a positive association between depression and type 2 
diabetes (Musselman, Betan, Larsen, & Phillips, 2003) that is more commonly found 
among women than men (Ali, et al., 2006). A meta-analysis reported that adults with 
depression (either clinical diagnosed depression or depressive symptoms) had a 37% 
increased risk of developing type 2 diabetes (Knol, et al., 2006) and the prevalence of 
depression was twice as high among adults with type 2 diabetes than those without 
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diabetes (Anderson, Freedland, Clouse, & Lustman, 2001). However, the 
relationship between depression and insulin resistance is not clear as studies that have 
examined this association report conflicting results (Adriaanse et al., 2006; Lawlor et 
al., 2005; Lawlor, Smith, & Ebrahim, 2003; Pan et al., 2008; Pearson et al., 2010; 
Roos et al., 2007; Timonen et al., 2005; Timonen et al., 2006; Timonen et al., 2007). 
Table 1 provides an overview of these studies, including study subjects, instruments 
used for depression and insulin resistance, covariates, and significant findings.  
A Positive Association 
A positive relationship between depressive symptoms and insulin resistance was 
found in several cross-sectional population-based studies (Adriaanse, et al., 2006; Pan, 
et al., 2008; Pearson, et al., 2010; Timonen, et al., 2005; Timonen, et al., 2006; 
Timonen, et al., 2007). Three of the studies focused on young adults (Pearson, et al., 
2010; Timonen, et al., 2006; Timonen, et al., 2007); while the other three investigated 
the association among middle- or older-aged adults (Adriaanse, et al., 2006; Pan, et 
al., 2008; Timonen, et al., 2005).  
Timonen et al. (2006) studied a birth cohort of 2,069 Finnish young men who 
were born between January 1
st
 and December 31
st
, 1966 and aged 31 years old at the 
time data were collected. They found that the means of the QUICKI values 
(Qualitative Insulin Sensitivity Check Index, QUICKI), a measure of insulin 
sensitivity, decreased with the increased severity of depressive symptoms measured  
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by Hopkins‟ Symptom Checklist-25 (HSCL-25). Furthermore, they reported 
that insulin resistance was positively associated with severe depressive symptoms 
(adjusted OR = 2.18, 95% CI = [1.19, 4.00]) in logistic regression analysis, when 
insulin resistance was defined as the lowest quartile (25%) of QUICKI values. The 
OR increased to 3.15 with a 95% CI of 1.48-6.68 when a tighter definition of insulin 
resistance was used (i.e., the lowest decile [10%] of QUICKI values). Participants in 
this study lived in northern Finland and other factors such as low exposure to sunlight 
must be considered when interpreting the study results. 
In a second study, Timonen et al. (2007) investigated the association between 
insulin resistance and depressive symptoms among 1,054 healthy Finnish male 
military conscripts aged 18-28 years. In this study, insulin resistance was measured by 
the HOMA-IR and defined as the highest decile (10%) of the HOMA-IR values. 
Depressive symptoms were assessed using the modified 13-item Beck Depression 
Inventory (R-BDI). Moderate-to-severe depressive symptoms were defined as a 
R-BDI score ≥ 8 and mild depressive symptoms were defined as a R-BDI score 
between 5 to 7. The researchers found that moderate-to-severe but not mild 
depressive symptoms was significantly associated with insulin resistance (OR = 2.8, 
95% CI = [1.2, 6.5]). However, stress associated with being newly recruited into 
military service might have contributed to depression among these young adults.  
In a more recent study, the relationship between depression and insulin resistance 
was examined among 1,732 Australian adults aged 26 to 36 years (Pearson, et al., 
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2010). Gender differences in the relationship also were investigated. The study 
sample was derived from a nationally representative sample of 8,498 children 
surveyed in 1985. This study used the CIDI to evaluate depression over the previous 
12 months. Depression was defined as those participants who had mild, moderate, or 
severe depressive disorder. Insulin resistance was measured by the HOMA-IR. The 
HOMA-IR scores were logarithmically transformed and used as a continuous variable 
in the analyses. Ratio of means, defined as the mean HOMA-IR score of participants 
with depression relative to that of those without depression, were reported in linear 
regression analysis. The authors found that the mean of insulin resistance was 
significantly higher among men (17.2%, p = .04) and women (11.4%, p = .02) with 
depressive disorder than those without in the unadjusted model. However, the positive 
relationship between depression and insulin resistance became insignificant, after 
adjusting for age, education, physical activity, smoking, alcohol, and use of 
antidepressants in men (p = .12) and after adjusting for age, education, polycystic 
ovary syndrome, fish consumption, and use of antidepressants among women (p 
= .25). Study findings also suggested that waist circumference was a mediator in the 
relationship between depression and insulin resistance. Clinical significance of the 
log-transformed HOMA-IR score is difficult to interpret. In this study, a significantly 
higher ratio of mean log-transformed HOMA-IR did not necessarily indicate the 
presence of insulin resistance. Moreover, the low response rate (1,732 of 8,498 or 
20%) of the study sample may impose non-response bias to the results of this study. 
In addition, the authors did not clearly specify if the two-stage unequal probability 
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sampling design was accounted for in the statistical analyses to produce 
reliable estimates.  
Studies that found a positive relationship between depression and insulin 
resistance in middle- or older-age adults included the study by Timonen et al. (2005) 
who examined 491 Finnish adults aged 61-63 years. In this study, insulin resistance 
was measured by the QUICKI and depressive symptoms were evaluated by Beck‟s 
depression inventory 21. Pan et al. (2008) examined the association among 3,285 
Chinese aged 50-70 years, using data from the Nutrition and Health of Aging 
Population in China Study. Depressive symptoms were assessed by the Center for 
Epidemiological Studies of Depression scale (CES-D) with a cut point of 16. Insulin 
resistance was calculated using the updated HOMA-IR (HOMA2-IR) and defined as 
the highest quartile of HOMA2-IR. The findings showed that participants with 
depressive symptoms had significantly higher HOMA2-IR than those without 
depressive symptoms and were 50% more likely to be insulin resistant (OR = 1.54, 
95% CI = [1.17-2.04]. Addriaanse et al. (2006) examined the relationship between 
depression and insulin resistance in 541 Dutch men and women aged 55-75 years 
with various glucose tolerance states (260 had normal glucose tolerance [NGT], 164 
had impaired glucose tolerance [IGT], and 117 had established type 2 diabetes). 
Depression was assessed by CES-D and insulin resistance was measured by 
HOMA-IR. Both CES-D and HOMA-IR scores were analyzed as continuous 
variables. A significant but weak overall correlation between depression and insulin 
resistance was found (r = .156, p < .001); however, the correlations were attenuated 
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and even became insignificant when subjects were stratified by glucose 
tolerance status (NGT: r = .041, p = .509, IGT: r = .112, p = .160, and type 2 diabetes: 
r = .007, p = .942). The relationship between depression and insulin resistance did not 
differ between men and women (men - NGT: r = .033, p = .712, IGT: r = .072, p 
= .517, and type 2 diabetes: r = -.019, p = .891; women - NGT: r = .063, p = .478, 
IGT: r = .101, p = .389, and type 2 diabetes: r = -.016, p = .901).  
A Negative Association 
Contradictory to the previous discussed studies, depression was found to be 
negatively associated with insulin resistance in one cross-sectional study conducted 
among a randomly selected sample of 4,286 British women aged 60-79 years (Lawlor, 
et al., 2003). In this study, depression was assessed via three methods: use of 
antidepressant medications, self-report of having a clinical diagnosis of depression, 
and the EQ5D mood question of the EuroQOL. Insulin resistance was calculated by 
HOMA-IR. Participants without diabetes were categorized into four groups by 
HOMA-IR quartiles (lowest 25%, 25-50%, 50-75%, and highest 25% of HOMA-IR). 
Participants with diabetes composed the fifth group. Logistic regression analysis of 
the relationship between insulin resistance categories as the independent variable and 
depression as the dependent variable showed that the prevalence of depression 
decreased linearly as insulin resistance increased among nondiabetic women, but 
increased in women with diabetes. For every increase in the HOMA-IR categories 
among nondiabetic women, the risk of being depression decreased (current 
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antidepressant use: OR = 0.86, 95% CI = [0.76 - 0.96]; ever being diagnosed 
with depression: OR = 0.84, 95% CI = [0.74 - 0.97]; reporting feeling depressed: OR 
= 0.89, 95% CI = [0.79 - 0.99]). The findings of this study indicated a potential 
protective effect of insulin resistance on depression, but as the authors noted that the 
results were novel and need further investigation.  
No Association 
Two studies have reported no significant association between depression and 
insulin resistance. In a prospective 4-phase cohort study (phase I: 1979-1983; phase II: 
1984-1988; phase III: 1989-1993; Phase IV: 1993-1997), Lawlor et al. (2005) found 
no significant association between depression and insulin resistance among Wales 
men aged 45-59 years. Insulin resistance was measured by HOMA-IR and depression 
was evaluated by General Health Questionnaire (GHQ) in this study.   
Similarly, Roos et al. (2007) found no association between insulin resistance and 
depressive symptoms in a retrospective study among 1,047 Swedish women with risk 
factors for diabetes aged 50- 64 years old. Insulin resistance was measured by 
HOMA-IR. Depressive symptoms were examined by items retrieved from the 
Gothenburg Quality of Life instrument which posed a threat to the internal validity of 
the study because the validity and reliability of the measure for depressive symptom 
had not been appropriately evaluated.    
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Summary of Previous Studies 
All of the above studies were correlational studies; therefore, no causation 
between depression and insulin resistance was established. Of the nine previous 
studies, six were limited to middle and older-aged adults, and often failed to examine 
the effect of gender on the relationship between depression and insulin resistance. 
Moreover, all were conducted in Europe, Australia, or Asia. None of these previous 
studies have investigated the role of race/ethnicity in the relationship. Few examined 
the role of gender in this relationship in young adults. In addition, measures of 
depression and insulin resistance varied across the studies. Depression was primarily 
measured by self-report depression questionnaires or inventory, such as use of 
antidepressant medicine, self-report of being diagnosed with depression, and response 
to EuroQOL mood questions (Lawlor, et al., 2003), with the Beck‟s depression 
inventory (Timonen, et al., 2005; Timonen, et al., 2007), with the CES-D (Adriaanse, 
et al., 2006; Pan, et al., 2008), with the 30-item GHQ (Lawlor, et al., 2005), with 
Hopkins Symptom Checklist (Timonen, et al., 2006), or with self-rated symptoms of 
depression from the Gothenburg Quality of Life Instrument (Roos, et al., 2007). 
There was only one study that used the CIDI to make a clinical diagnosis of 
depression (Pearson, et al., 2010).  
Compared to the wide range use of depression measures, methods used to 
estimate insulin resistance in these previous studies were limited to two. Insulin 
resistance was most often measured by the HOMA-IR (Adriaanse, et al., 2006; 
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Lawlor, et al., 2003; Pan, et al., 2008; Pearson, et al., 2010; Roos, et al., 2007; 
Timonen, et al., 2007), on occasion, QUICKI was used (Adriaanse, et al., 2006; 
Timonen, et al., 2005; Timonen, et al., 2006). However, two of the studies included 
subjects with type 2 diabetes in their analyses (Adriaanse, et al., 2006; Pan, et al., 
2008) confounding the generalizability of study results to the non-diabetic population.  
Pathophysiological Link between Depression and Insulin Resistance 
 Although the underlying mechanism is still unclear, several pathophysiological 
pathways have been proposed to explain the relationship between depression and 
insulin resistance, including hypothalamus-pituitary-adrenal (HPA) hyperactivity, 
increased immunoinflammatory cytokines and lifestyle risk behaviors. 
Hypothalamus-pituitary-adrenal Hyperactivity 
Evidence suggests that 40-60 % of patients with major depression had HPA 
hyperactivity that is followed by increased release of corticotrophin-releasing 
hormone, adrenocorticotropic hormone and cortisol. Excess cortisol and its disruption 
of glucoregulatory mechanisms can lead to insulin resistance, impaired glucose 
tolerance, and promote visceral fat deposition (Brown, Varghese, & McEwen, 2004; 
Musselman, et al., 2003; Ramasubbu, 2002). This was supported by Weber-Hamann, 
Gilles, Lederbogen, Heuser, and Deuschle (2005) in a study that examined 70 patients 
with moderate depression. They found significant differences in oral glucose 
tolerance test (OGTT) values across morning saliva cortisol levels (low: cortisol < 15 
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mmol/l; moderate: cortisol < 25 mmol/l; high: < 35 mmol/l; and very high: > 
35 mmol/l) and a significant negative association between the insulin sensitivity 
index (ISI, a measure of insulin receptor sensitivity) and HPA system activity. The 
HPA activity was measured by the mean of morning saliva cortisol concentrations 
collected for 6 days under drug-free conditions.  
Lending further support to this hypothesis, research has found that antidepressant 
medications can alter the activity of the HPA and improve insulin sensitivity. 
Amitriptyline, a tricyclic antidepressant (TCA), was found to decrease the HPA 
activity; while paroxetine, a selective serotonin reuptake inhibitor (SSRI), does not 
have the effect on the HPA activity (Deuschle et al., 2003). The effect of amitriptyline 
and paroxetine on the HPA activity and insulin sensitivity was further examined 
among 80 nondiabetic participants with an episode of MDD in a double-blinded 
randomized trial (Weber-Hamann, Gilles, Lederbogen, Heuser, & Deuschle, 2006). 
Depression was measured by Hamilton Rating Scale for Depression (HAM-D) and all 
80 participants in the study had a HAM-D score ≥ 18. The effectiveness of 
antidepressant treatment (amitriptyline vs paroxetine) was assessed by the change in 
HAM-D scores. Response to antidepressant treatment was defined as a decrease in 
HAM-D score of at least 50% during the active treatment phase. Remission was 
defined as a final HAM-D score of < 7. The study found a significant increase of 
insulin sensitivity among participants who were treated with either amitriptyline or 
paraxetine and had the HAM-D score of < 7. In contrast, there was no significant 
change in insulin sensitivity for participants who were treated with amitriptyline and 
 54 
responded to the antidepressant treatment (a drop of 50% HMA-D score), even 
though saliva cortisol concentrations had reduced. Interestingly, insulin sensitivity 
improved among participants who were treated and remitted with paraxetine, 
although no changes were observed in HPA activity. The authors commented that the 
results of the study do not exclude the HPA system as a major contributor to insulin 
resistance in depressed patients, but underscore the assumption of additional factors.  
Increased in Immunoinflammatory Cytokines 
Depression is associated with increased release of immunoinflammatory 
cytokines (CRP, interleukin [IL-1], IL-6, and tumor necrosis factor-α [TNF-α]). 
Central obesity probably is the link between depression and increased inflammatory 
cytokines. A recent meta-analysis by Howren et al. (2009) confirmed that CRP, IL-6, 
and IL-1 were positively associated with depression, although the strength of the 
relationships varied between populations (clinical-based v.s. community-based 
samples) and methods for depression assessment (clinical interview v.s. self-report 
measure of depressive symptoms). TNF-α is a cytokine that is primarily secreted by 
macrophages and regulates many biological processes such as cell proliferation, 
differentiation, apoptosis, lipid metabolism, and coagulation. A review by Borst (2004) 
found accumulating evidence to support TNF-α‟s role in the development of insulin 
resistance by impairing insulin signaling pathways. IL-6 is a protein that is mainly 
produced when there is acute or chronic inflammation. It exerts its functions in 
various inflammation associated disease states, such as insulin resistance, diabetes, 
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and systemic juvenile rheumatoid arthritis. Depression was found to be a 
significant predictor for IL-6 in a 6-year prospective cohort study (Stewart, Rand, 
Muldoon, & Kamarck, 2009). Elevated CRP was positively associated with 
depression among men. In contrast, the relationship between CRP and depression 
among women was not as strong as that in men (Danner, Kasl, Abramson, & 
Vaccarino, 2003; Elovainio et al., 2009; Liukkonen et al., 2006). Inflammation is one 
of the possible mechanisms through which depression exerts its effect on insulin 
resistance.  
The relationship between depression and insulin resistance may not be 
unidirectional. Insulin resistance also could play a role in the pathogenesis of 
depression, especially in combination with central obesity. The elevation of 
immunoinflammatory cytokines associated with insulin resistance can stimulate the 
noradrenergic stress system. Consequently, the dysregulation of HPA axis and 
diminished serotonergic activity in the central nervous system could lead to 
depression (Dunbar et al., 2008; Koponen, Jokelainen, Keinanen-Kiukaanniemi, 
Kumpusalo, & Vanhala, 2008). 
Depression in turn can lead to loss of interest in their usual activities or changes 
in appetite that is usually associated with overeating. Excessive consumption of food 
rich in carbohydrate and fat among depressed patients can promote development of 
obesity and release of various adipokines secreted from adipose tissue. Reduced 
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energy utilization associated with physical inactivity can in turn decrease 
insulin sensitivity of skeletal muscle. 
Conclusion 
 The relationship between depression and insulin resistance is not clear as studies 
that have examined their association reported conflicting results. Moreover, the 
pathophysiological pathway to explain this relationship is not well established. 
Nevertheless, depression has been implicated as a risk factor for insulin resistance. 
Therefore, the relationship between depression and insulin resistance warrants further 
investigation, especially among young adults in the U.S. by gender and racial/ethnic 
distribution.  
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CHAPTER III METHODOLOGY 
 The purpose of the study was to examine the relationship between major 
depression and insulin resistance among U.S. nondiabetic adults aged 20-39 years old. 
Review of the literature revealed the gap in knowledge regarding the relationship 
between major depression and insulin resistance among young adults and by gender 
and race/ethnicity in the U.S. population. The information is important as early 
intervention to ameliorate this risk factor for insulin resistance may help prevent or 
delay the progression of insulin resistance to type 2 diabetes. In Chapter III, the 
research design is presented followed by an overview of the National Health and 
Nutrition Examination Survey (NHANES), including its history, content, design, 
operations, and quality control methods. The sampling frame, study population and 
sample were discussed. Procedures for dataset derivation and the data collection 
methods for the main variables are delineated. Protection of human subject is 
addressed. Finally, pilot work for the study and proposed statistical analyses are 
described. 
Research Design 
 The study used a cross-sectional, correlational study design to examine the 
relationship between major depression and insulin resistance. A cross-sectional, 
correlational design is appropriate for this study because the purpose of the study is to 
describe the relationship between major depression and insulin resistance at a fixed 
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point in time (Polit & Beck, 2004). A correlational design provides a 
cost-effective way to observe the relationship between major depression and insulin 
resistance in a natural setting. The design also is suitable for this study as 
manipulation of some variables, for example, age, gender, or race/ethnicity, was 
impossible. A limitation to the design is lack of control over study variables. 
Therefore, this study does not identify a causal relationship between major depression 
and insulin resistance. 
Secondary analyses of existing data were performed for the study. Secondary 
analysis is a research method in which data collected in a previous study are used to 
test new hypotheses or are reanalyzed to answer new research questions. To perform a 
secondary analysis, the researcher must identify and gain access to the appropriate 
database, and thoroughly evaluate the quality of available dataset and its suitability to 
address the research questions (i.e., if variables of interest are included). Use of 
existing data is time- and cost- efficient and also provides opportunities to maximize 
use of the data (Polit & Beck, 2004). Data from the NHANES were determined to be 
appropriate to address the research questions because the NHANES includes 
variables of interest for this study.  
Overview of the NHANES 
History. The NHANES is a major program of the National Center for Health 
Statistics (NCHS), which is part of Centers for Disease Control and Prevention 
(CDC). The NHANES program was designed to evaluate the health and nutritional 
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status of civilian, non-institutionalized adults and children in the U.S. Starting 
in the early 1960s, the NHANES program conducted a series of surveys focusing on 
different population groups or health topics, including the National Health 
Examination Survey, Cycle I (NHES I) 1959-1962, NHES II 1963-1965, NHES III 
1966-1970, the Hispanic Health and Nutrition Examination Survey (HHANES), the 
First National Health and Nutrition Examination Survey (NHANES I), the Second 
National Health and Nutrition Examination Survey (NHANES II), and the Third 
National Health and Nutrition Examination Survey (NHANES III). Beginning in 
1999, the NHANES changed from a periodic survey to an ongoing annual 
cross-sectional survey. These NHANES focus on a variety of health and nutrition 
measurements among a nationally representative sample of the U.S. population. 
NHANES data are released on public use data files in two-year increments (i.e., 
NHANES 1999-2000, NHANES 2001-2002, or NHANES 2003-2004 etc.) and 
publicly available through the CDC website (CDC/NCHS, 2009b).   
Survey content. Specific purposes of NHANES have been to: 1) estimate the 
prevalence of diagnosed and undiagnosed chronic conditions in the U.S. population; 2) 
examine the risk factors or behaviors that may increase the chances of developing a 
certain disease; and 3) collect information on certain aspects of reproductive health, 
such as use of oral contraceptives and breastfeeding practice. The full list of the 
diseases, medical conditions, and health indicators collected in NHANES include: 
anemia, cardiovascular disease, diabetes, environmental exposure, eye diseases, 
hearing loss, infectious disease, kidney disease, nutrition, obesity, oral health, 
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osteoporosis, physical fitness and physical functioning, reproductive history 
and sexual behavior, respiratory disease (asthma, chronic bronchitis, emphysema), 
sexually transmitted diseases, vision, and mental diseases (i.e., depression, 
generalized anxiety disorder, and panic disorder). 
Survey design. The NHANES uses a complex, stratified, multistage 
probability-based design to obtain a nationally representative sample of the 
non-institutionalized civilian U.S. population. Persons living in nursing homes, 
institutionalized persons, members of the armed forces, and U.S. nationals living 
abroad are not included in the sample. The NHANES sampling procedure is 
accomplished in four stages, which is illustrated in Figure 2 (CDC/NCHS, 1999d). 
The first stage of sampling involves the selection of primary sampling units (PSUs) 
that are usually single counties. In some special cases, small contiguous counties are 
combined to meet a minimum population size. The selection of PSUs is based on 
probability proportional to population size; in other words, the larger the population 
within a PSU, the higher probability of selection for the PSU than other PSUs. PSUs 
are selected from strata, which are defined by geography and proportions of minority 
populations. The second stage of sampling is selection of segments within PSUs that 
are usually a block or group of blocks containing a cluster of households. Same as 
each PSU, sample segments are selected with probability proportional to a measure of 
size. The third stage of sampling is to randomly select households within each 
selected segment. However, in some geographic areas where the proportion of age, 
ethnic, or income groups selected for oversampling (discussed in detail in the 
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Figure 2. Four Stages of NHANES Sampling Procedure. 
(Source: CDC (1999). Four stage of NHANES sampling procedure. Retrieved from: 
http://www.cdc.gov/nchs/tutorials/Nhanes/SurveyDesign/SampleDesign/Info1.htm) 
 
following paragraph) is high, then the probability of selection for those groups is 
greater than in other areas. The fourth stage of sampling includes the selection of one 
or more persons within a selected household to participate in the NHANES home 
interview and health examination. Selected households are first contacted by an 
advance letter followed by an NHANES interviewer. Each person in a selected 
household is screened for demographic characteristics (age, gender, and race/ethnicity) 
using a Household Screener Questionnaire to determine if they are eligible to 
participate in the NHANES home interview and health examination. In some cases, a 
fifth stage of sampling occurs. In the fifth stage of sampling, additional data such as 
mental health examination in NHANES 1999-2004 or morning fasting blood lab 
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work at the MEC are collected on a subsample of those that participated in the 
NHANES health examination. Participants in the subsample are selected randomly 
from those that were examined with a specified sampling fraction (i.e., 1/2 or 1/3 of 
the total examined participants). Because of the complex sampling procedure, it is 
highly unlikely that the same individual is selected to participate in more than one 
NHANES survey.  
Variations to the survey design. In NHANES 1999-2006, persons aged 60 years 
and older, adolescents aged 12-19 years, low-income persons, African Americans, and 
Mexican Americans were over-sampled to enhance the reliability and precision of 
estimates of health status indicator for these groups. The selection of subgroups for 
oversampling depended on public health trends and concerns. Beginning in 2007, 
there were several changes in the oversampling methods. These changes included: 1) 
the oversampling of Mexican Americans was extended to the entire Hispanic 
population; 2) the 12-15 and 16-19 year old age groups were combined to one; 3) the 
40-59 year old age group in minority was sub-divided into 40-49 year old and 50-59 
year old age groups; and 4) oversampling of pregnant women was discontinued to 
allow oversampling of the Hispanic population (CDC/NCHS, 2009c). The NHANES 
produced sample weights based on the stratification and clustering of the survey 
design that must be used in all analyses to obtain unbiased population estimates and 
the standard errors of estimates (CDC/NCHS, 2006a). Sample weights are discussed 
in detail in the section of Statistical Analyses.  
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During the years 1999-2001, the sampling frame in the first stage of 
selection was based on a design linked to the 1995 National Health Interview Survey 
(NHIS). The PSUs of NHANES 1999-2001 were a subset of the PSUs previously 
selected for the NHIS. An independent set of PSU‟s was selected for NHANES 
2002-2008 and the sampling frame for this design included all counties in the U.S. In 
NHANES 1999, 12 PSUs were visited. Beginning with NHANES 2000, 15 PSUs 
were visited each year.  
Survey operations. The NHANES survey includes a home interview and a health 
examination that involves a physical examination and laboratory tests. Eligible 
persons in the screened sample are contacted and invited to participate in the health 
interview which is conducted in the respondents‟ homes. Data on demographic, 
socioeconomic, dietary, and health-related questions are collected by highly trained 
interviewers. At the conclusion of the interview, all interviewed persons are asked to 
participate in the health examination. When persons agree to participate in the health 
examination, the interviewers call the NHANES field office from participants‟ home 
to establish an appointment for the examination.  
The health examinations are performed in specially-designed and equipped 
mobile examination centers (MEC, see Appendix A). The MEC is divided into rooms 
to assure the privacy of participants during the examination. The study team at the 
MEC consisted of a physician, a phlebotomist, medical and health technicians, as 
well as highly trained interviewers. There are two examination sessions a day, 
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including morning and afternoon or morning and evening sessions. Persons are 
randomly selected to participate in either the morning or afternoon or evening 
sessions, which is pre-determined by their household ID labels. Components of health 
examinations are determined by participants‟ age, gender, and current medical 
conditions. Various biological and environmental specimens are collected in the MEC. 
Specifically, blood is drawn on participants aged 1 year and above and urine is 
collected from individuals who are 6 years and older. Additional survey 
questionnaires are conducted in the MEC, including a dietary questionnaire, and 
questionnaires on selected special topics.  
All of the NHANES data are collected and processed by an advanced computer 
system using high-end servers, desktop PCs, and wide-area networking. This system 
allows interviewers to use notebook computers with electronic pens. Data collected at 
the MEC are automatically transmitted into databases through devices as digital 
scales and stadiometers. Touch-sensitive computer screens are used for certain 
sensitive questions entered by respondents themselves, insuring complete privacy. 
Specimens of blood, urine, oral rinse and vaginal swabs collected in the MEC are 
processed, stored, and shipped to different laboratories (federal, private, or 
university-based) under contract to NCHS for various laboratory analyses.  
 Quality control. The NHANES program uses multiple measures to ensure the 
high quality of data and minimize non-sampling and measurement errors. For 
example, extensive protocols are developed and reviewed by the public health and 
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scientific community prior to data collection. All NHANES field staffs 
participate in comprehensive training and annual refresher training for interviewers 
and MEC staff prior to and during data collection. In addition, a variety of quality 
control techniques are used during the field period to assure the quality of the 
interviews such as field observations, field editing, field office review of cases for 
errors and discrepancies, and validation. Extensive quality control procedures are 
applied when processing data. The detailed information on the NHANES can be 
found elsewhere (CDC/NCHS, 2009a). 
Population and Sample 
 For this study, data obtained during NHANES 1999-2000, NHANES 2001-2002, 
NHANES 2003-2004, NHANES 2005-2006, and NHANES 2007-2008 (CDC, 
1999-2008) were combined to achieve a sample size sufficient for the planned 
statistical analyses based on the author‟s preliminary work (Shen, Bergquist-Beringer, 
& Sousa, 2011) that is discussed later.  
Population  
The target population for the current study was nondiabetic U.S. adults aged 
20-39 years. The accessible population was nondiabetic U.S. adults aged 20-39 years 
who participated in NHANES 1999-2008. The choice of U.S. adults aged 20-39 years 
was made because few studies were found that investigated the relationship between 
depression and insulin resistance among this age group as identified in Chapter II of 
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this dissertation. In addition, studies have shown that persons aged 20-39 years 
have high likelihood of having depression (Jorm, 2000). Moreover, depression, one of 
the main variables for the current study, was measured on NHANES participants aged 
20-39 years from 1999-2008.  
The NCHS reported the total number of subjects who were screened and selected 
to participate in NHANES and the number of subjects who were actually interviewed 
and examined in the MEC by age for each two-year survey cycle (CDC/NCHS, 
1999-2008). As shown in Table 2, for NHANES 1999-2000, there were 12,160 
persons selected for the sample. Of these, 9,965 were interviewed (unadjusted 
response rate: 81.9%) and 9,282 (76.3%) were examined in the MEC. For NHANES 
2001-2002, there were 13,156 persons selected for the sample. Of these, 11,039 were 
interviewed (83.9%) and 10,477 (79.6%) were examined in the MEC. For NHANES 
2003-2004, there were 12,761 persons selected for the sample. Of these, 10,122 were 
interviewed (79.3%) and 9,643 (75.6%) were examined in the MEC. For NHANES 
2005-2006, there were 12,862 persons selected for the sample. Of these, 10,348 were 
interviewed (80.5 %) and 9,950 (77.4 %) were examined in the MEC. For NHANES 
2007-2008, there were 12,943 persons selected for the sample. Of these, 10,149 were 
interviewed (78.4 %) and 9,762 (75.4 %) were examined in the MEC. In total, 63,882 
persons were selected to participate in NHANES during 1999-2008. Of these, 51,623 
were interviewed (80.8%) and 49,130 were examined in the MEC (76.9%). Among 
adults aged 20-39 years, a total of 11,617 adults were selected to participate in  
 67 
 
T
ab
le
 2
 
U
n
w
ei
g
h
te
d
 R
es
p
o
n
se
 R
a
te
 f
o
r 
N
a
ti
o
n
a
l 
H
ea
lt
h
 a
n
d
 N
u
tr
it
io
n
 E
xa
m
in
a
ti
o
n
 S
u
rv
ey
 (
N
H
A
N
E
S
) 
1
9
9
9
-2
0
0
8
 
 
Y
ea
r 
pe
ri
o
d
 
S
cr
ee
n
ed
 s
am
p
le
 a
  
In
te
rv
ie
w
ed
 s
am
p
le
 b
 
E
x
am
in
ed
 s
am
p
le
 c
 
C
o
n
tr
o
l 
to
ta
l 
d
 
S
am
p
le
 s
iz
e 
U
n
w
ei
g
h
te
d
 
sa
m
p
le
 s
iz
e 
U
n
w
ei
g
h
te
d
 
re
sp
o
n
se
 r
at
e 
 
(%
) 
e 
U
n
w
ei
g
h
te
d
 
sa
m
p
le
 s
iz
e 
U
n
w
ei
g
h
te
d
 
re
sp
o
n
se
 r
at
e 
(%
) 
f 
1
9
9
9
-2
0
0
0
 
  
 A
ll
 a
g
es
 
  
 2
0
-3
9
 y
ea
rs
 
 
 2
7
2
,1
5
6
,8
3
3
 
8
2
,7
9
9
,7
7
9
 
 1
2
,1
6
0
 
2
1
2
7
 
 9
9
6
5
 
1
6
9
5
 
 8
1
.9
 
7
9
.7
 
 9
2
9
8
 
1
5
6
9
 
 7
6
.3
 
7
3
.8
 
2
0
0
1
-2
0
0
2
 
A
ll
 a
g
es
 
2
0
-3
9
 y
ea
rs
 
 
 2
7
9
,9
7
2
,7
8
6
 
8
0
,7
8
7
,8
3
9
 
 1
3
,1
5
6
 
2
3
5
3
 
 1
1
,0
3
9
 
1
9
2
5
 
 8
3
.9
 
8
1
.8
 
 1
0
,4
7
7
 
1
8
4
3
 
 7
9
.6
 
7
8
.3
 
2
0
0
3
-2
0
0
4
 
  
 A
ll
 a
g
es
 
  
 2
0
-3
9
 y
ea
rs
 
 
 2
8
6
,2
2
2
,7
5
7
 
7
9
,3
9
2
,8
4
1
 
 1
2
,7
6
1
 
2
2
5
0
 
 1
0
,1
2
2
 
1
7
4
2
 
 7
9
.3
 
7
7
.4
 
 9
6
4
3
 
1
6
5
6
 
 7
5
.6
 
7
3
.6
 
2
0
0
5
-2
0
0
6
 
  
 A
ll
 a
g
es
 
  
 2
0
-3
9
 y
ea
rs
 
 
 2
9
1
,6
1
6
,8
9
2
 
7
9
,8
5
7
,2
1
2
 
 1
2
,8
6
2
 
2
4
3
6
 
 1
0
,3
4
8
 
1
9
2
3
 
 8
0
.5
 
7
8
.9
 
 9
9
5
0
 
1
8
3
9
 
 7
7
.4
 
7
5
.5
 
2
0
0
7
-2
0
0
8
 
  
 A
ll
 a
g
es
 
  
 2
0
-3
9
 y
ea
rs
 
 
 2
9
7
,1
3
6
,0
9
5
 
8
0
,7
3
7
,5
2
6
 
 1
2
,9
4
3
 
2
4
5
1
 
 1
0
,1
4
9
 
1
9
1
0
 
 7
8
.4
 
7
7
.9
 
 9
,7
6
2
 
1
8
4
4
 
 7
5
.4
 
7
5
.2
 
T
o
ta
l 
  
 A
ll
 a
g
es
 
  
 2
0
-3
9
 y
ea
rs
 
 
 
 6
3
,8
8
2
 
1
1
,6
1
7
 
 5
1
,6
2
3
 
9
1
9
5
 
 8
0
.8
 
7
9
.2
 
 4
9
,1
3
0
 
8
7
5
1
 
 7
6
.9
 
7
5
.3
 
N
o
te
. 
S
o
u
rc
e:
 C
D
C
 (
1
9
9
9
-2
0
0
8
).
 N
at
io
n
al
 H
ea
lt
h
 a
n
d
 N
u
tr
it
io
n
 E
x
am
in
at
io
n
 S
u
rv
ey
 r
es
p
o
n
se
 r
at
es
 a
n
d
 C
P
S
 t
o
ta
ls
. 
R
et
ri
ev
ed
 
S
ep
te
m
b
er
 1
5
, 
2
0
1
0
, 
fr
o
m
 h
tt
p
:/
/w
w
w
.c
d
c.
g
o
v
/n
ch
s/
n
h
an
es
/r
es
p
o
n
se
_
ra
te
s_
C
P
S
.h
tm
. 
a T
h
e 
sc
re
en
ed
 s
am
p
le
 c
o
n
si
st
s 
o
f 
p
ar
ti
ci
p
an
ts
 w
h
o
 w
er
e 
sc
re
en
ed
 a
n
d
 s
el
ec
te
d
 t
o
 p
ar
ti
ci
p
at
e 
in
 N
H
A
N
E
S
. 
b
T
h
e 
in
te
rv
ie
w
ed
 s
am
p
le
 
co
n
si
st
s 
o
f 
p
ar
ti
ci
p
an
ts
 w
h
o
 w
er
e 
ac
tu
al
ly
 i
n
te
rv
ie
w
ed
. 
c T
h
e 
ex
am
in
ed
 s
am
p
le
 c
o
n
si
st
s 
o
f 
p
ar
ti
ci
p
an
ts
 w
h
o
 w
er
e 
ac
tu
al
ly
 e
x
am
in
ed
 i
n
 
th
e 
m
o
b
il
e 
ex
am
in
at
io
n
 c
en
te
r 
af
te
r 
h
o
m
e 
in
te
rv
ie
w
. 
d
C
o
n
tr
o
l 
to
ta
l 
is
 t
h
e 
es
ti
m
at
ed
 t
o
ta
l 
ci
v
il
ia
n
 n
o
n
in
st
it
u
ti
o
n
al
iz
ed
 U
.S
. 
p
o
p
u
la
ti
o
n
 
fo
r 
th
e 
m
id
p
o
in
t 
o
f 
ea
ch
 2
-y
ea
r 
N
H
A
N
E
S
 c
y
cl
e.
 e
U
n
w
ei
g
h
te
d
 r
es
p
o
n
se
 r
at
e 
fo
r 
in
te
rv
ie
w
ed
 s
am
p
le
 i
s 
th
e 
p
er
ce
n
ta
g
e 
o
f 
p
ar
ti
ci
p
an
ts
 i
n
 
th
e 
to
ta
l 
sc
re
en
ed
 s
am
p
le
 w
h
o
 w
er
e 
ac
tu
al
ly
 i
n
te
rv
ie
w
ed
. 
f U
n
w
ei
g
h
te
d
 r
es
p
o
n
se
 r
at
e 
fo
r 
ex
am
in
ed
 s
am
p
le
 i
s 
th
e 
p
er
ce
n
ta
g
e 
o
f 
p
ar
ti
ci
p
an
ts
 i
n
 t
h
e 
to
ta
l 
sc
re
en
ed
 s
am
p
le
 w
h
o
 w
er
e 
ac
tu
al
ly
 e
x
am
in
ed
. 
 
 68 
NHANES during 1999-2008. Of these, 9,195 were interviewed (79.2 %) and 
8,751 (75.3%) were examined in the MEC.  
Sample 
Subjects for this study were drawn from the 8,751 adults aged 20-39 years who 
participated in both the home interview and health examination during NHANES 
1999-2008. Subjects were included in the study if they had documented measures on 
depression, fasting glucose, and fasting insulin. Subjects were excluded from the 
study if they: 1) had known diabetes; 2) had fasting glucose level ≥ 126 mg/dl; and 3) 
had fasted less than 8 hours or more than 24 hours before the fasting blood sample 
was drawn. No other co-morbid conditions were used to exclude participants. Study 
variables also included age, gender, race/ethnicity, waist circumference, BMI, systolic 
blood pressure, triglyceride level, high sensitivity C-reactive protein (hs-CRP), 
smoking status, alcohol consumption and leisure time physical activity.  
Data Collection 
The process of data collection was discussed under the overview of the NHANES 
in the Research Design section. NHANES data are made available to the public and 
can be downloaded from the CDC/NCHS website. The NHANES web tutorial 
(CDC/NCHS, 2008a) provided at the CDC/NCHS website was used as a guide to 
prepare the analytic dataset for the current study. The variables of interest to the study 
(demographic: age, gender, and race/ethnicity; examination: blood pressure, BMI, 
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waist circumference; laboratory: hs-CRP, fasting glucose and insulin, 
triglycerides; questionnaire: diabetes status, depression screener, smoking and 
tobacco use, alcohol use, leisure time physical activity) were first located within each 
survey cycle (NHANES 1999-2000, NHANES 2001-2002, NHANES 2003-2004, 
NHANES 2005-2006, and NHANES 2007-2008). Data files containing these 
variables for each 2-year survey cycle were then downloaded to a local laptop. Each 
variable within the different survey cycles was appended. These data files were then 
merged by the sequence number (SEQN), a unique identifier for each sample person, 
to obtain a combined dataset. Study inclusion and exclusion criteria were applied to 
determine the final dataset for the current study.  
Diabetes Status 
Diabetes status in NHANES was determined by the question “Have you ever 
been told by a doctor or health professional that you have diabetes or sugar diabetes?” 
and the responses included: “1 = Yes”, “2 = No”, “3 = borderline or prediabetes”, “7 
= refused”, or “9 = Don‟t know”. Borderline or prediabetes was considered as having 
no diabetes in this study. This variable was used to exclude participants who 
answered “Yes” to this question and had known diabetes.  
Insulin Resistance 
The estimate of insulin resistance was calculated using the homeostasis model 
assessment for insulin resistance (HOMA-IR), which is expressed as: HOMA-IR = 
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[fasting glucose (mmol/L) × fasting insulin (U/mL)]/22.5 (Matthews et al., 
1985; Wallace, Levy, & Matthews, 2004). The formula required fasting glucose and 
insulin levels for calculation. 
Blood specimens were processed, stored, and shipped to the University of 
Missouri-Columbia for analysis of fasting plasma glucose and insulin in NHANES 
1999-2004. For NHANES 2005-2008, glucose and insulin were analyzed by the 
Fairview Medical Center Laboratory at the University of Minnesota. Participants with 
fasting plasma glucose and insulin values were a subsample of the health examination 
sample that were randomly selected to provide morning fasting blood sample in the 
fifth stage of sampling.  
Fasting plasma glucose. Fasting plasma glucose concentration was measured 
using the enzyme Hexokinase method with a series enzymatic reaction on Roche 
Cobas Mira system (Cobas Mira Chemistry System; Roche Diagnostic Systems, Inc., 
Montclair, NJ) in NHANES 1999-2004. Collection and assay methodologies for 
glucose were identical in NHANES 1999-2004. There was change in the equipment 
and laboratory in NHANES 2005-2006. Plasma glucose was measured using the 
method of Hexokinase on Roche/Hitachi 911 (Roche Diagnostics, Indianapolis, IN). 
A linear regression analysis was done in a crossover study to compare the 
Roche/Hitachi 911 method used in NHANES 2005-2006 to the Roche Cobas Mira 
method in NHANES 2003-2004. The glucose (mg/dl) in NHANES 2005-2006 was 
converted using this regression equation to make it comparable to those in NHANES 
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1999-2004: Y (Cobas Mira) = 0.9835 * (Hitachi 911) (Equation 1) 
(CDC/NCHS, 2008b). In NHANES 2007-2008, glucose analysis was conducted on 
the Roche Modular P chemistry analyzer (Roche ModP) (Roche Diagnostic, 
Indianapolis, IN). A crossover study was conducted to compare glucose data in 
2007-2008 to those in 2005-2006. A Deming regression analysis was completed and a 
regression equation was suggested for the conversion of glucose data in 2007-2008 to 
be comparable to those in 2005-2006: Y (Hitachi 911) = X (Roche ModP) - 1.139 
(Equation 2) (CDC/NCHS, 2010a). The glucose values in NHANES 2007-2008 were 
first converted to be comparable with those in NHANES 2005-2006 using Equation 2 
and then to be comparable with those in NHANES 1999-2004 using Equation 1. The 
instruments, lab methods, and conversion equations for glucose in NHANES 
1999-2008 are listed in Table 3.  
The fasting glucose value in mg/dl was converted to mmol/L by multiplying by 
0.05551 (rounded to 3 decimals). The coefficient of variation (CV) for glucose assay 
ranged from 1.3 to 3.0% in NHANES 1999-2004, 1.3 to 2.2% in NHANES 
2005-2006, and 0.8 to 2.6% in NHANES 2007-2008. 
Fasting insulin. Concentrations of fasting insulin in NHANES 1999-2000 and 
2001-2002 were measured by the Pharmacia method using insulin radioimmunoassay 
(RIA) (Pharmacia Diagnostics AB, Uppsala, Sweden). There were changes to the 
equipment and lab method in NHANES 2003-2004. A Tosoh method using a two-site 
immunoenzymometric assay was used for NHANES 2003-2004. The mean value for 
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the Tosoh method was about 11% lower than the Pharmacia method mean 
value. Two crossover studies were performed to compare the Pharmacia to the Tosoh 
values on split specimens. The value of insulin (μU/mL) in NHANES 2003-2004 was 
converted using the recommended regression equation based on the results of the 
crossover studies to make it comparable to those in NHANES 1999-2002: Y 
(Pharmacia) = (Tosoh + 2.2934)/1.0027 (Equation 3) (CDC/NCHS, 2006b). 
Additional changes were made to the equipment and laboratory in NHANES 
2005-2008. Insulin was measured by ELISA on Merocodia insulin in NHANES 
2005-2008. The values of insulin (μU/mL) in NHANES 2005-2008 were adjusted 
using the recommended regression equation based on a crossover study to make it 
comparable to those in NHANES 2003-2004: Y (Tosoh) = 1.0526 * (Mercodia) - 
1.5674 (Equation 4) (CDC/NCHS, 2008b). Then they were converted to be 
comparable to NHANES 1999-2002, using equation 3. The instruments, lab methods, 
and conversion equations for insulin in NHANES 1999-2008 are listed in Table 4. 
The coefficient of variation (CV) for insulin assay ranged from 3.3 to 5.4% in 
NHANES 1999-2002, 2.0 to 4.6% in NHANES 2003-2004, 3.4 to 4.9% in NHANES 
2005-2006, and 5.5 to 8.8% in NHANES 2007-2008.  
 HOMA-IR. HOMA-IR is a simple surrogate index for insulin resistance derived 
from fasting steady-state condition where blood glucose concentration is 
homeostatically maintained in the normal range and there is no significant change in 
insulin level and hepatic glucose production. The method was developed by  
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Matthews et al. (1985) and is a model of interactions between glucose and 
insulin dynamics which is used to predict levels of glucose and insulin for a wide 
range of possible combinations of insulin resistance and β-cell function under fasting 
steady state. HOMA-IR is widely used in large epidemiological or clinical studies. 
HOMA-IR was found to be highly and negatively correlated with the 
hyperinsulinemic euglycemic glucose clamp (r = -.820, p < .001), the gold standard 
for assessing insulin sensitivity (Bonora et al., 2000). Lansang, Williams and Carroll 
(2001) also found a significant negative association between insulin sensitivity 
derived from hyperinsulinemic euglycemic clamp and HOMA-IR scores in both 
hypertensive (p < .0001) and normotensive subjects (p = .002). The sensitivity of 
HOMA-IR for detecting individuals who were insulin resistant was comparable to the 
hyperinsulinemic euglycemic clamp (κ = .63). The CV of HOMA-IR scores range 
from 9.4% to 15%.  
For an individual with normal insulin sensitivity, HOMA-IR = 1. The top 25% 
with highest HOMA-IR values among normal healthy population were defined as 
insulin resistant individuals (Balkau & Charles, 1999), which is the most commonly 
used definition of insulin resistance in research studies. More strictly defined insulin 
resistance (i.e., use the lowest quintile [20%] (Bonora et al., 1998) or decile [10%] of 
the HOMA-IR values) was sometimes used by other researchers. Because no 
standardized insulin assay has been established, it was not possible to define a 
universal cutoff point of HOMA-IR for insulin resistance (Muniyappa, Lee, Chen, & 
Quon, 2008). Nevertheless, several researchers have suggested threshold values of 
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HOMA-IR for insulin resistance, which ranged from 1.7 (Nakai et al., 2002) to 
3.8 (Ascaso et al., 2001), depending on the studied racial/ethnic populations. The 
current study defined insulin resistance using the 75% percentile of HOMA-IR value 
among nondiabetic adults aged ≥ 20 years in NHANES 1999-2008 as the cut-point, 
according to Balkau and Charles (1999). Participants with a HOMA-IR score ≥ 75% 
percentile were defined as insulin resistant and were coded as “1 - yes”. Those with a 
HOMA-IR score < 75% percentile were defined as non-insulin resistant and were 
coded as “0 - no”.  
Major Depression 
 Depression was measured by the WHO CIDI on a half-sample of examination 
participants aged 20-39 years in NHANES 1999-2004. In NHANES 2005-2008, 
depression was measured by the PHQ-9, a screener for depression, on all participants 
aged 12 years and above. For this study, depression was defined as a positive 
diagnosis of major depression by the CIDI for participants in NHANES 1999-2004 or 
a positive diagnosis of major depression by the PHQ-9 for those who participated in 
NHANES 2005-2008. In the following section, these two measurements are described 
and their psychometric properties are discussed, followed by a comparison between 
the CIDI and the PHQ-9.  
The composite international diagnostic interview. The CIDI is a standardized 
interview developed by the WHO that is used to make clinical diagnoses of mental 
disorders, according to the fourth edition of the American Psychiatric Association‟s 
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Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (American 
Psychiatric Association, 1994) and the International Classification of Diseases 
(ICD-10) diagnostic criteria (WHO, 1994). The CIDI is available in lifetime and 
12-month versions and in both paper-and-pencil and computer-administered forms. 
The NHANES CIDI was developed as a computer-administered version and consisted 
of three diagnostic modules, including panic disorder, generalized anxiety disorder, 
and major depression (see Appendix B). These modules assessed symptoms present in 
the past 12 months. The NHANES CIDI was administered by trained interviewers in 
the MEC following guidelines instituted by CIDI. The self-report responses from 
participants obtained during the interview were entered into a computer program and 
compared to the diagnostic algorithm (CDC/NCHS, 2006c). In brief, major 
depression was diagnosed when either a depressed mood or markedly diminished 
interest in nearly all activities was present for at least 2 weeks plus four of seven 
additional symptoms: significant appetite/weight change, insomnia or hypersomnia, 
psychomotor agitation or retardation, fatigue or loss of energy, excessive guilt or 
feelings of worthlessness, diminished ability to think or concentrate or indecisiveness, 
and suicidal thoughts. A negative diagnosis of major depression was made if the 
symptoms did not meet the diagnostic criteria. The variable of major depression 
diagnostic score of the CIDI was used in the study. A positive diagnosis of major 
depression was coded as “1” and a negative diagnosis of major depression was coded 
as “5” in the NHANES data. The coding for negative diagnosis was recoded to “0” 
for this study. 
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The CIDI has been shown to be reliable in WHO CIDI Field Trails and 
other numerous studies conducted throughout the world. Two systemic reviews by 
Wittchen (1994) and by Andrews and Peters (1998) have been conducted on the 
psychometric properties of the CIDI. Kappas for inter-rater reliability of the CIDI 
were greater than .90 in 17 diagnoses modules except for somatization (.67), bulimia 
nervosa (.78), and anorexia nervosa (.80) (Wittchen, 1994). The kappas of inter-rater 
reliability for major depression were .97 for single episode and .93 for recurrent 
episodes. The diagnostic sensitivity of the CIDI for major depression ranges from .84 
to .98; diagnostic specificity ranges from .46 to .74. Overall kappa agreement 
between the CIDI and other diagnostic interview methods (i.e., Present State 
Examination [PSE], Schedules for Clinical Assessment in Neuropsychiatry [SCAN]) 
ranges from .55 to .77.  
The patient health questionnaire 9. The PHQ is a self-administered version of the 
Primary Care Evaluation of Mental Disorders (PRIME-MD) diagnostic instrument for 
common mental disorders. It is a relatively new instrument developed to make 
criteria-based diagnoses of depressive and other mental disorders commonly 
encountered in primary care and non-psychiatric settings (Spitzer, Kroenke, & 
Williams, 1999). The PHQ-9 is the depression module, which consists of nine items 
of depressive symptoms derived from the DSM-IV criteria for the diagnosis of 
depressive disorders (See Appendix C). It is half the length of many other depression 
instruments. The nine items are: 1) loss interest in activity; 2) depressed mood; 3) 
trouble in sleeping; 4) feeling tired; 5) change in appetite; 6) feeling guilty or 
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worthlessness; 7) trouble in concentrating; 8) feeling slowed down or restless; 
9) suicidal thoughts. The PHQ-9 aims to measure the presence of these nine 
symptoms in the previous 2 weeks. There are four responses to each symptom 
question with “0” (not at all), “1” (several days), 2 “more than half the days”, and “3” 
(nearly every day). Participants‟ responses to each symptom item were recorded in 
NHANES 2005-2008.  
The PHQ-9 can work as a dual-purpose instrument: 1) it can establish the 
diagnoses of depressive disorder; 2) it can help estimate the severity of depressive 
symptom (Kroenke, Spitzer, & Williams, 2001). Major depression is diagnosed if 5 or 
more of the 9 depressive symptom criteria have been present at least “more than half 
the days” in the past 2 weeks, and 1 of the symptoms is depressed mood or loss 
interest in activity. Minor depression is diagnosed if 2, 3, or 4 depressive symptoms 
have been present at least “more than half the days” in the past 2 weeks, and 1 of the 
symptoms is depressed mood or loss interest in activity. One of the 9 symptom 
criteria (“thoughts that you would be better off dead or of hurting yourself in some 
way”) counts if present at all, regardless of duration. No depression is diagnosed if 1 
or less depressive symptoms were present “more than half of the days” in the past 2 
weeks (Kroenke, et al., 2001). When used as a severity measure, PHQ-9 scores of 5, 
10, 15, 20 represented mild, moderate, moderately severe, and severe depression 
respectively (Kroenke, et al., 2001).  
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In this study, the PHQ-9 was used as a diagnostic tool. Syntax was written 
in the statistical program to establish a diagnosis of major depression, according to 
the diagnostic criteria described above. A variable named diagnosis score was created 
with 1 representing a positive diagnosis of major depression and 0 representing a 
negative diagnosis of major depression (including minor depression and no 
depression).  
Studies have shown that the PHQ-9 is a reliable and valid measure of depression 
for the purpose of diagnosis. The meta-analysis by Gilbody, Richards, Brealey, and 
Hewitt (2007) showed that the pooled sensitivity of PHQ-9 as a diagnostic tool for 
major depression was .80 (95% confidence interval [CI]: .71-.87) and specificity 
was .92 (95% CI: .88-.95).  
Comparison of the PHQ-9 to the CIDI. The CIDI is well recognized as the gold 
standard for diagnosis of major depression, but it requires a trained interviewer and a 
complex diagnostic algorithm to make a clinical diagnosis. It may take up to 10 
minutes to complete the CIDI. The PHQ-9 also consists of the 9 DSM-IV diagnostic 
criteria for depression, but is much easier to administer and can be used as a screening 
tool in clinical practice to identify patients with depression. Accumulated evidence 
shows that the PHQ-9 is a valid and reliable instrument in diagnosing depression, 
when comparing it to the CIDI (Gilbody, et al., 2007; Kroenke, Spitzer, Williams, & 
Lowe, 2010). Diagnostic criteria of the CIDI for major depression exclude conditions 
that might cause depressive symptoms, such as substance abuse, general medical 
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condition, or bereavement; while the PHQ-9 does not exclude these conditions 
that cause depressive symptoms.   
Demographic Data and Other Covariates 
 Age, gender, race/ethnicity. Age, gender, race/ethnicity were self-reported during 
the NHANES home interview. Based on the self-reported information, race/ethnicity 
was differentiated into four categories: non-Hispanic White, non-Hispanic Black, 
Mexican American, and other race/ethnicity. Other race/ethnicity included those with 
single racial/ethnic identity other than non-Hispanic White, non-Hispanic Black or 
Mexican American; those who reported being multi-racial and missing values on 
race/ethnicity. As mentioned previously, covariates important to the study were 
selected according to the review of literature and the clinical guidelines of NCEP APT 
III and WHO on metabolic syndrome. These covariates included systolic blood 
pressure, triglyceride level, hs-CRP, BMI or waist circumference, leisure time 
physical activity, smoking status, and alcohol consumption.  
Systolic blood pressure. Blood pressure was measured by physicians who were 
trained and certified for blood pressure measurement in the training program from 
Shared Care Research and Education Consulting. All blood pressures were taken in 
the MEC. Each participant was instructed to rest quietly in a sitting position for 5 
minutes prior to the measurement. Appropriate cuffs were selected for participant‟s 
arm circumference. After determining the maximum inflation level, three consecutive 
blood pressure readings were obtained with a mercury sphygmomanometer. A fourth 
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attempt was made, if a blood pressure measurement was interrupted or 
incomplete. An average systolic blood pressure was then calculated as follows: if 
only one blood pressure reading was obtained, the systolic pressure identified was 
recorded as the average; if two blood pressure readings were obtained, the second of 
the two systolic readings was recorded as the average; if more than two blood 
pressure readings were obtained, the first reading was excluded from the calculation 
of the average. The average systolic blood pressure was recorded in the NHANES 
and was used as the measure of systolic blood pressure for the current study.  
Triglyceride level. Blood specimens were processed, stored, and shipped to the 
Lipoprotein Analytical Laboratory at Johns Hopkins University School of Medicine 
for analysis of triglycerides in NHANES 1999-2006. Triglyceride level was measured 
enzymatically in serum using a series of coupled reactions (Hitachi 704 Analyzer, 
Roche Diagnostics, Indianapolis, IN) in NHANES 1999-2004. No changes were 
made to the lab method or lab site in NHANES 2005-2006; however, the lab 
equipment was changed from Hitachi 704 to Hitachi 717 and Hitachi 912 
(CDC/NCHS, 2008c). In NHANES 2007-2008, serum triglycerides were analyzed by 
the Fairview Medical Center Laboratory at the University of Minnesota on Roche 
Modular P chemistry analyzer. However, no adjustment or conversion of values was 
necessary to account for the change in instrumentation for triglycerides between 
NHANES 1999-2004, NHANES 2005-2006 and NHANES 2007-2008 (CDC/NCHS, 
2010b). The ranges of CV were 1.5 to 3.1% in NHANES 1999-2004, 1.8 to 2.1 % in 
NHANES 2005-2006 (CDC/NCHS, 2008d), 1.3 to 2.4% in NHANES 2007-2008 
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(CDC/NCHS, 2010c). The sensitivity for triglycerides glycerophosphate 
oxidase (GPO) determination was 10mg/dl. The variable of LBXTR in the unit of 
mg/dl from NHANES data was used for the current study. 
High sensitivity C-reactive protein. Blood specimens were processed, stored and 
shipped to Department of Laboratory Medicine in University of Washington for 
analysis. Hs-CRP was quantified by latex-enhanced nephelometry on Dade Behring 
Nephelometer II Analyzer System (Dade Behring Diagnostic Inc, Somerville, New 
Jersey). The equipment, lab methods, and lab site was consistent in NHANES 
1999-2008. The CV ranges from 3.1 to 9.9%. The lowest detectable hs-CRP is 0.02 
mg/dL and results were reported to the nearest hundredth (0.01). For this study, 
hs-CRP values were categorized as low (< 1.0 mg/L), moderate (1.0 to 3.0 mg/L), and 
high levels (> 3.0 mg/L). The three concentration categories were used in the data 
analyses.  
BMI and waist circumference. BMI, an indicator for overall obesity, and waist 
circumference, an index for central obesity, were used in the study to evaluate the 
strength of their association with insulin resistance. Because these variables are likely 
highly correlated, they were tested during data analyses to determine which is more 
highly associated with insulin resistance. BMI was calculated by weight (kg)/height 
(m) 
2
 and was provided in the NHANES data.  
Measurement of weight and height were included in the health examination and 
were performed in the body measurement room at the MEC by a trained health 
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technician and a recorder. For these anthropometry measurements, participants 
wore the standard MEC examination gown and underwear beneath the gown. Weight 
was measured on a Toledo digital weight scale in pounds and converted to kilograms 
in the automated system in NHANES 1999-2006 (CDC/NCHS, 2000, 2002, 2004, 
2005) and weight was measured in kilogram in NHANES 2007-2008 (CDC/NCHS, 
2007). Participants were instructed to stand still in the center of weight scale platform, 
put their hands at side, and look straight ahead. The displayed weight would be 
recorded when the reading became stable and the recorder clicked the “Get Weight” 
button on the screen. The maximum capacity of the digital scale is 440 pound. Two 
portable weight scales were available to use when participants‟ weight exceeded 440 
pounds, the digital weight scale malfunctioned or there was a power outage. 
Standing height was measured with a fixed standiometer with a vertical 
backboard and a moveable headboard. Participants were instructed to stand on the 
floor, positioning the heels of both feet together with the toes pointing outward at 
approximately a 60 degree angle. Body parts of the heels, the buttocks, shoulder 
blades, and the back of the head were positioned to contact with the vertical 
backboard. The head was aligned in a way that the horizontal line from the ear canal 
to the lower border of the orbit of the eyes was parallel to the floor and perpendicular 
to the vertical backboard. Participants were instructed to take a deep breath and stand 
as tall as possible. The health technicians lowered the headboard to firmly position on 
the top of the head and the height was recorded automatically.  
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Toledo digital weight scale was calibrated formally at the beginning of 
each stand and in the mid-term. Six of the 50 pounds calibration weights were placed 
on the scale and technicians would check for displayed weight. If the displayed 
weight was outside the acceptable range (299.75 to 300.25 pounds), the weight scale 
would be recalibrated by a service representative. Informal calibration was performed 
daily. The technicians checked the weight scale by weighing themselves first on the 
weight scale and then adding one or two 10-pound calibrated weights on the weight 
scale and checking if the displayed weight increased correspondingly. There have 
been changes in calibration procedures for digital weight scale since 2007 
(CDC/NCHS, 2007). Full calibration of the digital scale was done at the start, middle, 
and end of a stand and 15 of the 10 kilogram calibration weights were used. The 
acceptable weight ranges were 149.85 - 150.15 kg. The daily calibration procedures 
included placing five of the 10 kilogram calibration weights on the scale and the 
acceptable weight ranges were 49.70 - 50.30 kg. If the results fell outside the 
acceptable range, the full calibration procedures would be performed. If the result fell 
within the acceptable range of the full calibration, then the daily calibration procedure 
would be repeated. If the results still were outside the acceptable range, then the scale 
would be recalibrated by a service representative.  
The standiometer was calibrated at the start of each stand and weekly. One 80 cm 
- long calibration rod was placed on the floor of the standiometer and the horizontal 
bar of the standiometer was then put firmly against the top of the calibration rod. If 
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the displayed reading was not 80 cm, the standiometer would be recalibrated 
by technicians.   
Waist circumference was measured by a highly trained health technician in the 
MEC and validated by a data recorder who accompanied the health technician for the 
waist circumference measurement. Participants were instructed to stand and hold the 
examination gown above the waist, lower the pants and underclothing slightly. The 
health technicians stood behind and to the right of the participants to palpate the hip 
area to locate the right ilium. A horizontal line was drawn above the uppermost lateral 
border of the right ilium and then a vertical line was drawn cross the line to indicate 
the midaxillary line of the body. The measuring tape was placed around the trunk in a 
horizontal plane at the level marked on the right side of the trunk and the zero end of 
the measuring tape was placed below the measurement value. The mirror on the wall 
was used to ensure correct horizontal alignment of the measuring tape. The recorder 
validated that the tape was parallel to the floor and that the tape was snug, but did not 
compress the skin. The measurement was made at the end of a normal expiration to 
the nearest millimeter. 
Leisure-time physical activity. In NHANES, physical activity was assessed by a 
physical activity questionnaire that was completed during the home interview. This 
physical activity questionnaire included questions on daily activities, leisure time 
activities, and sedentary activities. These questions have been used in previous 
NHANES questionnaires or in other federal surveys. Participants‟ responses to the 
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questions on leisure-time physical activities (LTPA) were used as the measure 
of physical activity for the current study because research has shown that LTPA can 
produce long-term health benefits (U.S. Department of Health and Human Services, 
2008). In NHANES 1999-2008, participants were asked if they did any moderate or 
vigorous LTPA for at least 10 minutes in the past 30 days. If the answer was “yes”, 
they were asked to report the frequency and duration of LTPA they performed. In 
NHANES 1999-2006, participants also were asked to specify the types of moderate 
or vigorous LTPA.  
To quantify the absolute intensity of the physical activity, a metabolic equivalent 
(MET) score was assigned by NHANES to each type of LTPA. A MET is a measure 
of energy expenditure of a physical activity relative to the rate of energy expenditure 
at rest. In general, 1 MET is the rate of energy expenditure during rest and equals 3.5 
mL oxygen uptake per kilogram of body weight per minute. The METs for moderate 
activities range from 3.0 to 5.9 and vigorous activities have METs of 6.0 or above. 
According to the 2008 Physical Activity Guidelines for Americans by U.S. 
Department of Health and Human Services, adults should do at least 150 minutes of 
moderate-intensity or 75 minutes of vigorous-intensity physical activity per week. 
This equals 500-1000 MET-minutes per week (U.S. Department of Health and 
Human Services, 2008).  
For this study, the total MET-minutes per week were calculated for participants 
who reported participating in either moderate or vigorous LTPA in the past 30 days. 
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In NHANES 1999-2006, total MET-minute per week = [(MET score for 
activity 1 * Frequency of activity 1 (in number of times/30 days) * Duration of 
activity 1 (in minutes/time) + MET score for activity 2 * Frequency of activity 2 * 
Duration of activity 2…)/30]*7. In NHANES 2007-2008, total MET-minute per week 
= [MET score for moderate LTPA* Frequency of moderate LTPA (in days/week) * 
Duration of moderate LTPA (in minutes/day) + MET score for vigorous LTPA * 
Frequency of vigorous LTPA (in days/week) * Duration of vigorous LTPA (in 
minutes/day)]. For participants who reported they did not engage in any moderate or 
vigorous LTPA, a value of zero was assigned. Total MET-minute per week indicated 
level of LTPA. Using criteria established in the 2008 Physical Activity Guidelines for 
Americans, participants were categorized into four groups: no LTPA (total 
MET-minute per week = 0), low LTPA (total MET-minute per week < 500), moderate 
LTPA (500 ≤ total MET-minute per week ≤ 1000), and high LTPA (total MET-minute 
per week > 1000) (US Department of Health and Human Services, 2008).   
Smoking status. Smoking and tobacco use were assessed by two questions during 
the home interview. The wording and responses to these two questions were 
consistent in NHANES 1999-2008. The first question is “Have you smoked at least 
100 cigarettes in your entire life?” and the responses were coded as 1 = “yes” and 2 = 
“no”. The second question is “Do you now smoke cigarettes?”. The responses were 
coded as 1 = “every day”, 2 = “some days”, and 3 = “not at all”. The responses to 
these two questions were used to determine smoking status. Current smoker was 
defined as report of having smoked ≥ 100 cigarettes during a person‟s lifetime and 
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currently smoking every day or some days. Former smoker was defined as 
having smoked ≥ 100 cigarettes during a person‟s lifetime, but not currently smoking. 
Nonsmoker was defined as report of having smoked < 100 cigarettes during a 
person‟s lifetime.  
Alcohol consumption. Alcohol consumption was assessed by a set of questions 
related to lifetime and past 12 months use of alcohol in the questionnaire 
administered to participants during the physical examination at the MEC using a 
computer-assisted personal interview (CAPI) system. For the current study, alcohol 
consumption status was determined by the following questions: 1) “In any one year, 
have you had at least 12 drinks of any type of alcoholic beverage?”; 2) “In your entire 
life, have you had at least 12 drinks of any type of alcoholic beverage?”; 3) “In the 
past 12 months, how often did you drink any type of alcoholic beverage (i.e., days per 
week, per month, or per year)?”; 4) “In the past 12 months, on those days that you 
drank alcoholic beverages, on the average, how many drinks did you have?”. The 
wording of these questions was identical in NHANES 1999-2008.  
Current drinker was defined as report of having at least 12 drinks in one‟s 
lifetime and 1 or more drinks in the past 12 months. Former drinkers were defined as 
report of having at least 12 drinks in one‟s lifetime but had no drinks in the past 12 
months. Nondrinker was defined as report of having less than 12 drinks in one‟s 
lifetime. Current drinkers were further differentiated into light, moderate, and heavy 
drinkers based on weekly drinking amount. It was calculated by the product of 
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self-reported drinking frequency (in number of days per week) and number of 
drinks per day. If drinking frequency was reported in days per month or per year, it 
was calculated as the following: [(number of days per month) * (number of drinks per 
day)/30]*7, or [(number of days per year) * (number of drinks per day)/365]*7 
respectively. Light drinkers were defined as report of having an average of ≤ 3 drinks 
per week. Moderate drinkers were defined as report of having an average of more 
than 3 drinks, but up to 14 drinks per week for men or more than 3 drinks to 7 drinks 
per week for women (U.S. Department of Agriculture and U.S. Department of Health 
and Human Services, 2005). Heavy drinkers were defined as report of having an 
average of >14 drinks per week for men and > 7 drinks per week for women (CDC, 
2010a).  
Human Subject Review 
 The NHANES 1999-2008 were approved by CDC/NCHS institutional review 
board/ ethnics review board. Participation in NHANES was fully voluntary. Informed 
consent was obtained from all subjects prior to home interview, physical examination 
and laboratory testing. All identifying information was kept confidential to protect 
participants.  
 Approval for this study was obtained from the University of Kansas Medical 
Center (KUMC) Human Subject Committee and was deemed to not involve human 
subjects. The study was a secondary analysis of NHANES data that were available to 
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the public through the CDC/NCHS website (CDC, 1999-2008). All public use 
NHANES data had been de-identified and subject sequence number assigned to each 
participant. This investigator has not had direct contact with the participants in 
NHANES nor has this investigator had access to information that links participants 
with their survey responses. Findings are reported in the aggregate.  
Preliminary Study 
 A preliminary study was done in Fall 2007 to fulfill the requirement of NRSG 
959 Research Project and to explore the possibility for a dissertation topic. The study 
was a secondary analysis of NHANES data 1999-2002, looking at the relationship 
between major depressive disorder (MDD) and insulin resistance among non-diabetic 
young adults aged 20-39 years old in the United States. The study also examined the 
role of gender in the association between MDD and insulin resistance. The sample 
consisted of 279 men and 358 women aged 20-39 years (N = 637) who were 
nondiabetic and had complete data on depression, fasting glucose and insulin. This 
sample was derived from 3,620 young adults aged 20-39 years who participated in 
NHANES 1999-2002. Logistic regression analyses found no statistically significant 
association between MDD and insulin resistance, but gender had a moderating effect 
on the relationship. For men, MDD was negatively associated with insulin resistance 
after adjusting for age, race/ethnicity, waist circumference, smoking status, systolic 
blood pressure and triglyceride level (B = -2.12, p = .01, OR = 0.12, 95% CI [0.02, 
0.62]). No significant association between MDD and insulin resistance among women 
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was found (B = 0.61, p = .38, OR = 1.84, 95% CI [0.47,7.14]) (Shen, et al., 
2011). Findings from this preliminary study suggested the need for increasing sample 
size. Due to the small sample size in the preliminary study, the analysis of the effect 
of race/ethnicity on the relationship between depression and insulin resistance could 
not be performed. Moreover, previous studies failed to examine the effect of 
race/ethnicity on the relationship between depression and insulin resistance. 
Therefore, the current study was expanded to add adults of the same age range that 
participated in NHANES 2003-2008 for a total NHANES sample of 20-39 years old 
spanning 1999-2008 to examine this relationship.  
Data Analysis 
Data analyses for this study incorporated the complex design information of the 
NHANES. According to the September 2006 update of the NHANES Analytic 
Guidelines (CDC/NCHS, 2006a), SUDAAN, SAS and STATA are appropriate 
statistical software to use for analyses of NHANES data, although SUDAAN was 
specifically designated for NHANES data analyses. The CDC/NCHS released 
NHANES data sets as SAS transport files. The survey procedures provided in SAS 
can adequately estimate appropriate sampling errors by using the Taylor series 
method. Because of previous experience of using SAS in the preliminary study and its 
appropriateness in analyzing NHANES data as recommended by CDC/NCHS, data 
analyses for this study were conducted using survey procedures in SAS version 9.2 
(SAS Institute, Inc., Cary, NC).  
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Survey Procedures in SAS 
The survey procedures in SAS are different from traditional SAS procedures in 
that they can make statistically valid estimates by accounting for the 
probability-based complex sample designs (i.e., stratification, clustering and unequal 
weighting), while the traditional SAS procedures compute statistics under the 
assumption that the sample is drawn from an infinite population by simple random 
sampling. The CDC/NCHS recommends the following survey procedures for 
analyses of NHANES data: SURVEYMEANS, SURVEYFREQ, SURVEYREG, and 
SURVEYLOGISTIC. These procedures can produce variance of estimates (or 
sampling error) through the method of Taylor Series Linearization, a variance 
approximation procedure that accounts for the complex survey design and computes 
design effects. Specifically, the SURVEYMEANS procedure calculates descriptive 
statistics for sample survey data, including means, totals, proportions, ratios, and their 
standard errors. The SURVEYFREQ procedure produces one-way to n-way 
frequency and cross tabulation tables from sample survey data, including estimates of 
population totals, population proportions, and their standard errors. It also can 
compute confidence limits, coefficients of variation, and design effects. The 
SURVEYREG procedure fits linear regression models, performs hypothesis tests and 
provides estimates for survey data (An & Watts, 2000). The SURVEYLOGISTIC fits 
linear logistic regression models for categorical response survey data by the method 
of maximum likelihood (An, 2002). To produce valid statistical estimates of 
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population, the complex survey design information, including stratification, 
clustering, and unequal weighting were incorporated into all the analyses 
(CDC/NCHS, 2006a).  
Survey Design Variables 
 Because the NHANES was a complex, stratified, multistage probability-based 
clustered design, survey design information such as strata and PSUs was applied in 
the data analyses to obtain valid estimates of statistics as recommended by 
CDC/NCHS. Strata and PSUs represented the variance units, which were defined as 
sampling units used to estimate sampling error. In NHANES data, the design 
variables for the stratum and the PSU were sdmvstra and sdmvpsu respectively. These 
two variables were incorporated in all data analyses discussed later. 
Sample Weights 
A sample weight was assigned to each sample person in the NHANES. It is a 
measure of the number of people in the population represented by a sample person in 
NHANES. The sample weight accounted for unequal selection probability, 
nonresponse adjustment, and adjustment to match 2000 U.S. Census population totals 
(CDC/NCHS, 1999b). Each sample person was a member of the interview sample. 
Some sample persons also were members of the health examination sample. As 
previously mentioned, the subsample was defined as a subset of individuals that were 
randomly selected from the examined sample during the fifth stage of selection. 
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However, each of these samples (interview, examination, or subsample) in the 
NHANES survey was a nationally representative sample (CDC/NCHS, 1999f). Each 
sample was assigned a weight. Consequently, there were three types of sample 
weights in NHANES: interview weights, examination weights, and subsample 
weights. Subsample weights accounted for this additional sampling stage and 
nonresponse and were different from the full examination weights (CDC/NCHS, 
1999f). Selection of the correct sample weight to use in the analyses is important to 
produce unbiased national estimates and depends on the variables of interest included 
for the data analyses. The rule of thumb is to use the weight associated with the 
variable on which data were collected from the smallest sample subpopulation 
(CDC/NCHS, 1999a). For example, if only variables from the interviewed sample are 
used, then the interview weights should be used. If one or some of variables of 
interest were collected during the MEC examination is used, the appropriate sample 
weight to use is the examination weight. If data analyses include variables collected 
from a subsample of the examination sample, the proper weight to be applied the 
analyses is the subsample weight specific to that variable. For the current study, 
variables such as fasting glucose and insulin were collected from a subsample of the 
examined sample; therefore, fasting sample weights were used in the analyses in 
order to produce unbiased statistical estimates.   
The NHSC provided sample weights for each 2-year cycle of NHANES. 
Therefore, it was necessary to calculate new sample weights when combining two or 
more 2-year cycles of NHANES data except for NHANES 1999-2002 which had 
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special 4-year sample weights. This special 4-year sample weight was 
calculated by the NCHS, because there were differences in Census population 
estimates used in NHANES 1999-2000 and NHANES 2001-2002. In particular, the 
sample weights for NHANES 1999-2000 were based on population estimates 
developed by the Bureau of the Census before the Year 2000 Decennial Census Count 
became available; while the two-year sample weights for NHANES 2001-2002 were 
based on population estimates of the year 2000 Census counts. The population 
estimates in NHANES 2003-2008 also were based on the year 2000 Census counts 
(CDC/NCHS, 2006a).  
Sampling weights for subjects in the study were applied according to the 
NHANES web tutorial and the analytic guideline provided by the NCHS on how to 
construct 10-year sample weights when combining NHANES 1999-2008 for data 
analyses. Using this guideline, a 10-year fasting sample weight variable was created 
by: 1) assigning 2/5 of the 4 year fasting sample weight for 1999-2002 if the person 
was sampled in 1999-2002, or 2) assigning 1/5 of the 2 year fasting sample weight for 
2003-2004 if the person was sampled in 2003-2004, or 3) assigning 1/5 of the 2 year 
fasting sample weight for 2005-2006 if the person was sampled in 2005-2006, or 4) 
assigning 1/5 of the 2 year fasting sample weight for 2007-2008 if the person was 
sampled in 2007-2008 (CDC/NCHS, 1999e). According to CDC/NCHS, the fractions 
used to calculate the new 10-year fasting sample weight were derived from averaging 
the sample weights from each survey cycle. For example, in NHANES 1999-2002, 
the averaged sample weight for the 4-year weight in a 10-year dataset was 4/10 
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(which equals to 2/5) and the average sample weight for a 2-year weight was 
2/10 (which equals to 1/5). 
Statistical Analyses 
The NHANES web tutorial provided by CDC/NCHS includes an NHANES 
analyses course that demonstrates how to select appropriate statistical techniques 
when analyzing NHANES data. These statistical techniques include descriptive 
statistics, hypothesis testing, age standardization and population estimates, linear 
regression and logistic regression. This NHANES analyses course was used as a 
guide for the data analyses conducted in SAS in this study (CDC/NCHS, 1999c).  
Descriptive analyses were performed to describe the sample and the population 
represented. For continuous variables (age, waist circumference, BMI, systolic blood 
pressure, triglycerides), results were reported as mean and standard deviation (SD) for 
the sample and weighted mean and standard error (SE) for the population. For 
categorical variables (gender, race/ethnicity, smoking status, alcohol consumption 
status, leisure time physical activity, insulin resistance, major depression diagnosis, 
and hs-CRP status), frequency and percentage were reported for the sample and 
weighted percent and SE were reported for the population. Statistical significance was 
set at p < .05. The analyses were outlined by research questions as follows: 
Question #1: What is the overall prevalence of major depression among 
nondiabetic U.S. adults aged 20-39 years?  
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This was reported as weighted percent and standard error using PROC 
SURVEYFREQ.  
Question #2: What is the overall prevalence of insulin resistance among 
nondiabetic U.S. adults aged 20-39 years?  
This was reported as weighted percent and standard error using PROC 
SURVEYFREQ. 
Question #3: What is the relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years? 
a) What is the unadjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years?  
Logistic regression analysis was performed with major depression as 
independent variable and insulin resistance as the dependent variable, using 
PROC SURVEYLOGISTIC.  
b) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by gender, 
adjusting for age, race/ethnicity, systolic blood pressure, triglyceride level, 
hs-CRP, obesity (BMI or waist circumference), leisure time physical activity 
(LTPA), smoking status, and alcohol consumption? 
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b1) Is there an interaction between gender and major depression in 
the relationship with insulin resistance among nondiabetic U.S. adults 
aged 20-39 years?  
An interaction term of major depression and gender (major depression * 
gender) was introduced into logistic regression analysis with major depression, 
major depression * gender and gender as independent variables and insulin 
resistance as the dependent variable. The interaction term was significant with p 
≤ .05.  
b2) If the interaction between gender and major depression is significant, 
what is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by gender, 
adjusting for age, race/ethnicity, systolic blood pressure, triglyceride 
level, hs-CRP, obesity (BMI or waist circumference), LTPA, smoking 
status, and alcohol consumption? 
Logistic regression analysis with major depression, age, race/ethnicity, 
systolic blood pressure, triglyceride level, hs-CRP, obesity (BMI or waist 
circumference), LTPA, smoking status, and alcohol consumption as independent 
variables and insulin resistance as the dependent variable was conducted 
separately for men and women, using PROC SURVEYLOGISTIC. The 
correlations among independent variables were performed to detect any 
collinearity. The two indexes for obesity: BMI and waist circumference were 
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tested in separate models to investigate the strength of their relationships 
to insulin resistance and determine which variable best fits the model. Odds ratios 
and 95% confidence intervals (CI) generated from the two models were 
compared. The goodness of fit of the two models was determined by model fit 
statistics such as -2 log likelihood and Akaike information criterion (AIC). The 
best model is the one with the minimum -2 log likelihood and AIC value. 
b3) If the interaction between gender and major depression is not significant, 
what is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years, adjusting for 
age, gender, race/ethnicity, systolic blood pressure, triglyceride level, 
hs-CRP, obesity (BMI or waist circumference), LTPA, smoking status, 
and alcohol consumption?  
Logistic regression analysis with major depression, age, gender, 
race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, obesity (BMI 
or waist circumference), LTPA, smoking status, and alcohol consumption as 
independent variables and insulin resistance as the dependent variable were 
conducted using PROC SURVEYLOGISTIC. The two indexes for obesity: BMI 
and waist circumference were tested in separate models to investigate the 
strength of their relationships to insulin resistance and determine which variable 
best fits the model. Odds ratios and 95% CI generated from the two models were 
compared. The goodness of fit of the two models was determined by model fit 
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statistics such as -2 log likelihood and AIC. The best model is the one 
with the minimum -2 log likelihood and AIC value. 
c) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by race/ethnicity, 
adjusting for age, gender, systolic blood pressure, triglyceride level, hs-CRP, 
obesity (BMI or waist circumference), LTPA, smoking status, and alcohol 
consumption?  
c1) Is there an interaction between race/ethnicity (non-Hispanic White, 
non-Hispanic Black, Mexican American, and other) and major 
depression in the association with insulin resistance among nondiabetic 
U.S. adults aged 20-39 years?  
An interaction term of depression and race/ethnicity (major depression * 
race/ethnicity) were introduced into logistic regression analysis with major 
depression, major depression * race/ethnicity and race/ethnicity as independent 
variables and insulin resistance as the dependent variable. The interaction term 
was significant with p ≤ .05.  
c2) If the interaction between race/ethnicity and depression is significant, 
what is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by 
race/ethnicity, adjusting for age, gender, systolic blood pressure, 
 102 
triglyceride level, hs-CRP, obesity (BMI or waist circumference), 
LTPA, smoking status, and alcohol consumption? 
Logistic regression analysis with depression, age, gender, systolic blood 
pressure, triglyceride level, hs-CRP, obesity (BMI or waist circumference), LTPA, 
smoking status, and alcohol consumption as independent variables and insulin 
resistance as the dependent variable were conducted separately for each 
race/ethnicity (non-Hispanic White, non-Hispanic Black, Mexican American, and 
other), using PROC SURVEYLOGISTIC. The two indexes for obesity: BMI and 
waist circumference were tested in separate models to investigate the strength of 
their relationships to insulin resistance and determine which variable best fits the 
model. Odds ratios and 95% CI generated from the two models were compared. 
The goodness of fit of the two models was determined by model fit statistics such 
as -2 log likelihood and AIC. The best model is the one with the minimum -2 log 
likelihood and AIC value. 
c3) If the interaction between race/ethnicity and depression is not significant, 
what is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years, adjusting for 
age, gender, race/ethnicity, systolic blood pressure, triglyceride level, 
hs-CRP, obesity (BMI or waist circumference), LTPA, smoking status, 
and alcohol consumption?  
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Logistic regression analysis with depression, age, gender, 
race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, obesity (BMI 
or waist circumference), LTPA, smoking status, and alcohol consumption as 
independent variables and insulin resistance as the dependent variable were 
conducted using PROC SURVEYLOGISTIC. The two indexes for obesity: BMI 
and waist circumference were tested in separate models to investigate the 
strength of their relationships to insulin resistance and determine which variable 
best fits the model. Odds ratios and 95% CI generated from the two models were 
compared. The goodness of fit of the two models was determined by model fit 
statistics such as -2 log likelihood and AIC. The best model is the one with the 
minimum -2 log likelihood and AIC value. 
Question #4: What is the relationship between major depression and insulin 
resistance by type of depression measure among nondiabetic U.S. adults aged 20-39 
years? 
a) What is the unadjusted relationship between major depression and 
insulin resistance among nondiabetic U.S. adults aged 20-39 years by 
type of depression measure? 
Separate logistic regression analyses were performed for participants in 
NHANES 1999-2004 using the CIDI as depression measure and for participants 
in NHANES 2005-2008 using the PHQ-9 as depression measure. PROC 
SURVEYLOGISTIC was used with depression as independent variable and 
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insulin resistance as the dependent variable. Odds ratios and 95% CI 
generated from the two models were then compared. 
b) What is the adjusted relationship between major depression and insulin 
resistance among nondiabetic U.S. adults aged 20-39 years by type of 
depression measure, adjusting for age, gender, race/ethnicity, xsystolic 
blood pressure, triglyceride level, hs-CRP, obesity (BMI or waist 
circumference), LTPA, smoking status, and alcohol consumption?  
Separate logistic regression analyses were performed for participants in 
NHANES 1999-2004 using the CIDI as the depression measure and for 
participants in NHANES 2005-2008 using the PHQ-9 as the depression measure. 
PROC SURVEYLOGISTIC was used with depression, age, gender, race/ethnicity, 
systolic blood pressure, triglyceride level, hs-CRP, obesity (BMI or waist 
circumference), LTPA, smoking status, and alcohol consumption as independent 
variables and insulin resistance as the dependent variable. The two indexes for 
obesity: BMI and waist circumference were tested in separate models to 
investigate the strength of their relationships to insulin resistance and determine 
which variable best fits the model. Odds ratios and 95% CI generated from the 
two models were compared. The goodness of fit of the two models was 
determined by model fit statistics such as -2 log likelihood and AIC. The best 
model is the one with the minimum -2 log likelihood and AIC value. Research 
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questions, measurements of variables, level of measurements, and data 
analyses are summarized in Table 5. 
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CHAPTER IV RESULTS 
This chapter presents the findings from analyses of cross-sectional data from the 
National Health and Nutrition Examination Survey (NHANES) 1999-2008 on: 1) the 
prevalence of major depression and insulin resistance among nondiabetic adults aged 
20-39 years in the United States; 2) the relationship between major depression and 
insulin resistance among nondiabetic U.S. adults aged 20-39 years; and 3) the role of 
gender, race/ethnicity, and measure of depression on the relationship between major 
depression and insulin resistance. The findings reported include information about 
derivation of the study sample, demographic characteristics of the study sample and 
the represented population, prevalence of major depression and insulin resistance, risk 
factors associated with insulin resistance, and the relationship between major 
depression and insulin resistance.  
Derivation of the Study Sample 
Initial stratified multistage sampling procedures identified a total of 63,882 
persons at all ages (from birth to 85 years and above) that were eligible to participate 
in NHANES 1999-2008. Of these, 51,623 were interviewed (80.8%) in the home and 
49,130 (76.9%) completed both the home interview and health examination at the 
mobile examination center. Among adults aged 20-39 years, a total of 11,617 adults 
were selected to participate in NHANES 1999-2008. Of these, 9,195 were 
interviewed (79.2%) in the home and 8,751 (75.3%) completed both the home 
 113 
interview and health examination. Of the 8,751 adults aged 20-39 years who 
participated in the home interview and health examination, 2,548 had participated in 
the fifth stage of sampling, and had complete data on measures of major depression, 
fasting glucose and insulin levels. Among these 2,548 subjects, 60 had known 
diabetes, 27 had fasting glucose ≥ 126 mg/dl, and 196 had fasted less than 8 hours or 
more than 24 hours before the fasting blood sample was drawn. These participants 
were excluded from the study, leaving 2,265 participants for inclusion in the current 
study sample. No other co-morbid conditions were used to exclude participants. See 
Figure 3 for the flow chart of the steps for including and excluding subjects for this 
study.  
Description of the Study Sample 
The study sample was comprised of 2,265 U.S. adults aged 20-39 years who 
participated in NHANES 1999-2008 and did not have known diabetes or fasting 
glucose level ≥ 126 mg/dl at the time of participation. These subjects had complete 
data on measures of major depression, fasting glucose and insulin level. The weighted 
mean age of the population was 29.5 years (SE = 0.18). The demographic 
characteristics of the study sample and the weighted percent for the population that 
the study sample represented are shown in Table 6. In the study sample, 1,054 
subjects (46.5%) were male and 1,211 (53.5%) were female. The weighted percent of 
males and females in the population that the study sample represented was 50.2% (SE 
= 1.15) and 49.8% (SE = 1.15) respectively. Most participants were non-Hispanic  
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Study sample 
(n = 2,265) 
Had known 
diabetes? Yes (n = 60) 
No (n = 2,488) 
Had fasting 
glucose ≥ 
126 mg/dl? 
Yes (n = 27) 
No (n = 2,461) 
Yes (n = 2,265) 
Had fasted ≥ 
8 hours but 
≤ 24 hours? 
No (n = 196) 
Eligible adults aged 20-39 years selected to 
participate in NHANES 1999-2008 
(N = 11,617) 
Complete home 
interview? 
Yes (n = 9,195) 
No (n = 2,422) 
Complete health 
examination? 
Yes (n = 8,751) 
No (n = 444) 
No (n = 6,203) 
Yes (n = 2,548) 
Had complete data 
on major depression, 
fasting glucose and 
insulin level? 
 
Figure 3. Flow Chart of Study Subjects‟ Inclusion and Exclusion 
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Whites (n = 978, 43.2%), followed by Mexican Americans (n = 568, 25.1%), 
non-Hispanic Blacks (n = 462, 20.4%), and other race/ethnicity (n = 257, 11.3%). 
The weighted percent for each race/ethnicity in the population that the study sample 
represented was 64.4% (SE = 1.6), 12.0% (SE = 0.9), 11.8% (SE = 1.0), and 11.8% 
(SE = 1.1) for non-Hispanic Whites, Mexican Americans, non-Hispanic Blacks, and 
other race/ethnicity respectively.  
Two subjects had missing values for education status. Among the remaining 
2,263 subjects, more (n = 685; 30.3%) had some college education or an Associate‟s 
degree, 575 (25.4%) had graduated from high school or had passed a general 
education development (GED) test, 458 (20.2%) were college graduates, 384 (17.0%) 
had finished the 9
th
 to 11
th
 grade, and 161 (7.0%) had less than the 9
th
 grade education. 
The weighted percentages for education levels in the population represented by the 
study sample were 32.2% (SE = 1.2), 25.1% (SE = 1.5), 25.0% (SE = 1.3), 13.2% (SE 
= 1.1), and 4.5% (SE = 0.5) for some college education or an Associate‟s degree, 
college graduates, high school graduate or GED, the 9
th
 to 11
th
 grade, and less than 
the 9
th
 grade, correspondingly.  
Data on marital status were available for 2,235 of the 2,265 (98.7%) subjects. 
Approximately half (n = 1,046, 46.8%) were married, about one third (n = 721, 
32.3%) were never married, more than 10% (n = 309, 13.8%) were living with 
partner, less than 5% (n = 98, 4.4%) were divorced, 2.6% (n = 59) were separated, 
and 0.1% (n = 2) were widowed. The weighted percentages of marital status in the 
 117 
population that the study sample represented were 45.2% (SE = 1.5), 33.9% 
(SE = 1.5), 13.5% (SE = 1.3), 5.1% (SE = 0.5), 2.2% (SE = 0.4), and 0.1% (SE = 0.1) 
accordingly for married, never married, living with partner, divorced, separated, and 
widowed.  
Prevalence of Major Depression 
Prevalence of Major Depression among Nondiabetic U.S. Adults Aged 20-39 Years 
for NHANES 1999-2008 
The prevalence of major depression among nondiabetic adults aged 20-39 years 
was estimated from data on subjects aged 20-39 years who were nondiabetic and had 
data on the measures of major depression but may not have had data on fasting 
glucose and insulin levels (N = 2,287). The number of subjects who had major 
depression, regardless of depression measures, was 84 or 3.8 % (84/2287, SE = 0.4). 
The prevalence rates of major depression among nondiabetic adults aged 20-39 years 
are presented in Table 7 by gender, race/ethnicity, and measures of depression. 
Females (48 out of 1223, weighted % = 4.3, SE = 0.7) had a higher prevalence of 
major depression than males (36 out of 1064, weighted % = 3.3, SE = 0.7), but the 
differences were not statistically significant (Rao-Scott modified χ
2
 = 1.09, df = 1, p 
=.30). Major depression was the most prevalent among non-Hispanic Whites (45 out 
of 989, weighted % = 4.4, SE = 0.6), followed by non-Hispanic Blacks (18 out of 468, 
weighted % = 4.0, SE = 1.0), Mexican Americans (16 out of 572, weighted % = 2.5,  
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SE = 0.7), and other race/ethnicity (5 out of 258, weighted % = 1.4, SE = 0.8) 
(Rao-Scott modified χ
2
 = 12.12, df = 3, p = .007). When stratified by the measures of 
depression, 54 out of 941 subjects (weighted % = 6.6, SE = 0.9) in NHANES 
1999-2004 had major depression measured by the Composite International Diagnostic 
Interview (CIDI). In contrast, only 1.8 % of subjects (30 out of 1346, SE = 0.4) in 
NHANES 2005-2008 had major depression that was assessed by the Patient Health 
Questionnaire 9 (PHQ-9). The differences by measures of depression were 
statistically significant (Rao-Scott modified χ
2
 = 24.50, df = 1, p <.0001) 
Prevalence of Major Depression in the Study Sample 
The overall prevalence rate of major depression among nondiabetic adults aged 
20-39 years in the study sample who had data on the measure of major depression, 
fasting glucose and insulin levels was comparable to the weighted rate (84 out of 
2,265 = 3.7%; weighted % = 3.8, SE = 0.4). The prevalence of major depression in 
the study sample by gender, race/ethnicity, and measures of depression are reported in 
Table 8. The number of female (n = 48) and male subjects (n = 36) who had major 
depression in the study sample was the same as that in the population. The prevalence 
of major depression for females (weighted % = 4.4, SE = 0.7) and males (weighted % 
= 3.3, SE = 0.7) in the study sample was relatively similar to the population 
proportion. Although the prevalence of major depression was higher among females 
in the study relative to males, the differences were not statistically significant 
(Rao-Scott modified χ
2
 = 1.13, df = 1, p = .29).  
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The prevalence of major depression by race/ethnicity found in the study 
sample also was significantly different (Rao-Scott modified χ
2
 = 12.23, df = 3, p 
=.007), and was similar to the population proportion. Non-Hispanic Whites had the 
higher prevalence of major depression (weighted % = 4.6, SE = 0.6), relative to 
non-Hispanic Blacks (weighted % = 4.1, SE = 1.0), Mexican Americans (weighted % 
= 2.5, SE = 0.7), or other race/ethnicity (weighted % = 1.4, SE = 0.8). As before, the 
prevalence of major depression in the study sample diagnosed by the CIDI in 
NHANES 1999-2004 (54 out of 931; weighted % = 6.6, SE = 0.9) was significantly 
higher than that evaluated by the PHQ-9 (30 out of 1,334; weighted % = 1.8, SE = 0.4) 
in NHANES 2005-2008 (Rao-Scott modified χ
2
 = 24.21, df = 1, p <.0001).  
Prevalence of Insulin Resistance 
A homeostasis model assessment for insulin resistance (HOMA-IR) score was 
calculated for all subjects in NHANES 1999-2008 who were aged ≥ 20 years, 
nondiabetic, and had complete data on fasting glucose and insulin levels (n = 8,894). 
According to Balkau and Charles (1999), it is important that the 75 percentile of 
HOMA-IR scores used to define insulin resistance be established from the general 
population without previously diagnosed diabetes. The formula used for the 
calculation was: HOMA-IR = [fasting glucose (mmol/L) × fasting insulin 
(U/mL)]/22.5. The 75 percentile of the HOMA-IR scores among nondiabetic adults 
aged ≥ 20 years in NHANES 1999-2008 was 3.4351, which was used as the cutoff 
value to define insulin resistance for this study.  
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Prevalence of Insulin Resistance among Nondiabetic U.S. Adults Aged 20-39 
Years for NHANES 1999-2008 
The prevalence of insulin resistance among nondiabetic adults aged 20-39 years 
was estimated from data on subjects aged 20-39 years who were nondiabetic and had 
data on fasting glucose and insulin levels but may not have data on the measure of 
major depression (N = 3,474). Of these, 874 subjects (25.2%) had a HOMA-IR score 
≥ 3.4351 and were defined as having insulin resistance (weighted % = 22.5, SE = 1.0). 
Table 9 presents the prevalence of insulin resistance in the population of nondiabetic 
adults aged 20-39 years by gender and race/ethnicity. As shown in Table 9, males 
(415 out of 1586, weighted % = 24.5, SE = 1.2) had a significantly higher prevalence 
of insulin resistance than females (459 out of 1888, weighted % = 20.5, SE = 1.3) 
(Rao-Scott modified χ
2
 = 6.97, df = 1, p = .008).  
Insulin resistance was the most prevalent among Mexican Americans (266 out of 
876, weighted % = 31.0, SE = 2.0), followed by non-Hispanic Blacks (214 out of 713, 
weighted % = 30.1, SE = 2.2), non-Hispanic Whites (307 out of 1499, weighted % = 
20.0, SE = 1.2), and other race/ethnicity (87 out of 386, weighted % = 20.0, SE = 2.7) 
(Rao-Scott modified χ
2
 = 29.9, df = 3, p < .0001). When stratified by gender, insulin 
resistance was most prevalent among non-Hispanic Black females (weighted % = 
36.2, SE = 2.8), followed by Mexican American females (weighted % = 29.4, SE = 
2.7), non-Hispanic White females (weighted % = 17.0, SE = 1.8), other race/ethnicity  
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(weighed % = 14.8, SE = 3.1) (Rao-Scott modified χ
2
 = 45.38, df = 3, p 
< .0001). In contrast, Mexican American males had the highest prevalence of insulin 
resistance (32.3%, SE = 2.61), in comparison to non-Hispanic White males 
(weighted % = 23.1, SE = 1.5), non-Hispanic Black males (weighted % = 22.8, SE = 
2.6), and other racial/ethnic males (weighted % = 24.9, SE = 3.6) (Rao-Scott modified 
χ
2
 = 8.48, df = 3, p = .037).  
Prevalence of Insulin Resistance in the Study Sample 
HOMA-IR scores among nondiabetic adults aged 20-39 years who had data on 
the measure of major depression, fasting glucose and insulin levels in the study 
sample ranged from 0.30 to 48.6 with a weighted mean of 2.7 (SE = 0.06). Of the 
2265, 582 (25.7%) subjects had a HOMA-IR score ≥ 3.4351 and were defined as 
insulin resistant. The weighted prevalence of insulin resistance in the study sample 
was 22.7% (SE = 1.1). Subjects with a HOMA-IR < 3.4351 (n = 1,683; 74.3%) were 
defined as non-insulin resistant. The prevalence of insulin resistance in the study 
sample by gender and race/ethnicity are summarized in Table 10. 
Males had a significantly higher prevalence of insulin resistance (weighted % 
=25.5, SE = 1.4) than females (weighted % =19.8, SE = 1.5) (Rao-Scott modified χ
2
 = 
9.15, df = 1, p = .0025). In the study sample, insulin resistance was most prevalent 
among non-Hispanic Blacks (Rao-Scott modified χ
2
 = 26.9, df = 3, p < .0001). 
Non-Hispanic Blacks had slightly higher prevalence of insulin resistance (weighted % 
= 31.3, SE = 3.1) than Mexican Americans (weighted % = 31.2, SE = 2.0).  
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Non-Hispanic Whites had about 10% lower prevalence of insulin resistance 
(weighted % = 20.1, SE = 1.4), compared to non-Hispanic Blacks or Mexican 
Americans. Non-Hispanic Black females (weighted % = 37.3, SE = 4.3) and Mexican 
American males (weighted % = 33.1, SE = 2.8) had the highest prevalence of insulin 
resistance, when stratified by gender.  
Risk Factors for Insulin Resistance among the Study Sample 
Systolic Blood Pressure 
Systolic blood pressure was available for 2,222 of 2,265 subjects (98.1%). 
Systolic blood pressure readings ranged from 84 mmHg to 174 mmHg and averaged 
113.9 mmHg (SE = 0.3). Seventy five of the 2,222 subjects had a systolic blood 
pressure ≥ 140 mmHg (weighted % = 3.3, SE = 0.5), which indicated hypertension 
according to the Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) (Chobanian et 
al., 2003). Males had a higher systolic blood pressure on average (weighted mean = 
118.4 mmHg, SE = 0.5) than females (weighted mean = 109.3 mmHg, SE = 0.4). The 
proportion of males with a systolic blood pressure ≥ 140 mmHg was 5.4% (SE = 0.9), 
whereas only 1.1% of females had systolic blood pressure equal or larger than 140 
mmHg (SE = 0.3) (Rao-Scott modified χ
2
 = 20.9, df = 1, p < .0001). Non-Hispanic 
Blacks (weighted mean = 117.3 mmHg, SE = 0.6) had the highest systolic blood 
pressure on average relative to Mexican Americans (weighted mean = 113.2 mmHg, 
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SE = 0.6), non-Hispanic Whites (weighted mean = 113.5 mmHg, SE = 0.4), 
and other race/ethnicity (weighted mean = 113.0 mmHg, SE = 0.7). The highest 
percentage of subjects with a systolic blood pressure ≥ 140 mmHg was found in 
non-Hispanic Blacks (weighted % = 5.4, SE = 1.0); the lowest proportion of subjects 
with a systolic blood pressure ≥ 140 mmHg was observed among Mexican Americans 
(weighted % = 2.7, SE = 0.6) (Rao-Scott modified χ
2
 = 5.02, df = 3, p = .17). Table 11 
presents the means of systolic blood pressure and the proportions of subjects whose 
systolic blood pressure ≥ 140 mmHg by gender, race/ethnicity, and insulin resistance 
status.    
The average systolic blood pressure was 119.1 mmHg (SE = 0.7) for insulin 
resistant subjects. Although this average was within normal limits (< 120 mmHg) 
(Chobanian, et al., 2003), it was about 7 mmHg higher than the average of 112.3 
mmHg (SE = 0.4) for non-insulin resistant individuals. As shown in Table 11, 38 out 
of 570 insulin resistant subjects had systolic blood pressure equal or larger than 140 
mmHg (weighted % = 7.3, SE = 1.4). In comparison, the weighted percentage of 
non-insulin resistant subjects with a systolic blood pressure ≥ 140 mmHg was 2.0% 
(37 out of 1,652; SE = 0.4). The proportions of subjects with a systolic blood pressure 
≥ 140 mmHg between insulin resistant and non-insulin resistant subjects were 
statistically significant (Rao-Scott modified χ
2
 = 15.8, df = 1, p < .0001).  
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Triglyceride Level 
Values of fasting triglyceride level were missing for nine subjects (0.4%). Fasting 
triglyceride level among the 2,256 subjects with data on these levels ranged from 
14.0mg/dl to 1,779 mg/dl with a mean of 122.5 mg/dl (SE = 2.5). Six hundred and 
five subjects of the 2,256 had a triglyceride level ≥ 150 mg/dl (weighted % = 23.1, SE 
= 1.2), indicating borderline high triglycerides according to the clinical guideline on 
high blood cholesterol in adults from the National Cholesterol Education Program 
Adult Treatment Panel III (NCEP ATP III) (NCEP ATP III, 2002). Because of the 
highly skewed distribution, triglyceride values were log-transformed to approximate a 
normal distribution for logistic regression analyses. After log-transformation, the 
average log-transformed triglycerides was 4.62 mg/dl (SE = 0.02) with a range of 
2.64 mg/dl to 7.48 mg/dl. Table 12 provides the means of triglyceride level and the 
proportions of subjects with triglyceride level ≥ 150 mg/dl by gender, race/ethnicity, 
and insulin resistance status. 
Males had an average triglyceride level of 136.9 mg/dl (SE = 3.9) with a range of 
14.0 to 1,779 mg/dl. Of the 1,047 males, 290 had a triglyceride level ≥ 150 mg/dl 
(weighted % = 27.8, SE = 1.6). In contrast, the average triglyceride level among 
females was 108.0 mg/dl (SE = 2.3) with a range of 19.0 to 857 mg/dl. The number of 
females with a triglyceride level ≥ 150 mg/dl was 315 (weighted % = 18.5, SE = 1.5). 
The proportions of male and female subjects with a triglyceride level ≥ 150 mg/dl 
were significantly different (Rao-Scott modified χ
2
 = 18.5, df = 1, p < .0001). The  
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means of the log-transformed triglyceride level for males (weighted mean = 
4.7, SE = 0.02) and females (weighted mean = 4.5, SE = 0.02) were relatively similar. 
Mexican Americans had the highest average triglyceride level (weighted mean = 
138.9 mg/dl, SE = 5.2), followed by non-Hispanic Whites (weighted mean = 124.4 
mg/dl, SE = 3.5), and non-Hispanic Blacks (weighted mean = 100.7, SE = 5.4). About 
30.1% of Mexican Americans had a triglyceride level ≥ 150 mg/dl (194 out of 566, 
SE = 2.0), which was significantly higher than the 24.0% of non-Hispanic Whites (SE 
= 1.6), or the 13.3% of non-Hispanic Blacks (SE = 1.8) (Rao-Scott modified χ
2
 = 25.3, 
df = 3, p < .0001). After log-transformation, the means of triglyceride level across 
race/ethnicity were similar as shown in Table 12.  
Insulin resistant subjects had higher levels of triglycerides (weighted mean = 
172.9 mg/dl, SE = 6.5) than non-insulin resistant subjects (weighted mean = 107.7 
mg/dl, SE = 2.5). Of the 580 subjects who were insulin resistant, 261 had triglyceride 
level equal or larger than 150 mg/dl (weighted % = 44.2, SE = 2.9). In contrast, 344 
of 1,676 subjects who were non-insulin resistant (weighted % = 17.0, SE = 1.0) had 
triglyceride level ≥ 150 mg/dl. There was a significant difference in the percentages 
of subjects whose triglyceride level ≥ 150 mg/dl between subjects who had and did 
not have insulin resistance (Rao-Scott modified χ
2
 = 80.5, df = 1, p < .0001).  
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High Sensitivity C-Reactive Protein 
Data on high sensitivity C-reactive protein (hs-CRP) were available for 2,264 of 
2,265 subjects (99.9%). The majority of subjects (n = 2,018, weighted % = 92.0, SE = 
0.6) were classified as having low hs-CRP (hs-CRP < 1.0 mg/L). The number of 
subjects with moderate hs-CRP (1.0 mg/L ≤ hs-CRP ≤ 3.0mg/L) was 216 
(weighted % = 6.9, SE = 0.6). Only 30 subjects had hs-CRP larger than 3.0 mg/L 
(high hs-CRP) (weighted % = 1.1, SE = 0.3).  
The proportion of subjects with low, moderate, and high hs-CRP differed 
significantly by gender (Rao-Scott χ
2 
= 19.2, df = 2, p < .0001). The majority of males 
had hs-CRP values less than 1mg/L (weighted % = 95.1, SE = 0.8), 4% males had a 
moderate level of hs-CRP, and less than 1% males had hs-CRP > 3mg/L. In contrast, 
nearly 10% females had moderate levels of hs-CRP (174 out of 1,210; weighted % = 
9.8, SE = 1.0). The weighted percentage of females with hs-CRP less than 1 mg/L was 
88.9% (1,016 out of 1,210; SE = 0.8) and 1.3% had high hs-CRP (20/1210; SE = 0.5). 
The descriptive analyses of hs-CRP categories by gender, race/ethnicity, and insulin 
resistance status can be found in Table 13. 
Race/ethnicity and hs-CRP status also were significantly associated (Rao-Scott χ
2 
= 20.7, df = 6, p = .002). Non-Hispanic Blacks had the highest prevalence of 
moderate hs-CRP (weighted % = 11.4, SE = 1.3), followed by Mexican Americans 
(weighted % = 9.7, SE = 1.0) and non-Hispanic Whites (weighted % = 5.9, SE = 0.8). 
The percentage of non-Hispanic Black subjects who had hs-CRP level > 3mg/L was  
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2.0% (SE = 0.7), which was higher than that of non-Hispanic Whites 
(weighted % = 0.9, SE = 0.4) and Mexican Americans (weighted % = 0.6, SE = 0.3) 
(Table 13).  
The proportion of subjects in each hs-CRP category were independent of 
race/ethnicity among males (Rao-Scott modified χ
2 
= 8.12, df = 6, p = .23). For 
females, there was a significant association between hs-CRP status and race/ethnicity 
(Rao-Scott modified χ
2
 = 31.39, df = 6, p < .0001). More non-Hispanic Black females 
had moderate levels of hs-CRP (n = 48, weighted % = 18.0, SE = 2.3) or high levels 
of hs-CRP (n = 5, weighted % = 2.0, SE = 0.9) than females in the other racial/ethnic 
group. In contrast, more non-Hispanic White females had low levels of hs-CRP (n = 
458, weighted % = 90.4, SE = 1.1), relative to Mexican American females (n = 242, 
weighted % = 83.3, SE = 2.2), and non-Hispanic Black females (n = 186, weighted 
percent = 80.0, SE = 2.3).  
Hs-CRP status was significantly associated with insulin resistance (Rao-Scott 
modified χ
2 
= 47.3, df = 2, p < .0001). The 582 insulin resistant subjects had a higher 
prevalence of moderate (weighted % = 16.0, SE = 1.8) and high levels of hs-CRP 
(weighted % = 1.7, SE = 0.7), relative to non-insulin resistant individuals and a lower 
prevalence of low hs-CRP (weighted % = 82.4, SE = 1.8) relative to non-insulin 
resistant subjects (weighted % = 94.8, SE = 0.6) (Table 13).  
 135 
Body Mass Index 
Data on body mass index (BMI) was complete for 2,254 of 2,265 subjects in the 
study sample (99.5%). Overall, the average BMI was 27.4 kg/m
2 
(SE = 0.16) with a 
range of 15.5 kg/m
2 
to 72.6 kg/m
2
. Mean BMI and BMI distribution by gender, 
race/ethnicity, and insulin resistance status are reported in Table 14.  
Approximately 2.9% of subjects (51 of 2,254; SE = 0.5) had a BMI < 18.5 kg/m
2
 
indicating they were underweight, 40.4% of subjects (809 out of 2,254; SE = 1.3) had 
normal weight, 28.9% of subjects (694 of 2,254; SE = 1.2) had a BMI of 25-29.9 
kg/m
2
 indicating they were overweight, and 27.8% of subjects (700 of 2,254; SE = 
1.2) had a BMI ≥ 30 kg/m
2
 indicating they were obese. By gender, the mean BMI for 
males was 27.3 kg/m
2 
(SE = 0.2) and the mean BMI for females was 27.4 kg/m
2
 (SE = 
0.3). However, more females were underweight (weighted % = 4.1, SE = 0.7) or 
obese (weighted % = 30.8, SE = 1.7) relative to males and more males were 
overweight (weighted % = 35.3, SE = 1.9) than females (weighted % = 22.5, SE = 1.5) 
(Rao-Scott modified χ
2 
= 32.66, df = 3, p < .0001).  
Non-Hispanic Blacks had the highest average BMI (weighted mean = 29.6 kg/m
2
, 
SE = 0.4), followed by Mexican Americans (weighted mean = 27.9 kg/m
2
, SE = 0.3), 
non-Hispanic Whites (weighted mean = 27.0 kg/m
2
, SE = 0.2), and other 
race/ethnicity (weighted mean = 26.7 kg/m
2
, SE = 0.5). Obesity (BMI ≥ 30 kg/m
2
) 
was most prevalent among non-Hispanic Blacks (weighted % = 43.3, SE = 2.1), 
followed by Mexican Americans (weighted % = 29.9, SE = 2.6), and non-Hispanic  
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Whites (weighted % = 25.2, SE = 1.7) (Rao-Scott modified χ
2 
= 60.57, df = 9, 
p < .0001). In contrast, more Mexican Americans (weighted % = 38.5, SE =2.4) were 
overweight than non-Hispanic Whites (weighted % = 27.8, SE = 1.7) or non-Hispanic 
Blacks (weighted % = 22.8, SE = 1.9). Normal BMI was highest among non-Hispanic 
Whites (weighted % = 43.4, SE = 1.8), relative to other races/ethnicities. When 
stratified by gender, non-Hispanic Black females had the highest BMI (weighted 
mean = 31.1 kg/m
2
, SE = 0.51), followed by Mexican American females (weighted 
mean = 28.4 kg/m
2
, SE = 0.51) and non-Hispanic White females (weighted mean = 
26.7 kg/m
2
, SE = 0.4). Among males, the average BMI was similar across 
race/ethnicity.  
Compared to non-insulin resistant subjects (weighted mean = 25.5 kg/m
2
, SE = 
0.2), insulin resistant subjects had a higher BMI (weighted mean = 33.8 kg/m
2
, SE = 
0.3). T-test showed that the average BMI differed significantly between insulin 
resistant and non-insulin resistant subjects [t (75) = 21.28, p < .0001]. Weight 
categories were significantly associated with insulin resistance status (Rao-Scott 
modified χ
2 
= 432.84, df = 3, p < .0001). More than 90% of insulin resistant subjects 
had a BMI ≥ 25 kg/m
2
. Of these, 67.1% were obese (SE = 2.4) and 23.5% were 
overweight (SE = 2.2). In comparison, most non-insulin resistant subjects had a BMI 
< 25 kg/m
2
 and were either underweight (weighted % = 3.7, SE = 0.6) or of normal 
weight (weighted % = 49.6, SE = 1.5) (Table 14).  
 138 
Waist Circumference 
Data on waist circumference were available for 2,236 of 2,265 subjects (98.7%). 
Mean waist circumference and the prevalence of central obesity by gender, 
race/ethnicity, and insulin resistance status are summarized in Table 15. The average 
waist circumference was 92.7 cm (SE = 0.39) with a range of 59.1 cm to 169.7 cm. 
Overall, males (weighted mean = 94.9 cm, SE = 0.5) had a larger waist circumference 
than females (weighted mean = 90.5 cm, SE = 0.6). Of the 2,236 subjects, 973 
(weighted % = 37.7, SE = 1.2) had central obesity, which is defined as a waist 
circumference > 88 cm (35 inches) for women and > 102 cm (40 inches) for men 
(NCEP ATP III, 2002). Females had a significant higher prevalence of central obesity 
than males (Rao-Scott modified χ
2 
= 67.71, df = 10, p < .0001).  
As shown in Table 15, waist circumference was largest among non-Hispanic 
Blacks (weighted mean = 95.1 cm, SE = 0.9), followed by Mexican Americans 
(weighted mean = 94.3 cm, SE = 0.7), non-Hispanic Whites (weighted mean = 92.5 
cm, SE = 0.6), and other race/ethnicity (weighted mean = 90.1 cm, SE = 1.2). Central 
obesity also was the most prevalent in non-Hispanic Blacks (weighted % = 45.8, SE = 
1.9) (Rao-Scott modified χ
2 
= 14.62, df = 3, p = .0022). When stratified by 
race/ethnicity, males generally had a larger waist circumference than females with the 
exception of non-Hispanic Blacks. Non-Hispanic Black females had larger waist 
circumference (weighted mean = 97.2 cm, SE = 1.17) than non-Hispanic Black males 
(weighted mean = 92.6 cm, SE = 1.19).  
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 140 
Insulin resistant subjects (weighted mean = 108.8 cm, SE = 0.8) had a 
significantly larger waist circumference than those without insulin resistance 
(weighted mean = 88.1 cm, SE = 0.4). T-test showed that the average waist 
circumference differed significantly between insulin resistant and non-insulin 
resistant subjects [t (75) = 21.01, p < .0001]. Over 70% of insulin resistant subjects 
had central obesity (SE = 2.3), in contrast to the 27.4% of non-insulin resistant 
subjects (SE = 1.3) (Rao-Scott modified χ
2 
= 172.88, df = 1, p < .0001).  
Leisure Time Physical Activity 
Data on leisure time physical activity (LTPA) were available for 2,264 of 2,265 
subjects (99.9%). Among these 2,264 subjects, 817 subjects (weighted % = 30.1, SE = 
1.2) self-reported having no LTPA. The number of subjects who reported that they 
participated in less than 500 MET minutes/week LTPA was 442 (weighted % = 20.9, 
SE = 1.0). Approximately 13.7 % of subjects (n = 292, SE = 1.1) reported 
participating in moderate LTPA (500 MET minutes/week ≤ LTPA ≤ 1000 MET 
minutes/week). Seven hundred and thirteen subjects (weighted % = 35.3, SE = 1.2) 
engaged in high levels of LTPA with a MET minutes/week larger than 1000. Table 16 
presents the prevalence of leisure time physical activity by gender, race/ethnicity, and 
insulin resistance status.  
LTPA varied significantly between males and females (Rao-Scott modified χ
2 
= 
20.44, df = 3, p = .0001). Among the 1,053 males, 422 subjects (weighted % = 41.0, 
SE = 1.7) reported high levels of LTPA with MET min/week larger than 1000, 127  
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subjects (weighted % = 12.6, SE = 1.3) reported engaging in moderate LTPA, 
185 subjects (weighted % = 18.5, SE = 1.5) reported participating in less than 500 
MET minutes/week (low level of LTPA), and 319 males (weighted % = 27.8, SE = 
1.8) reported having no LTPA. In total, more than half of males (549/1053, 
weighted % = 53.7) were physically active with a total MET minutes/week larger 
than 500, according to 2008 Physical Activity Guidelines for Americans by U.S. 
Department of Health and Human Services (2008). Among the females, less than one 
third (291/1,211; weighted % = 29.5, SE = 2.0) reported participating in high levels of 
LTPA, fewer than 15% of females (165/1,211; weighted % = 14.7, SE = 1.6) reported 
engaging in moderate levels of LTPA, approximately 20% of female subjects 
(257/1,211; weighted % = 23.4, SE = 1.3) reported participating in less than 500 MET 
minutes/week LTPA, and an alarming 30% females (498/1,211; weighted % = 32.4, 
SE = 1.6) reported having no LTPA. In sum, only 44.3% of females (456 out of 1,211) 
were physically active with a total MET minutes/week > 500.  
Rao-Scott modified Chi-Square test showed that LTPA differed by race/ethnicity 
(Rao-Scott modified χ
2 
= 54.4, df = 9, p < .0001). More than half of non-Hispanic 
Whites reported engaging in moderate or high levels of LTPA (weighted % = 14.4, SE 
= 1.4 for moderate level of LTPA; weighted % = 37.8, SE = 1.6 for high level of 
LTPA). In contrast, the majority of Mexican Americans were physically inactive with 
45.6% reporting no LTPA (279/568, SE = 2.2) and 16.5% reporting low levels of 
LTPA (87/598, SE = 2.3). About 35.2% of non-Hispanic Blacks also reported not 
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engaging in LTPA (169/462, SE = 2.0), but a similar number of non-Hispanic 
Blacks reported participating in high LTPA (160/462, weighted % = 34.6, SE = 2.3).  
Among males, Mexican Americans had the highest percentage of no LTPA (n = 
110, weighted % = 40.3, SE = 3.2), compared to non-Hispanic Whites (n = 118, 
weighted % = 25.0, SE = 2.5), non-Hispanic Blacks (n = 54, weighted % = 24.3, SE = 
3.1), or other race/ethnicity (n = 37, weighted % = 31.6, SE = 4.9). Similarly, 
Mexican American females (169 out of 300, weighted % = 52.6, SE = 3.6) had the 
highest percentage of no LTPA, compared to any other racial/ethnic group. In contrast, 
non-Hispanic White females were the most physically active with 49.2 % of subjects 
engaging in moderate (85/528; weighted % = 15.9, SE = 2.3) to high LTPA (158/528; 
weighted % = 33.3, SE = 2.4), followed by other race/ethnicity (47 out of 144, 
weighted % = 38.1), non-Hispanic Blacks (79 out of 239, weighted % = 36.1), and 
Mexican Americans (85 out of 300, weighted % = 29.9).   
LTPA was significantly associated with insulin resistance (Rao-Scott modified χ
2
 
= 11.8, df = 3, p = .008). As shown in Table 16, a higher percentage of non-insulin 
resistant individuals reported participating in moderate to high level of LTPA 
(weighted % = 50.6) relative to insulin resistant subjects (weighted % = 43.6). More 
than one third of insulin resistant subjects reported no LTPA (240/582, weighted % = 
35.1, SE = 2.2), compared to 28.6% of non-insulin resistant individuals (SE = 1.3).  
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Smoking Status 
Two thousand and two hundred and sixty three of the 2,265 subjects had adequate 
data on their smoking status (99.9%). As discussed in Chapter III, current smoker was 
defined as self-report having smoked ≥ 100 cigarettes during a person‟s lifetime and 
current smoking every day or some days in the current study. Former smoker was 
defined as having smoked ≥ 100 cigarettes during a person‟s lifetime, but not 
currently smoking. Nonsmoker was defined as report of having smoked < 100 
cigarettes during a person‟s lifetime. Smoking status by gender, race/ethnicity, and 
insulin resistance are presented in Table 17. The majority of subjects (n = 1,380; 
weighted % = 57.1, SE = 1.2) were nonsmokers. About 15.3 % of subjects (n = 330, 
SE = 1.0) were former smokers. The number of current smokers was 553 (weighted % 
= 27.6, SE = 1.2). Smoking status was significantly associated with gender (Rao-Scott 
modified χ
2 
= 24.9, df = 2, p < .0001). About one third of males were current smokers 
(weighted % = 33.0, SE = 1.5), compared to the 22.5% of females who were current 
smokers (SE = 1.7). More females were nonsmokers (weighted % = 63.3, SE = 2.0) 
than males (weighted % = 51.0, SE = 1.5).  
Smoking status differed significantly by race/ethnicity (Rao-Scott modified χ
2 
= 
86.5, df = 6, p < .0001). More non-Hispanic Whites were current smokers 
(weighted % = 32.1, SE = 1.7), relative to non-Hispanic Blacks (weighted % = 25.8, 
SE = 2.4), other race/ethnicity (weighted % = 17.3, SE = 2.6), and Mexican 
Americans (weighted % =15.8, SE = 1.7). However, when stratified by gender, the  
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proportion of non-Hispanic White males (171/449, weighted % = 37.2, SE = 
2.1) that were current smokers was similar to the proportion of non-Hispanic Black 
males (82 out of 223, weighted % = 37.4, SE = 3.0) that were current smokers. In 
contrast, fewer Mexican American males (weighted % = 22.2, SE = 2.4) and females 
(weighted % = 7.3, SE = 1.8) were current smokers relative to the other 
races/ethnicities.   
There were significant differences in smoking status among insulin resistant 
subjects and non-insulin resistant subjects (Rao-Scott modified χ
2 
= 11.7, df = 2, p 
= .0028). More insulin resistant subjects (weighted % = 20.0, SE = 1.9) were former 
smokers than the non-insulin resistant individuals (weighted % = 13.9, SE = 1.2). 
Smoking was more prevalent among non-insulin resistant subjects (weighted % = 
29.2, SE = 1.6) than insulin resistant subjects (weighted % = 22.3, SE = 1.7). A 
similar percentage of nonsmokers was found among insulin resistant (weighted % = 
57.7, SE = 2.3) and non-insulin resistant subjects (weighted % = 57.0, SE = 1.4). 
Alcohol Consumption Status 
Out of 2,265 subjects, 2,261 (99.8%) had complete data on alcohol consumption. 
As discussed in Chapter III, nondrinker was defined as report of having less than 12 
drinks in one‟s lifetime in the current study. Former drinker was defined as report of 
having at least 12 drinks in one‟s lifetime but had no drinks in the past 12 months. 
Light drinker was defined as report of having an average of ≤ 3 drinks per week. 
Moderate drinker was defined as report of having an average of 4 to 14 drinks per 
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week for men or 4 to 7 drinks per week for women (U.S. Department of 
Agriculture and U.S. Department of Health and Human Services, 2005). Heavy 
drinker was defined as report of having an average of > 14 drinks per week for men 
and > 7 drinks per week for women (CDC, 2010a).  
Nearly 90% of subjects (1,960/2,261) reported having had at least 12 drinks in 
their lifetime. Among these 1,960 subjects, 264 were former drinkers (weighted % = 
9.9, SE = 0.9) and 1,696 were current drinkers (weighted % = 79.2). Approximately 
48% of the 1,696 current drinkers were light drinkers (n = 1,088, weighted % = 47.9, 
SE = 1.3), 23.2% were moderate drinkers (n = 454, SE = 1.3), and 8.1% were heavy 
drinkers (n = 154, SE = 0.9). Alcohol consumption status by gender, race/ethnicity, 
and insulin resistance status are summarized in Table 18. 
Alcohol consumption status was significantly associated with gender (Rao-Scott 
modified χ
2 
= 164.00, df = 4, p < .0001). About 75% of the 1,052 males were either 
light (459/1,052; weighted % = 41.7, SE = 1.7) or moderate drinkers (339/1,052; 
weighted % = 33.6, SE = 1.8). Approximately 11% of males (107 out of 1,052; 
weighted % = 10.9, SE = 1.2) were heavy drinkers. In contrast, 66.9% females were 
either light drinkers (629 of 1,209; weighted % = 54.2, SE = 1.9) or moderate drinkers 
(115 out of 1,209; weighted % = 12.7, SE = 1.4). Less than 6% of females were heavy 
drinkers (47 out of 1,209; weighted % = 5.2, SE = 0.9). 
Alcohol consumption status differed by race/ethnicity (Rao-Scott modified χ
2 
= 
43.6, df = 12, p < .0001). Heavy drinkers were the most prevalent among  
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non-Hispanic Whites (weighted % = 9.8, SE = 1.4), followed by Mexican 
Americans (weighted % = 6.9, SE = 1.2), non-Hispanic Blacks (weighted % = 5.4, SE 
= 1.1), and other race/ethnicity (weighted % = 2.4, SE = 1.0). Conversely, other 
race/ethnicity had the highest percentage of light drinkers (weighted % = 55.3, SE = 
4.3) while non-Hispanic Whites had the lowest percentage (weighted % = 46.2, SE = 
2.1).  
By gender, non-Hispanic White males had the highest percentage of moderate 
(159 of 450, weighted % = 36.5, SE = 2.6) to heavy drinkers (60 of 450, weighted % 
= 13.5, SE = 1.9). Light drinkers were most prevalent among Mexican American 
males (130 of 268, weighted % = 47.6, SE = 3.2). Among females, non-Hispanic 
Whites had the highest prevalence of light (weighted % = 55.0, SE = 2.7), moderate 
(weighted % = 15.7, SE = 2.2) or heavy drinkers (weighted % = 6.2, SE = 1.4), 
compared to the other racial/ethnic groups.  
Alcohol consumption was significantly different between insulin resistant and 
non-insulin resistant subjects (Rao-Scott modified χ
2 
= 21.6, df = 4, p = .0002). As 
demonstrated in Table 18, more non-insulin resistant subjects were moderate 
(weighted % = 24.1, SE = 1.6) or heavy drinkers (weighed % = 9.1, SE = 1.0) relative 
to insulin resistant subjects. Conversely, more insulin resistant individuals were either 
nondrinkers (weighted % = 11.3, SE = 1.7), former drinkers (weighted % = 13.6, SE = 
1.7) or light drinkers (weighted % = 50.7, SE = 2.2).  
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Correlations among Independent Variables 
Correlations between Continuous Independent Variables  
Pearson correlations were conducted to examine the correlations among the 
continuous independent variables. According to Cohen (1988), a correlation 
coefficient of .1 is small, .3-.5 is moderate, and > .5 is large. In this study, most of the 
correlation coefficients ranged from .08 to .36, indicating low to moderate 
correlations (Cohen, 1988). Body mass index (BMI) and waist circumference were 
highly correlated with each other (r = .92, p < .0001). The highly correlated BMI and 
waist circumference were entered into multivariate logistic regression analyses 
separately to avoid their multicollinearity. The inter-correlation coefficients among 
continuous independent variables are presented in Table 19.  
Correlations between Categorical Independent Variables  
Pearson correlations also were conducted to examine the correlations among 
categorical independent variables. The correlation coefficients ranged from -.11 to .29, 
indicating small correlations (Cohen, 1988). Table 20 provides the inter-correlation 
coefficients among categorical independent variables.  
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Logistic Regression Analyses 
Univariate Logistic Regression 
Univariate logistic regression analyses revealed that major depression was not 
associated with insulin resistance (B = 0.1442, p = .5545). The odds ratio for subjects 
with major depression to develop insulin resistance was 1.155 with 95% confidence 
interval (CI) ranging from 0.716 to 1.863.  
Interaction between Gender and Major Depression 
Major depression was negatively associated with insulin resistance (B = -0.6715, 
p = .0324) in the model when major depression, gender and the interaction term for 
major depression and gender were entered. A significant interaction between gender 
and major depression (B = 1.3942, p = .0031) was found. Therefore, separate 
multivariate logistic regression models were conducted for men and women. 
Covariates entered into each model included age, race/ethnicity, systolic blood 
pressure, triglyceride level, hs-CRP, BMI or waist circumference, leisure time 
physical activity (LTPA), smoking, and alcohol consumption. BMI and waist 
circumference were tested in separate models.  
Adjusted Logistic Regression among Men in the Model with BMI   
Among men, major depression was negatively associated with insulin resistance 
(B = -1.2128, p = .0035, OR = 0.297, 95% CI = [0.132, 0.671]), when adjusting for 
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age, race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, BMI, 
LTPA, smoking, and alcohol consumption. Age was not associated with insulin 
resistance in this model (B = -0.0206, p = .2929, OR = 0.980, 95% CI = [0.943, 
1.018]). The model fit statistics of -2 log likelihood and AIC were 18738539 and 
18738579 respectively. Results of the adjusted logistic regression among men in the 
model with BMI as one of the covariates are presented in Table 21. 
Compared to non-Hispanic White men, Mexican American men were more likely 
to be insulin resistant (B = 0.4975, p = .0330, OR = 1.645, 95% CI = [1.041, 2.599]). 
However, no significant association between non-Hispanic Black men and insulin 
resistance was found (B = 0.2301, p = .3975, OR = 1.259, 95% CI = [0.739, 2.145]). 
Similarly, being of other race/ethnicity was not associated with insulin resistance (B = 
0.1212, p = .7008, OR = 1.129, 95% CI = [0.608, 2.094]). 
BMI was significantly and positively associated with insulin resistance (B = 
0.2268, p < .0001, OR = 1.255, 95% CI = [1.195, 1.318]) among men. For every 1 
unit change in BMI, the likelihood of having insulin resistance increases by 25.5%, 
after controlling for other variables including age, race/ethnicity, major depression, 
systolic blood pressure, triglyceride level, hs-CRP, smoking, LTPA and alcohol 
consumption.  
A significant positive relationship between systolic blood pressure and insulin 
resistance also was observed (B = 0.0213, p = .0358, OR = 1.022, 95% CI = [1.001, 
1.042]) among men, after adjusting for age, race/ethnicity, major depression,  
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triglyceride level, hs-CRP, BMI, smoking, LTPA and alcohol consumption. 
There also was a strong positive association between triglyceride level and insulin 
resistance (B = 1.1460, p < .0001, OR = 3.146, 95% CI = [2.185, 4.530]). However, 
hs-CRP was not significantly associated with insulin resistance, regardless of hs-CRP 
levels.  
Compared to nonsmokers, males who were former smokers were more likely to 
have insulin resistance (B = 1.0073, p < .0001, OR = 2.738, 95% CI = [1.758, 4.264]). 
There was no significant relationship between current smokers and insulin resistance 
(B = -0.0830, p = .7232, OR = 0.920, 95% CI = [0.581, 1.457]). The association 
between LTPA and insulin resistance was not statistically significant. Also, no 
significant relationship between alcohol consumption and insulin resistance was 
found among men.  
Adjusted Logistic Regression among Men in the Model with Waist Circumference 
Waist circumference was entered into the adjusted logistic regression model to 
replace BMI to examine the strength of the association with insulin resistance among 
men. Compared to the adjusted logistic regression model with BMI as one of the 
covariates, the significance of the model with waist circumference were: 1) the 
negative association between major depression and insulin resistance remained 
significant (B = -1.2219, p = .0033, OR = 0.295, 95% CI = [0.130, 0.666]); 2) age 
became a significant predictor for insulin resistance (B = -0.0394, p = .0465, OR = 
0.961, 95% CI = [0.925, 0.999]); 3) the association between Mexican Americans and 
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insulin resistance remained significant, but was stronger (B = 0.7116, p 
= .0033, OR = 2.037, 95% CI = [1.267, 3.275]); 4) the association between 
non-Hispanic Blacks and insulin resistance became significant (B = 0.6368, p = .0238, 
OR = 1.890, 95% CI = [1.088, 3.283]); 5) waist circumference was significantly 
associated with insulin resistance (B = 0.0909, p < .0001, OR = 1.095, 95% CI = 
[1.076, 1.115]), but the strength of this relationship was less than BMI to insulin 
resistance; 6) triglyceride level continued to be a significant predictor of insulin 
resistance, but the association between systolic blood pressure and insulin resistance 
was attenuated to nonsignificance; 7) former smoker remained a significant predictor 
of insulin resistance. The model fit statistics of -2 log likelihood and AIC were 
18446247 and 18446287 respectively. The complete results of the adjusted logistic 
regression model with waist circumference among men are presented in Table 22.  
Adjusted Logistic Regression among Women in the Model with BMI   
No significant association between major depression and insulin resistance was 
found among women (B = 0.5733, p = .2685, OR = 1.774, 95% CI = [0.643, 4.898]), 
when adjusting for age, race/ethnicity, systolic blood pressure, triglyceride level, 
hs-CRP, BMI, smoking, LTPA, and alcohol consumption. Age was not associated 
with insulin resistance (B = -0.0306, p = .1774, OR = 0.970, 95% CI = [0.928, 
1.014]). The model fit statistics of -2 log likelihood and AIC were 14617758 and 
14617798 respectively. Results of the adjusted logistic regression among women in 
the model with BMI as one of the covariates are presented in Table 23. 
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Compared to non-Hispanic Whites, non-Hispanic Black women were 
more likely to be insulin resistant (B = 0.8988, p = .0089, OR = 2.457, 95% CI = 
[1.252, 4.820]). However, no significant association between Mexican American 
women and insulin resistance was found (B = 0.4701, p = .1368, OR = 1.600, 95% CI 
= [0.861, 2.972]). Similarly, being of other race/ethnicity was not associated with 
insulin resistance (B = -0.2504, p = .5241, OR = 0.778, 95% CI = [0.360, 1.682]). 
BMI was a significant predictor for insulin resistance among women (B = 0.1990, 
p < .0001, OR = 1.220, 95% CI = [1.182, 1.260]). For every 1 unit change in BMI, 
the risk of insulin resistance increases 22%, controlling for age, race/ethnicity, major 
depression, systolic blood pressure, triglyceride level, hs-CRP, smoking, LTPA and 
alcohol consumption.  
A significant positive relationship between systolic blood pressure and insulin 
resistance also was found among women (B = 0.0306, p = .0097, OR = 1.031, 95% 
CI = [1.007, 1.055]), after adjusting for age, race/ethnicity, major depression, 
triglyceride level, hs-CRP, BMI, smoking, LTPA and alcohol consumption. 
Triglyceride level was significantly associated with insulin resistance among women 
(B = 1.5321, p < .0001, OR = 4.628, 95% CI = [3.276, 6.538]). Hs-CRP was not 
associated with insulin resistance, regardless of hs-CRP levels. Similarly, there was 
no association between smoking status and insulin resistance in women. No 
significant association was found between LTPA and insulin resistance. The 
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association between alcohol consumption and insulin resistance also was not 
significant either.  
Adjusted Logistic Regression among Women in the Model with Waist Circumference 
Waist circumference was entered into the adjusted logistic regression model to 
replace BMI to examine the strength of the association with insulin resistance among 
women. Compared to the adjusted logistic regression model with BMI as one of the 
covariates, the significances of the model with waist circumference were: 1) the 
relationship between major depression and insulin resistance remained insignificant 
(B = 0.5034, p = .2590, OR = 1.654, 95% CI = [0.690, 3.965]); 2) the association 
between being non-Hispanic Black and insulin resistance remained significant, but 
the strength of the association increased (B = 0.9415, p = .0030, OR = 2.564, 95% CI 
= [1.376, 4.776]); 3) waist circumference was significantly associated with insulin 
resistance (B = 0.0808, p < .0001, OR = 1.084, 95% CI = [1.064, 1.105]), however, 
the strength of this relationship was less than the strength of relationship of BMI to 
insulin resistance; 4) systolic blood pressure and triglyceride level continued to be 
significant predictors for insulin resistance; 5) moderate level of hs-CRP became a 
significant predictor for insulin resistance (B = 0.5924, p < .0295, OR = 1.808, 95% 
CI = [1.061, 3.083]). The model fit statistics of -2 log likelihood and AIC were 
14868518 and 14868558 respectively. The complete results of the adjusted logistic 
regression model with waist circumference among women are presented in Table 24.  
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Interaction between Race/Ethnicity and Major Depression 
Major depression was not significantly associated with insulin resistance (B = 
0.1909, p = .5420) in the model when major depression, race/ethnicity and the 
interaction term for major depression and race/ethnicity were entered. Although there 
was a significant association between race/ethnicity and insulin resistance (Wald χ
2
 = 
30.7612, p < .0001), the interaction between race/ethnicity and major depression was 
not statistically significant (Wald χ
2 
= 4.2927, p = .2315).  
Because of the nonsignificant interaction between race/ethnicity and major 
depression, no separate multivariate logistic regression models were conducted by 
race/ethnicity. However, the alternative, as identified in the list of research questions 
and statistical analysis was logistic regression analysis to examine the association 
between major depression and insulin resistance (main effect), controlling for age, 
gender, race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, BMI or 
waist circumference, LTPA, smoking, and alcohol consumption. BMI and waist 
circumference were tested in separate models. The results of these logistic regression 
analyses are presented below.  
Adjusted Logistic Regression Model among the Study Sample in the Model with BMI 
Logistic regression model was performed in the whole study sample, adjusted for 
age, gender, race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, BMI, 
LTPA, smoking, and alcohol consumption. Major depression was not associated with 
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insulin resistance (B = -0.1878, p = .6360, OR = 0.829, 95% CI = [0.381, 
1.804]), when adjusting for age, gender, race/ethnicity, systolic blood pressure, 
triglyceride level, hs-CRP, BMI, smoking, leisure-time physical activity (LTPA), and 
alcohol consumption. Age was not associated with insulin resistance (B = -0.0217, p 
= .1113, OR = 0.979, 95% CI = [0.953, 1.005]). The model fit statistics of -2 log 
likelihood and AIC were 34159478 and 34159520 respectively. Table 25 
demonstrates the results of adjusted logistic regression analyses among the whole 
study sample with BMI as one of the covariates. 
Compared to non-Hispanic Whites, Mexican Americans were more likely to be 
insulin resistant (B = 0.5014, p = .0040, OR = 1.651, 95% CI = [1.174, 2.322]). 
Similarly, a significant association between non-Hispanic Black and insulin resistance 
was found (B = 0.5252, p = .0149, OR = 1.691, 95% CI = [1.108, 2.581]). However, 
being of other race/ethnicity was not associated with insulin resistance (B = 0.00925, 
p = .9716, OR = 1.009, 95% CI = [0.606, 1.608]). 
BMI was positively associated with insulin resistance (B = 0.2091, p < .0001, OR 
= 1.233, 95% CI = [1.201, 1.265]). For every 1 unit change in BMI, the likelihood of 
having insulin resistance increases 23.3%, after controlling for other variables 
including age, gender, race/ethnicity, major depression, systolic blood pressure, 
triglyceride level, hs-CRP, smoking, LTPA and alcohol consumption.  
A significant positive relationship between systolic blood pressure and insulin 
resistance was observed (B = 0.0244, p = .0023, OR = 1.025, 95% CI = [1.009,  
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1.041]), after adjusting for age, gender, race/ethnicity, major depression, 
triglyceride level, hs-CRP, BMI, smoking, LTPA and alcohol consumption.  
There was a strong positive association between triglyceride level and insulin 
resistance (B = 1.1962, p < .0001, OR = 3.307, 95% CI = [2.651, 4.126]). Hs-CRP 
was not significantly associated with insulin resistance, regardless of hs-CRP levels.  
Compared to nonsmokers, former smokers were more likely to have insulin 
resistance (B = 0.4754, p = .0137, OR = 1.609, 95% CI = [1.102, 2.347]). LTPA was 
not associated with insulin resistance, regardless of level. No significant association 
between alcohol consumption and insulin resistance was observed.  
Adjusted Logistic Regression among the Study Sample in the Model with Waist 
Circumference 
Logistic regression modeling was performed again after removing BMI from the 
model and replacing this variable with waist circumference to examine the strength of 
the association with insulin resistance. The modeling procedure adjusted for age, 
gender, race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, waist 
circumference, LTPA, smoking, and alcohol consumption in the analyses. Compared 
to the adjusted logistic regression model with BMI, the significance of the model with 
waist circumference were: 1) the negative association between major depression and 
insulin resistance remained insignificant (B = -0.1451, p = .6660, OR = 0.865, 95% 
CI = [0.447, 1.672]); 2) age became a significant predictor for insulin resistance (B = 
 167 
-0.0278, p = .0434, OR = 0.973, 95% CI = [0.947, 0.999]); 3) the association 
between Mexican Americans and insulin resistance remained significant, but the 
strength of the relationship increased (B = 0.6330, p = .0005, OR = 1.883, 95% CI = 
[1.319, 2.689]); 4) being a non-Hispanic Black remained a significant predictor for 
insulin resistance (B = 0.7604, p = .0004, OR = 2.139, 95% CI = [1.402, 3.264]); 5) 
waist circumference was significantly associated with insulin resistance (B = 0.0849, 
p < .0001, OR = 1.089, 95% CI = [1.077, 1.101]), however, the strength of the 
relationship to insulin resistance was less than for BMI (B = 0.2091, p < .0001, OR = 
1.233, 95% CI = [1.201, 1.265]); 6) systolic blood pressure and triglyceride level 
continued to be significant predictors for insulin resistance; 7) moderate hs-CRP was 
positively associated with insulin resistance (B = 0.5887, p = .0109, OR = 1.802, 95% 
CI = [1.145, 2.834]); 8) former smoker remained as a significant predictor for insulin 
resistance. The model fit statistics of -2 log likelihood and AIC were 34080111 and 
34080153 respectively. The complete results of the adjusted logistic regression model 
among the whole study sample with waist circumference are presented in Table 26.  
Univariate Logistic Regression by Measures of Depression 
The relationship between major depression and insulin resistance was 
investigated by type of depression measures to examine the influence of measurement 
type in the results. Univariate logistic regression analyses showed that major 
depression measured by the CIDI was not significantly associated with insulin 
resistance (B = 0.1083, p = .7470, OR = 1.114, 95% CI = [0.577, 2.152]). No  
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significant relationship was observed between major depression assessed by 
the PHQ-9 and insulin resistance, but the B coefficient became larger (B = 0.4816, p 
= .1556, OR = 1.619, 95% CI = [0.833, 3.146]). 
Adjusted Logistic Regression in the Model with BMI by Measures of Depression   
When adjusting for age, gender, race/ethnicity, BMI, systolic blood pressure, 
triglyceride level, hs-CRP, smoking status, LTPA, and alcohol consumption, the 
direction of the relationship between major depression and insulin resistance became 
negative but remained nonsignificant (B = -0.1621, p = .7560, OR = 0.850, 95% CI = 
[0.306, 2.364]) among participants whose measure of major depression was the CIDI. 
BMI, systolic blood pressure, and triglyceride level were significant predictors for 
insulin resistance, after controlling for major depression, age, gender, race/ethnicity, 
hs-CRP, smoking status, LTPA, and alcohol consumption. The model fit statistics of 
-2 log likelihood and AIC were 12849175 and 12849217 respectively. The results of 
the adjusted logistic regression analyses with BMI as one of the covariates among 
NHANES 1999-2004 participants who had measure of major depression by the CIDI 
are presented in Table 27. 
When major depression was measured by the PHQ-9 in NHANES 2005-2008, 
the direction of the relationship between major depression and insulin resistance 
changed but remained insignificant (B = -0.0634, p = .9043, OR = 0.939, 95% CI = 
[0.334, 2.640]), after adjusting for age, gender, race/ethnicity, BMI, systolic blood 
pressure, triglyceride level, hs-CRP, smoking status, LTPA, and alcohol consumption.  
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Non-Hispanic Blacks, Mexican Americans, BMI, triglyceride level, and 
former smokers were significant positive predictors for insulin resistance. The model 
fit statistics of -2 log likelihood and AIC were 20839533 and 20839575 respectively. 
The results of the adjusted logistic regression analyses with BMI as one of the 
covariates among NHANES 2005-2008 participants who had measure of major 
depression by the PHQ-9 are reported in Table 28. 
Adjusted Logistic Regression with Waist Circumference by Measures of Depression 
Major depression was insignificantly associated with insulin resistance (B = 
-0.0884, p = .8380, OR = 0.915, 95% CI = [0.392, 2.137]) among participants whose 
measure of major depression was the CIDI, after adjusting for age, gender, 
race/ethnicity, waist circumference, systolic blood pressure, triglyceride level, hs-CRP, 
smoking status, LTPA, and alcohol consumption. Being non-Hispanic Black, waist 
circumference, systolic blood pressure, and triglyceride level were significant 
predictors for insulin resistance, after controlling for major depression, age, gender, 
hs-CRP, smoking status, LTPA, and alcohol consumption. The model fit statistics of 
-2 log likelihood and AIC were 12824610 and 12824652 respectively. The results of 
the adjusted logistic regression analyses with waist circumference as one of the 
covariates among NHANES 1999-2004 participants who had measure of major 
depression by the CIDI are presented in Table 29. 
When major depression was measured by the PHQ-9 in NHANES 2005-2008, 
major depression was not associated with insulin resistance (B = 0.1406, p = .7174,  
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OR = 1.151, 95% CI = [0.538, 2.464]), after adjusting for age, gender, 
race/ethnicity, waist circumference, systolic blood pressure, triglyceride level, hs-CRP, 
smoking status, LTPA, and alcohol consumption. Being non-Hispanic Blacks or 
Mexican American, waist circumference, triglyceride level, and moderate hs-CRP 
were significant positive predictors for insulin resistance. The model fit statistics of -2 
log likelihood and AIC were 20735491 and 20735533 respectively. The results of the 
adjusted logistic regression analyses with waist circumference as one of the 
covariates among NHANES 2005-2008 participants who had measure of major 
depression by the PHQ-9 are reported in Table 30. 
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CHAPTER V DISCUSSION, RECOMMENDATIONS AND CONCLUSIONS 
The purpose of this study was to 1) determine the prevalence of major depression 
and insulin resistance among nondiabetic adults aged 20-39 years in the United States; 
2) examine the relationship between major depression and insulin resistance among 
nondiabetic U.S. adults aged 20-39 years; and 3) investigate the role of gender, 
race/ethnicity, and measure of depression on the relationship between major 
depression and insulin resistance. Data obtained from nondiabetic adults aged 20-39 
years who participated in the National Health and Nutrition Examination Survey 
(NHANES) 1999-2008 were analyzed for the prevalence of major depression and 
insulin resistance and their relationship. This chapter discusses the results of the study, 
identifies limitations to the study, conclusions and implications of the study, and 
makes recommendations for future research.  
Prevalence of Major Depression 
The overall prevalence of major depression among nondiabetic adults aged 20-39 
years was 3.8%. This 3.8% prevalence rate is lower than the 6.9% (Aalto-Setala, et al., 
2001) to 9% prevalence of depression reported by previous studies in young adults 
aged 20-39 years (Gwynn, et al., 2008). The rate also is lower than the 6.6% 
prevalence of major depression among nondiabetic adults aged 20-39 years who 
 177 
participated in NHANES 1999-2002 (Shen, et al., 2011). This finding is 
surprising as previous research reported that the prevalence of depression among 
young adults was higher than middle- and older-age adults in a review by Jorm 
(2000).  
When measured by the CIDI, the prevalence of major depression in the current 
study was 6.6%. This is lower than the 9% prevalence of 12-month major depression 
among adults aged 20-39 years reported by Gwynn et al. (2008), but comparable to 
the 6.6% prevalence of major depression among nondiabetic adults aged 20-39 years 
who participated in NHANES 1999-2002 reported by Shen et al. (2011). The 
prevalence of major depression evaluated by the PHQ-9 was 1.8%, which is 
surprisingly lower than the 7% found among adults aged 20 and older (Pratt & Brody, 
2010).  
Differences in reported depression rates for nondiabetic adults aged 20-39 years 
may result from variations in the definition of major depression and measures of 
depression. In Aalto-Setala et al.‟s study (2001), major depression for the previous 4 
weeks was measured by the Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN). Gwynn et al. (2008) examined the 12-month prevalence of major depression 
using the CIDI. However, in the study by Prat and Brody (2010), depression was 
assessed by the PHQ-9 and defined as a PHQ-9 score of 10 or higher which included 
moderate, moderately severe, and severe depression. In comparison, DSM-IV 
diagnostic criteria for major depression were applied in the current study by using the 
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CIDI which includes DSM-IV diagnostic criteria in its algorithm for a 
diagnosis of major depression (yes/no) and evaluating depressive symptoms reported 
in the PHQ-9 according to DSM-IV criteria to establish a diagnosis of major 
depression (yes/no); although the PHQ-9 may have underestimated the prevalence of 
major depression relative to the CIDI. In addition, it is possible that individuals 
experiencing major depression may have declined participation in NHANES, which 
may have contributed to the potential underestimation of the prevalence of major 
depression among nondiabetic adults aged 20-39 years. Further, the much lower 
prevalence rate of major depression, when evaluated by the PHQ-9, may be attributed 
to a time effect. The CIDI evaluates symptoms of depression present in the past 12 
months; while the PHQ-9 examines the presence of depressive symptoms in the past 
two weeks. Estimation of the prevalence rate of major depression by each NHANES 
period should be examined in future studies.  
Females had a higher overall prevalence rate of major depression (4.3%) than 
males (3.3%). Results are consistent with those from Gwynn et al. (2008), who found 
a 9% prevalence of depression in females and a 6% prevalence of depression among 
community-based adults in New York. This higher prevalence of major depression 
among females may be from gender differences in genetic predisposition, hormonal, 
and responses to adverse life events (CDC, 2010b). However, the 4.3% prevalence of 
major depression among females found in the current study is nearly half the 9% 
found in the study by Gwynn et al. (2008). The 3.3% prevalence of major depression 
found in males also is much lower than the 6% reported by Gwynn et al. (2008). The 
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discrepancies in the prevalence of major depression among females and 
males may be attributed to differing definitions of depression. The prevalence of 
depression reported by Gwynn et al. (2008) was estimated from any type of 
depression; while only major depression was included to calculate the prevalence rate 
in this study. Without delineation of the severity of depression, the prevalence rate of 
major depression was possibly overestimated in the study by Gwynn et al. (2008).  
The prevalence of major depression varied by race/ethnicity in the current study. 
Major depression was found to be the most prevalent among non-Hispanic Whites 
aged 20-39 years (4.4%). Compared to non-Hispanic Whites, non-Hispanic Blacks 
had a slightly lower prevalence rate of major depression (4.0%). The 2.5% rate of 
major depression found among Mexican Americans in the study was surprisingly 
lower than the 7% reported by Gwynn et al. (2008) in a community-based study 
among New York adults aged 20 years and older. Despite the 2.5% to 4.4% difference 
in prevalence rates, there was no significant interaction effect of race/ethnicity on the 
relationship between major depression and insulin resistance found in the study.  
The pattern of highest prevalence of major depression among non-Hispanic 
Whites, followed by non-Hispanic Blacks and Mexican Americans varied from the 
study conducted by Gwynn et al. (2008) that found the prevalence of major 
depression was highest among Black Americans (9%), followed by Whites (8%), 
Hispanics (7%), and Asians (5%). The race/ethnicity composition of the population 
for the current study also differed from that of the community-based New York adult 
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population in Gwynn et al.‟s study. The sample in the current study consisted 
of 11.8% non-Hispanic Blacks, and 12.0% Mexican Americans, in contrast to the 
26.6% Blacks and 27.0% Hispanics in Gwynn et al.‟s study. Therefore, the findings 
from Gwynn et al.‟s study may not be generalizable to general population in other 
regions. The different definitions of major depression also may have contributed to 
the discrepancies of prevalence rate across race/ethnicity.  
Prevalence of Insulin Resistance 
The prevalence of insulin resistance among nondiabetic adults aged 20-39 years 
who participated in NHANES 1999-2008 was 22.5%. This is slightly higher than the 
reported 21.5% of insulin resistance among Thai adults aged 35 years and older (Do, 
et al., 2010), but much lower than the 32.2% prevalence rate of insulin resistance 
among adults aged 20 to 85 years old found by Ioannou, Bryson, and Boyko (2007). 
The variations in the prevalence of insulin resistance may result from age differences 
in the study samples. Subjects in this study were younger than those in previous 
studies. Findings provide further evidence that insulin resistance can be present in 
young adults with euglycemia (Reaven, 1988).  
Insulin resistance was found to be significantly more prevalent among males 
(24.5%) than females (20.5%). This contradicts findings from previous research 
which showed that females are more insulin resistant than males from birth 
throughout adulthood (Wilkin & Murphy, 2006). Findings also were surprising given 
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that males had a higher level of self-reported leisure time physical activity 
than females in the study. Contextual information to explain these results were not 
collected and warrant further study.   
Both nondiabetic Mexican Americans and non-Hispanic Blacks aged 20-39 years 
had higher prevalence rates of insulin resistance than non-Hispanic Whites. The 
prevalence of insulin resistance among Mexican Americans was 31.0%, the rate of 
insulin resistance among non-Hispanic Blacks was 30.1%, and the prevalence of 
insulin resistance among non-Hispanic Whites was 20.0%. This 10% higher rate of 
insulin resistance among non-Hispanic Blacks and Mexican Americans is consistent 
with previous research, showing that Mexican Americans and non-Hispanic Blacks 
were the two racial/ethnic groups that have higher prevalence rates of insulin 
resistance and type 2 diabetes (Aguirre, et al., 1997; Karim, et al., 2005). The higher 
prevalence of insulin resistance among these two racial/ethnic groups may be 
attributed to genetic variants and environmental factors.  
The 75 percentile of HOMA-IR scores among normal healthy population is the 
most commonly used definition of insulin resistance in epidemiological research 
(Balkau & Charles, 1999). The current study used the 75 percentile of HOMA-IR 
scores (P75 = 3.4351) among nondiabetic adults aged 20 and above who participated 
in NHANES 1999-2008 and had complete data on fasting glucose and insulin levels 
to define insulin resistance. The cutoff value of HOMA-IR used in the study is lower 
than the value of 3.8 suggested by Ascaso et al. (2001). If the value of 3.8 were used 
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in the study, fewer subjects would have been classified as insulin resistance 
and the prevalence of insulin resistance would have been lower. Appel (2005) 
recommended a HOMA-IR of 2.8 - 3.0 as the cut point for insulin resistance to be 
used in clinical practice. This range of 2.8 - 3.0 is lower than the value of 3.4351 
found in the current study. More individuals would have been defined as insulin 
resistant in the current study if this range of 2.8 - 3.0 had been applied. Also the 
prevalence of insulin resistance would have been higher. Since there is no 
standardized insulin assay available, it is impossible to establish a universal cutoff 
HOMA-IR score to define insulin resistance.  
Risk Factors Associated with Insulin Resistance 
Univariate analyses of risk factors for insulin resistance revealed that eight 
variables were significantly associated with insulin resistance in the study. Discussion 
of results of univariate analyses are presented by risk factors.   
Systolic Blood Pressure 
The average systolic blood pressure in the study sample was 113.9 mmHg and 
was within the normal range of systolic blood pressure (< 120 mmHg) (Chobanian, et 
al., 2003). However, 75 of 2,222 subjects (3.3%) had a systolic blood pressure ≥ 140 
mmHg. Among males, 59 out of 1,042 had a systolic blood pressure ≥ 140 mmHg 
(5.4%), in contrast to the 1.1% of females. Although both proportions are small, this 
finding is consistent with results from a previous study which identified that 
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hypertension was more prevalent among men than women in Europe (49.7% 
vs 38.6%), Canada (31.0% vs 23.8%), and the United States (29.8% vs 25.8%) 
(Wolf-Maier et al., 2003). Hypertension is a known risk factor for insulin resistance 
(Lima, et al., 2009). Consequently, the higher average systolic blood pressure among 
males in the current study may partially explain the higher prevalence of insulin 
resistance in males relative to females in this study. The gender difference in systolic 
blood pressure may begin at puberty (Dasgupta et al., 2006). However, the prevalence 
of hypertension among women increases as sex hormones (i.e., estrogens and 
progesterone) decline during the peri- and postmenopausal period (Boschitsch, 
Mayerhofer, & Magometschnigg, 2010).  
Findings from this study also showed that the mean systolic blood pressure of 
non-Hispanic Blacks was 4 mmHg higher than that of Mexican Americans, 
non-Hispanic Whites, or other race/ethnicity. The highest prevalence of systolic blood 
pressure ≥ 140 mmHg (5.4%) also was observed among non-Hispanic Blacks. Results 
parallel those reported by the National Center for Health Statistics in the publication 
of Health, United States, 2010: With Special Feature on Death and Dying (National 
Center for Health Statistics, 2011, p. 268) that found the highest prevalence of 
hypertension was among non-Hispanic Blacks. Other research also has found that 
race/ethnicity is a risk factor for hypertension with non-Hispanic Blacks at increased 
risk for hypertension and more likely to have higher blood pressure compared to 
non-Hispanic Whites (Kurian & Cardarelli, 2007). The trend of higher blood pressure 
in non-Hispanic Blacks than that of non-Hispanic Whites was even observed among 
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children at as early as 13 years old (Brady, Fivush, Parekh, & Flynn, 2010). 
This may be partially explained by the genetic predisposition for alterations in the 
renin-angiotensin-aldosterone system among non-Hispanic Blacks.   
The average systolic blood pressure among insulin resistant subjects was about 7 
mmHg higher than that of non-insulin resistant subjects. Also, significantly more 
insulin resistant subjects (7.3%) had an average systolic blood pressure > 140 mmHg, 
compared to non-insulin resistant individuals (2.0%). This is consistent with results 
from previous research that found a positive relationship between hypertension and 
insulin resistance. However, the percentage of subjects with hypertension who were 
insulin resistant in the current study is much lower than the 50% or higher rate 
estimated by Lima et al. (2009). This makes sense given the average age of subjects 
in the 2009 study was above 50 years old, whereas subjects in the current study were 
age 20-39 years with a mean of 29.5 years. Hypertension was also defined as a 
systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, or 
use of antihypertensive medications in the study by Lima et al. (2009). This study 
defined hypertension as a systolic blood pressure ≥ 140 mmHg only. The difference in 
definitions also may help explain the lower prevalence of hypertension among insulin 
resistant subjects found in the current study. In addition, the cutoff value of 140 
mmHg in this study was higher than the 130 mmHg recommended by NCEP ATP III 
(2002) to identify individuals at risk for metabolic syndrome. More subjects would 
have had elevated systolic blood pressure if the value of 130 mmHg were applied in 
the current study. Results provide support for hypertension as a significant risk factor 
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for insulin resistance in the conceptual schema of factors thought to be 
associated with insulin resistance in the current study (Figure 1).  
Triglyceride Level 
The study observed a high prevalence (23.1%) of triglycerides ≥ 150 mg/dl 
among nondiabetic U.S. adults aged 20-39 years. This is comparable to the 24.0% 
prevalence rate of triglycerides ≥ 150 mg/dl found among U.S. adults aged 20-39 
years reported by Ford, Li, Zhao, Pearson, and Mokdad (2009), but 10% lower than 
the overall prevalence rate of 33.1% among U.S. adults ≥ 20 years and older found in 
the same study. The estimated prevalence of triglyceride level ≥ 150 mg/dl in Ford et 
al.‟s study was based on data from 5,610 participants aged 20 years or older from the 
National Health and Nutrition Examination Survey (NHANES) 1999-2004.  
The finding that men had a higher prevalence of triglyceride level ≥ 150 mg/dl 
than women also is consistent with that observed by Ford et al. (2009). However, the 
27.8% rate of triglyceride level ≥ 150 mg/dl among men in the current study is lower 
than the 36.7% overall rate for men in Ford et al.‟s study. Similarly, women in the 
current study had a lower rate of triglyceride level ≥ 150 mg/dl (18.5%) than the 
29.6% reported by Ford et al. (2009). The disparity in findings between studies may 
be explained by evidence that suggests biomarkers of cardiometabolic risk (e.g., 
triglyceride level) increase with age.  
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High triglyceride levels (≥ 150 mg/dl) were the most prevalent among 
Mexican Americans (30.1%), followed by non-Hispanic Whites (24.0%), and 
non-Hispanic Blacks (13.3%). Findings are similar to those observed by Ford et al. 
(2009). However, the rates found in this study are generally lower than the 37.9% of 
Mexican Americans, the 35.2% of non-Hispanic Whites, and the 16.3% of 
non-Hispanic Blacks reported by Ford et al. (2009). As expected, high triglyceride 
levels were more prevalent among individuals with insulin resistance (44.2%) relative 
to those without insulin resistance (17.0%). Results support the strong positive 
association between triglyceride level and insulin resistance found by Avramoglu et al. 
(2006). The study findings also provide support for high triglyceride level as a 
significant risk factor for insulin resistance in the conceptual schema of factors 
thought to be associated with insulin resistance in the current study (Figure 1). 
The high prevalence of triglyceride level ≥ 150 mg/dl found in the general U.S. 
population, or even nondiabetic young adults aged 20-39 years, is concerning. Many 
studies have shown that high triglyceride level is a significant risk factor for 
cardiovascular disease (Sarwar et al., 2007). Although high triglyceride level (≥ 150 
mg/dl) was less prevalent among women than men in the current study, previous 
studies report a higher risk for cardiovascular disease among women with high 
triglyceride level than men (McBride, 2008). In a meta-analysis by Hokanson and 
Austin (1996), women were found to have 75% increased risk for cardiovascular 
disease for every 1 mmol/L increase in triglyceride, compared to a 30% increased risk 
among men. Similarly, although high triglyceride level (≥ 150 mg/dl) was less 
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prevalent among non-Hispanic Blacks, this does not necessarily reduce their 
risk for insulin resistance. Sumner and Cowie (2008) investigated the racial/ethnic 
differences of triglyceride concentration in predicting insulin resistance, using 
NHANES 1999-2002. They found that in comparison to non-Hispanic Whites or 
Mexican Americans, non-Hispanic Blacks were more likely to be insulin resistant, but 
had a lower level of triglycerides.  
High Sensitivity C-Reactive Protein 
As a biomarker for systemic inflammation, research has shown that elevation of 
high sensitivity C-reactive protein (hs-CRP) is a significant risk factor for 
cardiovascular disease. Hs-CRP was found to be significantly associated with insulin 
resistance in univariate analyses in the current study. More than 17% of insulin 
resistant individuals had hs-CRP equal or greater than 1mg/L, compared to only 5.2% 
of individuals without insulin resistance. Findings are consistent with many studies 
which have found a significantly positive relationship between CRP and insulin 
resistance (Chou, et al., 2010; Gelaye, et al., 2010; Meng, et al., 2007; Nakanishi, et 
al., 2005). However, these previous studies examined regular CRP, not hs-CRP. The 
positive association between hs-CRP and insulin resistance also was observed by 
Kawamoto et al. (2010) among 1,919 Japanese community-dwelling participants. The 
available research data demonstrate that hs-CRP is a significant predictor for insulin 
resistance.  
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Gender and race/ethnicity also were significantly associated with hs-CRP 
that was categorized into low (< 1.0 mg/L), moderate (1.0 to 3.0 mg/L), and high (> 
3.0 mg/L) in the current study. Nearly one tenth of females had moderate levels of 
hs-CRP and more than 1 % of females had hs-CRP larger than 3.0 mg/L. In contrast, 
only about 4% males had moderate level of hs-CRP and less than 1 % of them had 
high hs-CRP. Females were more likely to have increased hs-CRP than males. The 
prevalence of elevated hs-CRP among non-Hispanic Blacks was higher than other 
non-Black races/ethnicities, which may indicate that non-Hispanic Blacks are at 
increased risk of developing cardiovascular disease due to elevation of hs-CRP.  
Body Mass Index 
The mean body mass index (BMI) of the study sample was 27.4 kg/m
2
. This falls 
within the range of BMI (25-29.9 kg/m
2
) that defines overweight, according to the 
World Health Organization (WHO) guidelines (WHO, 2000). Results suggest that 
subjects in the study sample were at risk for cardiovascular disease and type 2 
diabetes, even though they had not yet developed diabetes at the time of NHANES 
participation.  
The average BMI for subjects who were non-Hispanic Blacks was 29.6 kg/m
2
 
which was slightly higher than the average of 27.9 kg/m
2
 for Mexican Americans and 
the average of 27.0 kg/m
2
 for non-Hispanic White subjects. The prevalence rate of 
obesity among non-Hispanic Black subjects was 43.3%, which was the greatest 
among the three racial/ethnic groups. Mexican Americans had the second highest 
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prevalence rate of obesity (29.9%), followed by non-Hispanic Whites 
(25.2%). These findings are comparable to those reported by the Centers for Disease 
Control and Prevention (CDC), using data from the Behavioral Risk Factor 
Surveillance System (BRFSS) surveys conducted during 2006-2008 (CDC, 2009b). 
According to this CDC‟s report, the highest prevalence of obesity was found among 
non-Hispanic Blacks (35.7%), followed by Hispanics (28.7%), and non-Hispanic 
Whites (23.7%). However, the prevalence rates of obesity estimated from BRFSS 
2006-2008 were lower than those evaluated by Ogden et al. (2006) using data from 
NHANES 2003-2004. The NHANES 2003-2004 study reported that 45.0% of 
non-Hispanic Blacks were obese as were 36.8% of Mexican Americans, and 30.6% of 
non-Hispanic Whites (Ogden et al., 2006). The discrepancies in the prevalence 
estimates for obesity between the BRFSS and NHANES studies may be attributed to 
measures of height and weight needed for the calculation of BMI. The height and 
weight in the BRFSS were self-reported; whereas they were measured by trained 
health technicians in NHANES. The disproportional prevalence rates of obesity 
across racial/ethnic populations might be explained by culture differences in 
behaviors related physical activity, food consumption and access to healthy food, and 
attitudes toward bigger body size (CDC, 2009b).   
It was not surprising that insulin resistant individuals had a mean BMI of 33.8 
kg/m
2
 that met the WHO‟s definition of obesity (BMI ≥ 30 kg/m
2
). Previous studies 
have shown that BMI is positively associated with insulin resistance (Skidmore, et al., 
2008) and obesity is a strong risk factor for insulin resistance (Boden & Laakso, 
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2004). The prevalence of obesity among insulin resistant subjects found in 
this study was 67.1%, which was much higher than the 16.2% of non-insulin resistant 
individuals. The conceptual schema of factors thought to be associated with insulin 
resistance for the current study identifies that obesity is a significant risk factor for 
insulin resistance (Figure 1). Results from this study provide additional support for 
this relationship even among nondiabetic adults aged 20-39 years.  
Waist Circumference 
As an index for central obesity (NCEP ATP III, 2002), waist circumference is the 
distance around the abdomen between the lower rib cage and hips and is measured 
with minimal inspiration. Central obesity is defined as waist circumference > 35 
inches (88 cm) for women and > 40 inches (102 cm) for men, according to the 
National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) 
(NCEP ATP III, 2002). The subjects in this study had an average of 92.7 cm waist 
circumference. The mean waist circumference for males was approximately 4 cm 
larger than that of females, which is consistent with past literature (Stevens, Katz, & 
Huxley, 2010). However, females in this study had a mean of 90.5 cm in waist 
circumference, exceeding the cutoff value (88 cm) for central obesity. In contrast, the 
average of waist circumference in males was 94.9 cm that was less than 102cm, the 
cutoff value for central obesity for men. The finding is interesting given that both men 
and women were overweight as defined by their average BMI, but only women had 
central obesity. This probably relates to the attributes of the two obesity indexes. The 
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calculation of BMI is based on weight and height, thus does not account for 
the distribution of fat, muscle and bone mass; whereas waist circumference is a direct 
measure of abdominal distance and reflects subabdominal and visceral adipose tissue 
deposits. Having an overweight BMI but non-central obesity in men may suggest that 
men in this study probably had more muscles and bone mass but less centrally 
distributed fat, compared to women.    
Similar to the pattern of BMI distributed across race/ethnicity, non-Hispanic 
Blacks had the largest mean waist circumference (95.1 cm), followed by Mexican 
Americans (94.3 cm), and non-Hispanic Whites (92.5 cm). Females across 
race/ethnicity had a mean waist circumference greater than 88 cm with non-Hispanic 
Black females having the largest waist circumference (97.2 cm). The finding is more 
interesting in that non-Hispanic Black females had a larger waist circumference (97.2 
cm) than non-Hispanic Black males (92.6cm). This result is consistent with those 
from an earlier NHANES III study conducted among subjects aged 20 years old and 
above; however, the waist circumference of non-Hispanic Black females in the 
current study was 4.3 cm larger than that reported in the previous study (Zhu et al., 
2005). Moreover, the mean age of the non-Hispanic black females in this study (29.9 
years) was about 10 years younger than that of those in Zhu‟s study (41.4 years). The 
finding that women had a larger waist circumference than men also was observed in a 
Japanese population, although the definition of central obesity in this study was > 90 
cm for Japanese women and > 85 cm for Japanese men (Japan Society for the Study 
of Obesity, 2002). More research is needed to examine whether the finding that 
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non-Hispanic Black females had a larger waist circumference than 
non-Hispanic Black males is only observed in the age group of 20-39 years.  
Significant differences in waist circumference were observed between subjects 
with insulin resistance and those without insulin resistance. On average, the waist 
circumference of insulin resistant subjects was 108.8 cm, which was almost 20 cm 
larger than the average of 88.1 cm for non-insulin resistant individuals. Central 
obesity was highly prevalent among insulin resistant subjects (73%) relative to the 
27.4% of non-insulin resistant subjects. This finding provides support for the positive 
relationship between central obesity and insulin resistance reported in previous 
studies (Farin, Abbasi, & Reaven, 2005; Farin, et al., 2006). The conceptual schema 
of factors thought to be associated with insulin resistance in the current study 
identifies a positive relationship between obesity and insulin resistance (Figure 1). 
Study findings provide support for this relationship among nondiabetic adults aged 
20-39 years.   
Leisure Time Physical Activity 
Fewer than 50% of nondiabetic adults aged 20-39 years reported engaging in 
leisure time physical activity (LTPA) to meet the minimum goal of 150 minutes of 
moderate-intensity or 75 minutes of vigorous-intensity physical activity per week 
recommended by the 2008 Physical Activity Guidelines for Americans (U.S. 
Department of Health and Human Services, 2008). About one third of subjects did not 
participate in any LTPA; only 21% reported participating in a low level of LTPA (< 
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500 MET min/week). This is concerning as previous research has 
demonstrated that physical inactivity may increase the risk of insulin resistance 
(Booth, et al., 2008; Kump & Booth, 2005). Although not fully understood, the 
proposed underlying mechanism of insulin resistance induced by physical inactivity is 
that insulin sensitivity for glucose uptake is possibly impaired when less 
energy-producing substrates are utilized by skeletal muscles because of physical 
inactivity (Booth, et al., 2008). 
Men were more physically active during leisure time than women. More than 
53.7% of men reported participating in at least 500 MET minute/week LTPA, 
compared to only 44.3% of women. The majority of men (41.0%) who were 
physically active, engaged in a high level of LTPA with a MET minute/week larger 
than 1000. In contrast, only 29.5% of women participated in a high level of LTPA. 
The findings are consistent with previous studies that investigated the gender 
differences in LTPA and found that men in both developed (Martinez-Gonzalez et al., 
2001) and developing countries (Azevedo et al., 2007) engaged more time in LTPA, 
relative to women. Azevedo et al. (2007) explored men and women‟s main reasons 
for participating in LTPA and found that about 50% men reported that they 
participated in LTPA for enjoyment, whereas more women engaged in LTPA because 
of medical advice from health professionals.  
When comparing LTPA across race/ethnicity, non-Hispanic Whites were the most 
physically active racial/ethnic group with 52.2% reporting participating in ≥ 500 
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MET minute/week LTPA. In contrast, the most physically inactive 
racial/ethnic group was Mexican Americans with 62.1% reporting engaging no LTPA 
or < 500 MET minute/week LTPA, followed by non-Hispanic Blacks (54.6%) and 
non-Hispanic Whites (47.9%). The findings are consistent with results from previous 
studies which reported that Mexican Americans and non-Hispanic Blacks were the 
two racial/ethnic minority groups that were more physically inactive, compared to 
other racial/ethnic minority groups (Crespo, Smit, Andersen, Carter-Pokras, & 
Ainsworth, 2000; Marshall et al., 2007). Parallel to the finding that most Mexican 
Americans were physically inactive was the finding that Mexican Americans had the 
highest mean BMI. The racial/ethnic disparities in LTPA may be related to different 
culture perspectives toward to body weight and body size. In addition, the low 
socio-economic status of minority racial/ethnic groups could restrict their time in 
participating in LTPA because of long working hours or limit their access to fitness 
facilities.  
LTPA was significantly associated with insulin resistance among nondiabetic 
adult males and females aged 20-39 years in univariate analyses. The proportions of 
subjects who engaged in different levels of LTPA between insulin resistant and 
non-insulin resistant subjects were different. Compared to non-insulin resistant 
subjects, insulin resistant individuals were more physically inactive, as evidenced by 
the 56.4% who did not participated in LTPA or participated in LTPA that was less than 
500 MET minute/week. In contrast, more than 50% of non-insulin resistant subjects 
met the recommended physical activity level by U.S. Department of Health and 
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Human Services (2008). In accordance with results from prior studies (Booth, 
et al., 2008; Kump & Booth, 2005), physical inactivity was a risk factor for insulin 
resistance in this study. Interestingly, research has been conducted to investigate the 
effects of two months of moderate physical exercise on insulin sensitivity among 
nonobese and nondiabetic individuals. A significant decrease in plasma glucose and 
insulin levels and an increase in insulin sensitivity were found in the study by 
Hasbum et al. (2006). They reported that these changes were independent of changes 
in body weight, BMI, waist-hip ratio, lipid profile, and oxygen consumption. The 
improved insulin sensitivity may result from increased transportation of glucose 
transporters 4 (GLU-4) to cellular membrane of the skeletal muscle during physical 
activity.  
Smoking Status 
Accumulating evidence has demonstrated that smoking has detrimental effects on 
many aspects of health, including increased risk of insulin resistance. Even so, 
smoking behavior is still highly prevalent among the U.S. population. The prevalence 
of current cigarette smoking among subjects in this study was over 27.6%, which is 
higher than the 20.6% overall prevalence rate of current cigarette smokers in U.S 
adults estimated in 2008 (CDC, 2009a) and two times higher than the target 12% for 
cigarette smoking in Healthy People 2020 (U.S. Department of Health and Human 
Services, 2010a). Results indicate that efforts to reduce cigarette smoking should be 
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strengthened, even though various smoking prevention and smoking cessation 
programs have been initiated and implemented. 
More men in the study smoked than women (33.0% vs 22.5%). The prevalence of 
smoking among men was about 10% higher than the national estimate of men‟s 
smoking rate (23.1%) from 21,781 persons aged 18 years or above in the 2008 
National Health Interview Survey (NHIS) (CDC, 2009a). Similarly, the prevalence of 
smoking among women in the study was about 4% higher than the 18.3% for women 
estimated from the 2008 NHIS. The definition of current cigarette smoking applied in 
the 2008 NHIS was the same as the one used in the current study. Therefore, the 
differences in the prevalence rate of cigarette smoking between the two studies may 
be related to age variations. The subjects in the current study were aged 20-39 years; 
while the subjects in the 2008 NHIS were aged 18 years and above. Results suggest 
that the prevalence of cigarette smoking was higher in the younger age group, 
regardless of gender.  
Variations in cigarette smoking prevalence also were observed by race/ethnicity. 
Mexican Americans had the lowest prevalence (15.8%), which was approaching the 
target 12% of Healthy People 2020. Non-Hispanic Blacks had a lower prevalence of 
smoking (25.8%) than non-Hispanic Whites (32.1%). These proportions are 
consistent with the racial/ethnic estimates of cigarette smoking from the 2008 NHIS 
(CDC, 2009a). However, non-Hispanic Whites in the current study had a 10% higher 
prevalence of smoking, compared with non-Hispanic Whites in the 2008 NHIS 
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(22.0%). Similarly, the prevalence of smoking among non-Hispanic Blacks in 
the current study was 4.5% higher than the non-Hispanic Blacks who participated in 
the 2008 NHIS (21.3%). Estimates of smoking prevalence for Mexican Americans in 
the current study and the 2008 NHIS were the same (15.8%). Again, differences in 
age ranges between the two studies may have contributed to the discrepancies in the 
prevalence of smoking in both non-Hispanic Whites and non-Hispanic Blacks. Study 
findings suggest that younger non-Hispanic Whites and non-Hispanic Blacks had a 
higher prevalence of smoking than those who were older. In contrast, the prevalence 
of smoking in younger and older Mexican Americans may not differ.  
A significant association between smoking and insulin resistance was observed in 
the study. Unexpectedly, non-insulin resistant subjects had a 9.2% higher prevalence 
of current cigarette smoking (29.2%) than insulin resistant subjects (20.0%). This 
finding differs from the positive association between smoking and insulin resistance 
found in previous studies (Anan, et al., 2006; Bergman, et al., 2009; Daniel & Cargo, 
2004; Ko, et al., 2007). Some suggest that smoking impairs the pathway of insulin 
action, thus increases the risk of insulin resistance. However, one study found no 
significant association between active smoking and insulin sensitivity (Henkin, et al., 
1999). No study that reported a negative relationship between smoking and insulin 
resistance was found in the literature. Other contextual information is needed to better 
explain the negative finding observed in this current study. Inconsistencies in the 
relationship between smoking and insulin resistance observed across studies warrant 
further exploration.   
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Alcohol Consumption 
Alcohol consumption was highly prevalent among nondiabetic adults aged 20-39 
years in the study with about 90% having had at least 12 drinks in their lifetime. 
Overall, nearly 80% of subjects were current drinkers who consumed at least 12 
drinks in their lifetime and had at least one or more drinks in the past year. This was 
much higher than the 65% of current drinkers among U.S. adults aged ≥ 18 years of 
age in the 2009 National Health Interview Survey (NHIS) (U.S. Department of Health 
and Human Services, 2010b). The differences in the prevalence rate of current 
drinkers may be attributed to the age range of subjects in the two studies. As reported 
by the U.S. Department of Health and Human Services (2010b), the proportion of 
adults who were current regular drinkers decreased as age advanced. About 86% of 
men were current drinkers, in contrast to 72% of women. Approximately 10% of the 
subjects in this study were former drinkers, which was lower than the 15% estimated 
from the 2009 NHIS. Women were more likely to be nondrinkers, former drinkers or 
light drinkers than men, whereas men were more likely to be moderate or heavy 
drinkers than women. Results are consistent with those found in the 2009 NHIS (U.S. 
Department of Health and Human Services, 2010b).  
Alcohol consumption varied significantly by race/ethnicity. Specifically, 82% of 
non-Hispanic Whites were current drinkers compared with 76.3% of Mexican 
Americans and 70.9% of non-Hispanic Blacks. These rates are higher than the rates 
reported in the 2009 NHIS. Stratified by drinking levels, non-Hispanic Whites were 
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more likely to be moderate or heavy drinkers. Mexican Americans were more 
likely to be light drinkers than either non-Hispanic Whites or Blacks. In contrast, 
non-Hispanic Blacks were more likely to be nondrinkers. This pattern of alcohol 
consumption by race/ethnicity found in the current study is consistent with those 
reported by U.S. Department of Health and Human Services (2010b).  
Alcohol consumption was found to be significantly associated with insulin 
resistance. Eighty percent of non-insulin resistant subjects were current drinkers, 
compared with 75.2% of insulin resistant subjects. Although significant, the 
prevalence of current drinkers between non-insulin resistant and insulin resistant 
subjects did not differ more than 5%. Non-insulin resistant individuals were more 
likely to be moderate (24.1%) or heavy drinkers (9.1%) than insulin resistant 
individuals (moderate: 20.1%; heavy: 4.4%). In contrast, insulin resistant subjects 
were more likely to be light drinkers (50.7%) than non-insulin resistant subjects 
(47.1%). The rates of nondrinkers between insulin resistant (11.3%) and non-insulin 
resistant subjects (10.8%) were comparable. The findings from this study are 
consistent with those from previous studies, which demonstrated a significantly 
negative relationship between alcohol consumption and insulin resistance (Fueki et al., 
2007; Joosten, et al., 2008; Kawamoto et al., 2009; Player, Mainous, King, Diaz, & 
Everett, 2010). Alcohol consumption, especially moderate levels, may help improve 
insulin sensitivity, thus, decrease insulin resistance. Kawamoto et al. (2009) evaluated 
the effect of alcohol consumption on insulin resistance among 678 Japanese 
community dwelling men and found that the mean log HOMA-IR was significantly 
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lower in heavy drinkers. They also demonstrated that the effect of alcohol 
consumption on insulin resistance was independent of BMI. Player, Mainous, King, 
Diaz and Everett (2010) reported that moderate alcohol consumption can decrease the 
risk of insulin resistance among subjects with vitamin D insufficiency. Research has 
explored the mechanisms underlying the relationship between alcohol consumption 
and improved insulin resistance. A decrease in insulin resistance may be attributed to 
an elevation in plasma adiponectin associated with alcohol consumption. This 
proposed mechanism was supported by study findings from Sierksma et al. (2004) 
and Thamer, Haap, Fritsche, Haering, and Stumvoll (2004).  
Although accumulating evidence shows that moderate alcohol consumption can 
improve the status of insulin resistance and decrease risk of cardiovascular disease 
(Brinton, 2010), healthcare providers should be cautious in making such a 
recommendation to patients. Initiating drinking behavior to improve health may 
wrongly imply that it is appropriate to drink or even drink excessively or 
irresponsibly. Research also has demonstrated that heavy drinking can cause a myriad 
of health problems such as elevation of triglycerides, which is one of the biomarkers 
of increased risk for cardiovascular disease and diabetes (Foerster, et al., 2009). 
Despite the beneficial effects of alcohol consumption, it is difficult to implement this 
finding in clinical practice due to lack of appropriate strategies.  
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Correlations among Independent Variables 
The examination of the inter-correlations among independent variables showed 
small to moderate correlations. As expected, BMI and waist circumference were 
highly correlated (r = .92, p < .0001). This finding suggests that BMI may be as 
effective as waist circumference in identifying 20-39 years old individuals with 
insulin resistance. Results are consistent with the observation by Farin, Abbasi, and 
Reaven (2005) that BMI highly correlated with waist circumference among men (r 
= .90) and women (r = .86). A high correlation between BMI and waist circumference 
also was found among school-aged Japanese children (Ochiai et al., 2010) with a 
correlation coefficient of .94 for boys and .90 for girls.  
Relationship between Major Depression and Insulin Resistance 
The relationship between major depression and insulin resistance was 
investigated in univariate and multivariate logistic regression analyses. A significant 
interaction between gender and major depression was observed; however, no 
evidence was found to support the role of race/ethnicity on the relationship between 
major depression and insulin resistance. BMI and waist circumference were examined 
in separate models to investigate the strength of their relationships with insulin 
resistance and predicting values. The effect of depression measures on the association 
between major depression and insulin resistance also was explored. Discussion of 
univariate and multivariate results are presented by model. 
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Unadjusted Relationship between Major Depression and Insulin Resistance 
Major depression was not significantly associated with insulin resistance in the 
bivariate logistic regression analysis among nondiabetic adults aged 20-39 years in 
the current study. This finding is consistent with results of pilot work on the topic, 
which reported an insignificant relationship between major depression and insulin 
resistance, using data from National Health and Nutritional Examination Survey 
(NHANES) 1999-2002 (Shen, et al., 2011). Even though the relationship between 
major depression and insulin resistance was not significant in either study, the 
direction of the B coefficients for major depression differed. In the current study, a 
positive B coefficient (B = 0.14) was found; while a negative B coefficient was 
observed in the pilot study (B = -0.01). In the pilot study, major depression was 
measured by the Composite International Diagnostic Interview (CIDI); whereas in 
this study, major depression was assessed by the CIDI in NHANES 1999-2004 and 
the Patient Health Questionnaire 9 (PHQ-9) in NHANES 2005-2008. Differences in 
depression measures might also have contributed to the inconsistent direction of the B 
coefficients for major depression. A positive B coefficient for major depression (B = 
0.11) when measured by the CIDI and a negative B coefficient for major depression 
when measured by the PHQ-9 were found in the study, when the relationship between 
major depression and insulin resistance was examined by depression measures. This 
will be discussed in a later section. Nevertheless, both indicated nonsignificance in 
the relationship between major depression and insulin resistance.     
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Adjusted Relationship between Major Depression and Insulin Resistance by 
Gender 
A significant interaction between gender and major depression was observed (B = 
1.39, p = .0031) in this study. This finding is consistent with the earlier pilot work 
(Shen, et al., 2011), which also found a significant interaction between gender and 
major depression. Results indicate that the relationship between major depression and 
insulin resistance varies by gender.  
Among men, major depression was significantly and negatively associated with 
insulin resistance, after controlling for age, race/ethnicity, systolic blood pressure, 
triglyceride level, hs-CRP, BMI, leisure time physical activity, smoking, and alcohol 
consumption. The negative association between major depression and insulin 
resistance among men remained significant in the model when BMI was replaced by 
waist circumference. Both the B coefficients and odds ratio (OR) for major depression 
maintained relatively unchanged. The model with waist circumference had a lower -2 
log likelihood (18446247) and minimum AIC (18446287), suggesting it is better than 
the model with BMI (18738539 and 18738579 for -2 log likelihood and AIC 
respectively) among men.  
Results provide support for the significant negative association between major 
depression and insulin resistance among men found in the pilot study (Shen, et al., 
2011). However, findings differ from previous studies that reported a positive 
relationship between depression and insulin resistance among young Finnish men 
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aged 18-31 years (Timonen, et al., 2006; Timonen, et al., 2007) and 
Australian men aged 26-36 years (Pearson, et al., 2010) or no significant relationship 
among Welsh men aged 45-59 years (Lawlor, et al., 2005).  
All of these previous studies were cross-sectional studies with a relatively large 
sample size (> 1000 subjects). The variations in study findings may be attributed to 
differences in measurements of depression, definitions of depression, subjects‟ age 
range, or the characteristics of subjects. Depression questionnaires such as Beck‟s 
Depression Inventory (Timonen, et al., 2007), Hopkins Symptoms Checklist 
(Timonen, et al., 2006), or the General Household Questionnaire (Lawlor, et al., 2005) 
measure depressive symptoms, instead of making a clinical diagnosis of major 
depression. Although the CIDI was used in Pearson et al.‟s study (2010), depression 
was defined as any depression with various degree of severity, including major 
depression, minor depression and depression otherwise not specified. It was different 
than the definition of major depression applied in this current study that was based on 
the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, 
4
th
 edition (DSM-IV) (American Psychiatric Association, 1994). Although HOMA-IR 
also was used to measure insulin resistance in the study by Pearson et al (2010), 
HOMA-IR scored were log-transformed and used as a continuous variable. Clinical 
significance of a log-transformed HOMA-IR is difficult to interpret. The significantly 
higher ratio of mean log-transformed HOMA-IR reported by Pearson et al did not 
necessarily indicate the presence of insulin resistance. Age differences in subjects 
between Lawlor et al.‟s study (2005) (45-59 years) and this current study (20-39 years) 
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may also explain the discrepancy in findings. In addition, factors such as low 
exposure to sunlight among subjects living in northern Finland and stress associated 
with newly recruited military young men may have mediated the relationship between 
major depression and insulin resistance and contributed to the inconsistency between 
the findings (Timonen, et al., 2006; Timonen, et al., 2007). This researcher 
hypothesizes it is possible that it may be the cumulative effect of insulin resistance 
over time that leads to depression from continued overactivity of the 
hypothalamus-pituitary-adrenal (HPA) system. This hypothesis requires further study. 
No significant association between major depression and insulin resistance was 
observed among women in this study, when adjusting for age, race/ethnicity, systolic 
blood pressure, triglyceride level, hs-CRP, BMI, leisure time physical activity, 
smoking, and alcohol consumption. The association between major depression and 
insulin resistance among women remained nonsignificant in the model when BMI 
was replaced by waist circumference. The model with BMI had a lower -2 log 
likelihood (14617758) and minimum AIC (14617798) than the model with waist 
circumference (14868518 and 14868558 for -2 log likelihood and AIC respectively), 
suggesting it was the better model than the one with waist circumference among 
women.  
The finding of no association between major depression and insulin resistance 
among women is consistent with two previous studies (Roos, et al., 2007; Shen, et al., 
2011), but contradicted two others (Lawlor, et al., 2003; Pearson, et al., 2010). Roos 
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et al. (2007) reported no association between insulin resistance and 
depression among Swedish women aged 50-64 years and similar findings were 
reported among U.S. women aged 29-39 years by Shen et al. (2011). In contrast, 
Lawlor et al. (2003) identified a significant negative relationship between depression 
and insulin resistance among British women aged 60-79 years; whereas Pearson et al. 
(2010) demonstrated that depression was positively associated with insulin resistance 
among Australian women aged 26-36 years. It is important to note that the positive 
relationship between depression and insulin resistance reported by Pearson et al. 
(2010) became insignificant, after adjustment for covariates such as age, education, 
polycystic ovary syndrome, fish consumption, and use of antidepressants. The mixed 
results of the relationship between depression and insulin resistance among women 
may partially be attributed to age differences, variations in depression measures, and 
other covariates. Future research is needed to further explore the relationship between 
depression and insulin resistance among women, especially those at younger age.   
Adjusted Relationship between Major Depression and Insulin Resistance by 
Race/Ethnicity 
Surprisingly, the interaction between race/ethnicity and major depression was not 
statistically significant, although race/ethnicity was significantly associated with 
insulin resistance and past studies have identified significant differences in major 
depression by racial/ethnic groups. The hypothesis that the relationship between 
major depression and insulin resistance varied by race/ethnicity was not supported by 
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the study findings. This hypothesis could not be examined in the pilot study 
because of a relatively small sample size for certain racial/ethnic groups. All previous 
studies that have examined the association between depression and insulin resistance 
were limited to one racial/ethnic group (i.e., European Caucasians or Asian 
population). No prior studies were found that investigated the role of race/ethnicity on 
the relationship between major depression and insulin resistance. Lack of such studies 
that focus on minority racial/ethnic groups such as non-Hispanic Blacks or Mexican 
Americans made it difficult to compare and contrast the findings from this study. 
Even so, this finding was exploratory. Future research that explores the relationship 
between major depression and insulin resistance among minority racial/ethnic groups 
are necessary. 
Overall, a nonsignificant negative association between major depression and 
insulin resistance was observed, irrespective of racial/ethnic groups, with adjustment 
for age, gender, race/ethnicity, systolic blood pressure, triglyceride level, hs-CRP, 
BMI, leisure time physical activity, smoking, and alcohol consumption. The direction 
and strength of the relationship remained relatively stable, regardless of obesity index 
(BMI or waist circumference).  
Unadjusted Relationship between Major Depression and Insulin Resistance by 
Measures of Depression 
Major depression, as measured by the Composite International Diagnostic 
Interview (CIDI), was not significantly associated with insulin resistance, although 
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the direction of the relationship was positive. Similarly, a nonsignificant 
relationship was observed between major depression and insulin resistance, when 
measured by the Patient Health Questionnaire 9 (PHQ-9). However, the strength of 
the relationship between major depression and insulin resistance when measured by 
the PHQ-9 was stronger than when measured by the CIDI. This was evidenced by an 
increase in the B coefficient from .11 to .48 and a 50% increase in odds ratio.  
No prior studies were found that compared the effects of different depression 
measures on the relationship between major depression and insulin resistance. In 
contrast to the CIDI, which is the gold standard for clinical diagnosis of major 
depression, the PHQ-9 is usually used as a screening tool to identify individuals who 
are at risk of depression. Although a diagnosis of major depression can be made 
according to the DSM-IV diagnostic criteria, the PHQ-9 itself does not exclude 
conditions that can cause depressive symptoms, for example, substance abuse, 
general medical condition, or bereavement. Therefore, the increased strength of the 
relationship between major depression, when measured by the PHQ-9, and insulin 
resistance may be attributed to the underlying medical conditions that caused 
depressive symptoms, rather than major depression itself. More studies that use gold 
standard diagnostic tool such as the CIDI to measure major depression are needed to 
investigate whether a clinical diagnosis of major depression is associated with insulin 
resistance. When more evidence becomes available, comparison the relationships of 
insulin resistance to clinical diagnosed major depression and to depressive symptoms 
may be possible. Otherwise, it is premature to draw the conclusion that the 
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relationship between depression and insulin resistance found in previous 
studies may be due to underlying medical conditions.   
Adjusted Relationship between Major Depression and Insulin Resistance by Measures 
of Depression  
The study found no significant relationship between major depression and insulin 
resistance, when measured by the CIDI, after adjusting for age, gender, race/ethnicity, 
BMI, systolic blood pressure, triglyceride level, hs-CRP, smoking, leisure time 
physical activity, and alcohol consumption. Interestingly, the direction of the 
insignificant relationship was inversed after adjustment for the covariates. A similar 
pattern was observed when major depression was measured by the PHQ-9, 
controlling for the same covariates. Comparison of the two models found that the 
strength of the negative relationship between major depression and insulin resistance, 
when measured by the CIDI was stronger than the relationship when major 
depression was assessed by the PHQ-9, although neither was statistically significant. 
The findings suggest a possible mediating suppression effect by the covariates. More 
studies are needed to further explore this effect of major depression on insulin 
resistance.  
When controlling for waist circumference and other covariates, major depression, 
as evaluated by the CIDI, was not significantly associated with insulin resistance in 
the study. The direction of the relationship remained negative but the magnitude of 
the relationship was reduced relative to the model with BMI. The -2 log likelihood 
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and AIC were lower in the model with waist circumference, suggesting that it 
was the better model than the one with BMI. 
In comparison, the relationship between major depression measured by the 
PHQ-9 and insulin resistance also was not statistically significant, after adjusting for 
waist circumference and the same other covariates. Even though it was nonsignificant, 
the trend of the association of major depression and insulin resistance unexpectedly 
reverted to positive. The relatively small sample of those with a positive diagnosis of 
major depression as measured by the PHQ-9 may have limited the power to detect 
significance. Thus, this result from the study should be interpreted with caution.  
Summary 
The 3.8% overall prevalence of major depression found among nondiabetic U.S. 
adults aged 20-39 years in the study sample was lower than those previously reported. 
Similarly, the 6.6% prevalence of major depression when measured by the CIDI also 
was low. The 1.8% prevalence of major depression when measured by the PHQ-9 was 
surprisingly low. As expected, the weighted prevalence of insulin resistance among 
nondiabetic U.S. adults aged 20-39 years in the study sample was 22.7%, only 
slightly lower than the estimated 25% prevalence rate among the general population 
(Reaven, 1988). Similar to previous pilot work, this study found no significant 
relationship between major depression and insulin resistance among nondiabetic U.S. 
men and women aged 20-39 years, but observed a significant negative association 
 211 
between major depression and insulin resistance in men. Major depression 
was not significantly associated with insulin resistance among women. The role of 
race/ethnicity on the relationship between major depression and insulin resistance was 
not supported by findings from this study. There was no significant variation in the 
relationship between major depression and insulin resistance by measures of 
depression. The results of the study support that BMI and waist circumference were 
significant predictors for insulin resistance. Overall, -2 log likelihood and AIC values 
were lower for models with waist circumference relative to models with BMI, except 
among women, suggesting that waist circumference may be a better predictor than 
BMI, except among women. However, BMI had greater odds ratio for insulin 
resistance than waist circumference, suggesting a stronger relationship with insulin 
resistance. Together, results suggest that BMI and waist circumference may be 
equally effective for identifying insulin resistance among nondiabetic adults aged 
20-39 years. 
Findings provide support for the positive and significant relationship between 
insulin resistance and 1) systolic blood pressure; 2) triglyceride level, 3) and obesity 
as measured by BMI or waist circumference in multivariate analyses among 
nondiabetic adults aged 20-39 years.  
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Limitations 
There are several limitations to this study that must be acknowledged. Consistent 
with the disadvantages of using cross-sectional data, this study cannot provide 
information on the temporal sequence of major depression and insulin resistance. 
Although various methods and techniques were applied in the National Health and 
Nutrition Examination Survey (NHANES) to ensure the quality of data, the 
characteristics of secondary data analyses of existing data induced several of the 
following limitations to the study.  
First, 10 years of the NHANES data (1999-2008) were combined for this study to 
ensure a large sample size that was appropriate for the proposed statistical analyses. 
Time factor may have played a role in the study investigation due to a wide range of 
time elapsed between NHANES 1999-2000 and 2007-2008. Young adults may have 
become more obese over time.  
Second, although 10 years of NHANES data were combined, the sample size (N 
= 2,265) for the current study was only one-fifth of the eligible adults aged 20-39 
years (N = 11,617) who were selected to participate in NHANES 1999-2008. This 
may limit the generalizability of the study findings to adults aged 20-39 years. The 
75.3% response rate to the home interview and health examination can also partially 
explain the reduction of sample size in this study. More importantly, the significant 
reduction in sample size was attributed to missing data on measures of major 
depression, fasting glucose and insulin levels. This is because fasting glucose and 
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insulin levels were collected from a subsample of the examined sample. 
However, fasting sample weights provided in NHANES data to account for 
nonresponse rate and additional sampling stage have been used in the study analyses 
to produce unbiased statistical estimates of the population.       
Third, changes in laboratory methodologies for determining plasma glucose and 
insulin levels over NHANES periods may have imposed a threat to the internal 
validity of the study. However, several studies have been conducted by NHANES to 
compare and contrast the values. In addition, conversion equations were 
recommended to make the values comparable over the NHANES periods.  
Fourth, there were slight changes in the questions on leisure time physical 
activity between NHANES 1999-2006 and NHANES 2007-2008. Participants in 
NHANES 2007-2008 were not asked to specify the individual leisure time physical 
activities in which they engaged. However, calculation of MET minutes/week was 
performed to minimize the impact of these changes.  
Fifth, the changes in the measurement of depression imposed a threat to the 
internal validity of the study. The CIDI differs from the PHQ-9 that: 1) the CIDI is a 
clinical diagnostic tool for major depression; 2) it excludes conditions that can cause 
depressive symptoms such as general medical diseases, substance abuse, or 
bereavement; and 3) it measures depressive symptoms over the past 12 months, in 
contrast that the PHQ-9 evaluates symptoms of depression within the past 2 weeks. 
Despite these differences, the PHQ-9 has been found to be a reliable and valid 
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measure of depression with a pooled sensitivity of .80 and specificity of .92, 
in comparison to the CIDI (Gilbody, et al., 2007). In addition, the study applied the 
DSM-IV diagnostic criteria for major depression measured by the PHQ-9, which 
parallels the CIDI, hoping to make the data as comparable as possible. The results of 
investigating the relationship between major depression and insulin resistance 
separately by measure of depression showed no significant variations. However, 
separate logistic regression analyses among men and women by measures of 
depression were not conducted due to insufficient sample size for sub-analyses. In 
addition, the current study did not examine data on use of antidepressant medications, 
which could have helped detect subjects who had depression.  
Sixth, the NHANES did not contain all the variables of interest for the study. For 
example, the study could not control for risk factors that were found to be positively 
associated with insulin resistance such as tumor necrosis factor-α (TNF-α), 
interleukin (IL)-1 and IL-6. However, hs-CRP, one of the immunoinflammatory 
cytokines, was examined in this study and included in the regression analyses. Since 
multiple factors (e.g., common cold or muscle strain) can increase hs-CRP, CDC and 
American Heart Association (Pearson, et al., 2003) have recommended that 
measurement of hs-CRP should be conducted on persons who are metabolically stable 
and have no obvious inflammatory or infectious conditions. Two measurements of 
hs-CRP should be performed at least two weeks apart and averaged to obtain a more 
accurate estimate of hs-CRP (Pearson, et al., 2003). However, hs-CRP was measured 
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for only one time in NHANES data. Therefore, a single-point elevation of 
hs-CRP may not suggest increased risk for cardiovascular disease.  
Seventh, data on race/ethnicity collected in the NHANES were limited to 
non-Hispanic White, non-Hispanic Black, and Mexican American. Subjects who 
reported race/ethnicity other than non-Hispanic White, non-Hispanic Black, and 
Mexican American or reported more than one race/ethnicity were classified into 
“other” race/ethnicity category. Thus, the study findings could not be generalized to 
other minority racial/ethnic groups such as Asian Americans.  
Eighth, the coefficients of variation (CV) for insulin assay across NHANES 
periods were relatively higher, in comparison with the CV for glucose assay. By 
definition, the CV is the ratio of the standard deviation to the mean and can be used to 
describe dispersion of a variable. The higher the CV, the greater the dispersion is in 
the variable. The highest range of the CV for insulin assay was found in NHANES 
2007-2008 (5.5-8.8%), followed by those in NHANES 1999-2002 (3.3-5.4%), 
NHANES 2005-2006 (3.4-4.9%), and NHANES 2003-2004 (2.0-4.6%).    
Lastly, information on demographic variables (age, gender, and race/ethnicity), 
health risk behaviors (smoking, leisure time physical inactivity, and alcohol 
consumption), and the depression questionnaires (the CIDI and the PHQ-9) were 
self-reported. Self-reported demographic information may be subject to the least bias, 
in comparison to health risk behaviors and the depression questionnaires. Social 
desirability bias, the tendency to report responses that are consistent with social 
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norms and expectations, may have impacted self-reports of health risk 
behaviors in the study (Davis, Thake, & Vilhena, 2010; Tourangeau & Yan, 2007). 
Smoking and alcohol consumption may have been underreported, while leisure time 
physical activity could have been over-reported. Responses to the depression 
questionnaires could be subject to recall bias, especially for the CIDI, in which 
participants were required to recall their depressive symptoms over a 12-month 
period. Despite these possible biases, self-reports continue to be commonly used 
method to gather information on demographic variables and health risk behaviors in 
epidemiological research because of its cost-effectiveness.        
Besides the limitations induced by secondary analyses discussed above, readers 
also should note that the homeostasis model assessment for insulin resistance 
(HOMA-IR) was used to define insulin resistance in the study. The most accurate 
measurement of insulin resistance is the hyperinsulinemic euglycemic glucose clamp 
test. However, the clamp test involves complex techniques and is very time - and cost 
- consuming, so it is unrealistic to conduct the glucose clamp test in large 
epidemiological studies such as the NHANES. Previous studies have shown that 
HOMA-IR is highly correlated with the hyperinsulinemic euglycemic glucose clamp 
test (Bonora, et al., 2000; Lansang, et al., 2001; Wallace, et al., 2004). Even so, there 
was no consensus on a universal cutoff value of HOMA-IR to define insulin 
resistance. This is partially due to lack of standardization of the insulin agent. In 
addition, the cutoff value may vary depending on the characteristics of the studied 
populations. The most commonly used definition of insulin resistance is the 75 
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percentile of HOMA-IR among normal healthy population (Balkau & Charles, 
1999). However, implementation of the definition is not without difficulties. For 
practical purpose, some researchers used the 75 percentile of HOMA-IR based on a 
nondiabetic sample; while others estimated the 75 percentile of HOMA-IR from 
strictly selected normal subjects. For example, Nakai et al. (2002) defined normal 
subjects as those who had a BMI < 25 kg/m
2
, fasting plasma glucose < 6.1 mmol/L, 
serum total cholesterol < 5.7 mmol/L, HDL > 1.0 mmol/L, serum triglycerides < 1.7 
mmol/L, systolic blood pressure < 130 mmHg, and diastolic blood pressure < 85 
mmHg. This would greatly reduce the heterogeneity of the study sample. In this 
current study, the cutoff value of HOMA-IR to define insulin resistance was derived 
from the 75 percentile of HOMA-IR (P75 = 3.4351) among nondiabetic U.S. adults 
aged ≥ 20 years old who had data on plasma glucose and insulin levels. This value 
was comparable to the P75 of 3.233 found in the pilot study (Shen, et al., 2011), was 
relatively lower than the P75 of 3.8 in Ascaso et al.‟s study (2001), but was fairly 
higher than the P75 of 1.7 reported by Nakai et al. (2002). The strictly and loosely 
defined normal healthy populations between Nakai et al.‟s study and this study could 
have contributed to the differences. Also, the study by Ascaso et al. (2001) used the 
90 percentile rather than 75 percentile as the cutoff value. In previous studies that 
have examined the relationship between depression and insulin resistance estimated 
by the HOMA-IR (Lawlor, et al., 2003; Pan, et al., 2008; Timonen, et al., 2007), no 
specific cutoff values of the HOMA-IR were provided, making it impossible to 
compare and contrast to the cutoff value found in this study. The variations in 
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defining normal healthy population and the cutoff value of the HOMA-IR 
(quartile, quintile, or decile) continue to contribute to the debates.  
Subjects with borderline diabetes or prediabetes were classified as having no 
diabetes in the study. Except for diabetes, subjects in this study were not screened for 
other comorbidity that might have influenced the findings of the study. It is known 
that depression is closely associated with hypothyroidism with a prevalence rate of 
63.5% among those who had subclinical hypothyroidism (Demartini, Masu, Scarone, 
Pontiroli, & Gambini, 2010). In addition, the study did not examine pregnancy status 
of women and could have included subjects who were pregnant. Insulin resistance has 
been shown to be related to pregnancy, which may result from the significant changes 
in hormones during pregnancy (Mastrogiannis, Spiliopoulos, Mulla, & Homko, 
2009).    
The relatively small number of subjects with major depression as measured by 
the PHQ-9 was a potential limitation to the study. The study adjusted a large number 
of risk factors for insulin resistance in the multivariate logistic regression analyses 
relative to the number of with a diagnosis of major depression. This may have limited 
the power to detect significant relationship between major depression and insulin 
resistance in the model. 
Another possible limitation to the study is that the age range of the study subjects 
was 20-39 years old. This limits the generalizability of the study findings to other age 
groups. However, this was the purpose of the study to investigate if the relationship 
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between major depression and insulin resistance was present among young 
adults aged 20-39 years.  
The use of SAS 9.2 for the statistical analyses may have been a potential 
limitation to the study. The complex survey design of the NHANES was accounted 
for by using the survey procedures in SAS 9.2. In contrast, SUDDAN is the software 
that was designed specifically for survey data and is the ideal statistical program to be 
used when analyzing survey data like NHANES. Even so, SAS is one of the three 
programs (SUDDAN, SAS, STATA) that are deemed to be appropriate to use when 
conducting analyses of NHANES data (CDC/NCHS, 2006a). Furthermore, one study 
has been conducted to compare results of logistic regression analyses generated by 
SAS and SUDDAN and found that identical model parameters and variance estimates 
were produced by SAS and SUDDAN (Chen, 2006).  
Recommendations for Further Research 
The findings of this study stimulated additional research questions that can be 
explored in the future research. Recommendations for further research related to 
depression and insulin resistance are presented by research questions.  
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The Role of Depression Measures on the Relationship between Major 
Depression and Insulin resistance 
This study examined the relationship between major depression and insulin 
resistance by measures of depression due to the changes in the instruments over the 
NHANES periods. Results suggest that the clinical diagnoses of major depression 
made from a screening tool such as the PHQ-9 may underestimate the diagnoses of 
major depression made from the CIDI. Moreover, the relatively small sample size that 
had a positive diagnosis of major depression when measured by the PHQ-9 (30 out of 
1,134) may have modified the relationship between major depression and insulin 
resistance in unknown ways in the study. When data from NHANES 2009-2010 
become available, new studies can be conducted to investigate if there is an 
association between major depression and insulin resistance, when measured by the 
PHQ-9. Since the PHQ-9 can be used as a diagnostic tool as well as a severity tool, it 
would be interesting to compare and contrast the models when depression is 
operationalized as a diagnosis, categorized by severity (mild, moderate, or severe), or 
even used as a continuous score.  
The Role of Age on the Relationship between Major Depression and Insulin 
Resistance 
Exploration of the relationship between major depression and insulin resistance 
by age categories may provide additional information in understanding if the 
relationship varies by age. As previous studies reported mixed results from subjects 
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aged 18-79 years, analyses of the relationship stratified by age categories in 
one study may reveal additional information that is helpful in explaining the 
inconsistency of results. Age can be categorized into three groups: young adults 
(20-39 years), middle-aged adults (40-59 years), and older adults (60-79 years).  
The Cutoff Value of the HOMA-IR for Insulin Resistance 
Another area that is needed for further investigation is the cutoff value of the 
HOMA-IR for insulin resistance. The wide variations in the threshold of the 
HOMA-IR for insulin resistance and factors used to define the general healthy 
population made it difficult to compare and contrast results across studies. Future 
research can focus on if the universal definition of insulin resistance by 75 percentile 
of HOMA-IR among general population should be age-, gender-, or race/ethnicity- 
specific. Studies also can be conducted to compare and contrast the 75 percentiles of 
HOMA-IR when general healthy population is defined by different factors. The goal 
of investigating the cutoff value of the HOMA-IR for insulin resistance is not to find 
a universal cut point, but make recommendations for the range. In addition, studies 
can apply more restricted definition of insulin resistance using the 80 or 90 percentile 
of HOMA-IR to examine if the relationship between depression and insulin resistance 
varies.  
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Implications for Theory 
The study findings suggest that some risk factors for insulin resistance identified in 
other populations also are applicable to nondiabetic adults aged 20-39 years. Figure 4 
depicts modifications to the conceptual schema of factors thought to be associated 
with insulin resistance for nondiabetic adults aged 20-39 years. Factors positively 
associated with insulin resistance in univariate analyses are in bold. Factors 
negatively associated with insulin resistance in univariate analyses are underlined. 
Factors positively associated with insulin resistance in both univariate and 
multivariate analyses are in bold and italicized. Factors negatively associated with 
insulin resistance in multivariate analyses are underlined and italicized. 
Implications for Practice 
The insignificant association between major depression and insulin resistance 
found in the study does not necessarily indicate that individuals with major 
depression are not at risk for insulin resistance. Similarly, the significant negative 
relationship between major depression and insulin resistance among men does not 
imply that men with major depression are protected from having insulin resistance. 
Previous studies showed that other risk factors of insulin resistance such as obesity 
and physical inactivity were prevalent among patients with major depression. Thus, 
particular attention should be paid to patients with major depression who appear to 
have risk factors for insulin resistance. Assessment of these risk factors may help  
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DEMOGRAPHIC FACTORS: 
Age 
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PSYCHOLOGICAL FACTORS: 
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PHYSIOLOGICAL FACTORS: 
Systolic blood pressure 
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C-Reactive protein 
 
LIFESTYLE FACTORS: 
Smoking 
Alcohol consumption 
Physical inactivity 
Obesity 
 
INSULIN RESISTANCE 
Bold indicates factors positively 
associated with insulin resistance in 
univariate analyses. 
Underline indicates factors negatively 
associated with insulin resistance in 
univariate analyses. 
Bold and italic indicates factors 
positively associated with insulin 
resistance in both univariate and 
multivariate analyses. 
Underline and italic indicates factors 
negatively associated with insulin 
resistance in multivariate analyses. 
  
 
 
Figure 4. Modified Conceptual Schema of Risk Factors for Insulin Resistance among 
Nondiabetic Adults Aged 20-39 Years 
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healthcare providers identify patients at risk for insulin resistance and 
intervene at an early stage to prevent its progression to type 2 diabetes.  
According to the findings of this study, systolic blood pressure, triglyceride level, 
hs-CRP, BMI, waist circumference, leisure time physical activity, and alcohol 
consumption were significant risk factors for insulin resistance. Further, the positive 
associations of systolic blood pressure, triglyceride level, BMI and waist 
circumference to insulin resistance were independent of other risk factors. 
Hypertension, high triglyceride level, and obesity or central obesity are the main 
components of metabolic syndrome. Results from a previous study suggest that 
behavioral risk factors are usually clustered among individuals (Klein-Geltink, Choi, 
& Fry, 2006). Multiple exposures to these risk behaviors may potentially strengthen 
their individual effects on the development of insulin resistance and cardiovascular 
disease. Identification of persons with one or more of these risk factors can help alert 
healthcare professionals to target this group of individuals with appropriate 
interventions. Healthy lifestyle can help decrease the risk of insulin resistance. Nurses 
are in an ideal position to educate patients the risks of unhealthy lifestyles such as 
overeating and physical inactivity to the development of insulin resistance. Strategies 
and intervention should be developed to help patients initiate and make positive 
changes for healthy lifestyles.  
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Conclusion 
The overall findings of this study suggest that major depression is not associated 
with insulin resistance among nondiabetic adults aged 20-39 years. However, gender 
differences in this relationship were observed. No evidence was found to support the 
role of race/ethnicity in the relationship between major depression and insulin 
resistance. Study findings provide support for the significant positive relationships 
between insulin resistance and 1) systolic blood pressure, 2) triglyceride level, and 3) 
obesity as measured by BMI or waist circumference among nondiabetic adults aged 
20-39 years.  
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APPENDIX A. MOBILE EXAMINATION CENTER (MEC).  
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National Health and Nutrition Examination Survey (NHANES) Mobile 
Examination Center 
 
 
(Source: Centers for Disease Control and Prevention (CDC). National Center for 
Health Statistics (NCHS). National Health and Nutrition Examination Survey, 
2007-2008 overview. Hyattsville, MD: U.S. Department of Health and Human 
Services, Centers for Disease Control and Prevention. Retrieved from: 
http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/overviewbrochure_0708.pdf) 
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COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW (CIDI) 
12 MONTH MAJOR DEPRESSION  
 
PROGRAMMER: ROTATE WITH ANXIETY SECTIONS. RANDOM 50% OF 
TIME ASK PANIC AND GAD BEFORE DEPRESSION; THE OTHER 50% OF 
THE TIME ASK DEPRESSION BEFORE PANIC AND GAD.  
 
COMMENT: THE E1 SERIES IS THE FIRST OF THREE STEM QUESTION 
SEQUENCES. IF THE RESPONDENT ENDORSES THE FIRST STEM 
QUESTION AND SAYS IT LASTED MOST OF THE DAY NEARLY EVERY 
DAY FOR TWO WEEKS WE CONTINUE WITH THAT STEM FOR THE 
REMAINDER OF THE SECTION. IF NOT, WE GO TO THE SECOND STEM 
QUESTION SEQUENCE (E2 SERIES). IF R FAILS THIS SECOND CHANCE, 
WE GIVE A THIRD CHANCE IN THE E2.1 SERIES. ONLY AFTER FAILING 
ALL THREE CHANCES TO ENDORSE A STEM QUESTION DO WE SKIP R 
OUT OF THE MD SECTION.  
 
E1. [THIS IS THE INTRO FOR THE 50% WHO START WITH PANIC: The next 
questions are about periods of being sad or depressed]/[THIS IS THE INTRO FOR 
THE 50% WHO START WITH DEPRESSION AND THEN GO TO PANIC AND 
GAD: The next questions are about emotional problems that many people have. The 
first question is about periods of being sad or depressed.]  
 
(READ SLOWLY.) In the past 12 months, have you had a period of two weeks or 
longer when you felt sad or depressed or empty?  
 
1. YES  
5. NO GO TO E2  
8. DK GO TO E2  
9. REF GO TO E2  
 
E1a. Think of the two weeks during the past 12 months when this feeling was most 
persistent. During that two-week period, did you feel sad or depressed or empty 
every day, nearly every day, most days, about half the days, or less than half the 
days? (PROBE DK: What's your best estimate? REPEAT RESPONSE 
CATEGORIES)  
 
1. EVERY DAY  
NEARLY EVERY DAY  
MOST DAYS  
4. ABOUT HALF THE DAYS GO TO E2  
5. LESS THAN HALF THE DAYS GO TO E2  
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DK GO TO E2  
REF GO TO E2  
 
E1b. And did this feeling usually last all day long, most of the day, about half the 
day, or less than half the day? (PROBE DK: What's your best estimate? REPEAT 
RESPONSE CATEGORIES)  
 
1. ALL DAY LONG  
2. MOST OF THE DAY  
3. ABOUT HALF THE DAY  
4. LESS THAN HALF THE DAY GO TO E2  
DK GO TO E2  
REF GO TO E2  
 
E1c. (IVR: HAND CARD C TO R.) (NOTE: COMPLEX QUESTION. READ 
CAREFULLY.) Please look at Card C. People who have periods of being sad, 
depressed, or empty often have other problems on this list at the same time, like 
changes in sleep or energy or appetite or concentration or feelings of low self-worth. 
During the time you were sad, depressed or empty, did you also have any of these 
other problems?  
 
YES  
5. NO GO TO E2  
8. DK GO TO E2  
9. REF GO TO E2  
 
E1c.1 For the next questions, please think of the two weeks during the past 12 
months when you were sad, depressed, or empty and had the largest number of these 
other problems. During that two-week period, did you lack energy or feel tired all 
the time nearly every day, even when you had not been working very hard? (IF R 
SAYS THERE WAS NO SINGLE TWO-WEEK PERIOD THAT STANDS OUT, 
SAY: Then think of the most recent two weeks of this sort.)  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E1d. During that two-week period, did you lose interest in most things like work, 
hobbies, and other things you usually enjoy?  
 
1. YES  
5. NO  
8. DK  
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9. REF  
 
E1e. During that two-week period, did you feel irritable or grouchy or in a bad 
mood most of the time?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
GO TO E3  
 
COMMENT: THE E2 SERIES IS THE SECOND STEM QUESTION SEQUENCE  
 
E2. (READ SLOWLY) In the past 12 months, have you had a period of two weeks 
or longer when you lost interest in most things like work, hobbies, and other things 
you usually enjoy?  
 
1. YES  
5. NO GO TO E2.1  
8. DK GO TO E2.1  
9. REF GO TO E2.1  
 
E2a. Think of the two weeks when this loss of interest was most persistent. During 
that two-week period, did you lose interest in things every day, nearly every day, 
most days, about half the days, or less than half the days? (PROBE DK: What's your 
best estimate? REPEAT RESPONSE CATEGORIES).  
 
1. EVERY DAY  
NEARLY EVERY DAY  
MOST DAYS  
4. ABOUT HALF THE DAYS GO TO E2.1  
5. LESS THAN HALF THE DAYS GO TO E2.1  
DK GO TO E2.1  
REF GO TO E2.1 
  
E2b. And did this feeling usually last all day long, most of the day, about half the 
day, or less than half the day? (PROBE DK: What's your best estimate? REPEAT 
RESPONSE CATEGORIES).  
 
1. ALL DAY LONG  
2. MOST OF THE DAY  
3. ABOUT HALF THE DAY  
4. LESS THAN HALF THE DAY GO TO E2.1  
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DK GO TO E2.1  
REF GO TO E2.1  
 
E2c.  
CAN: IF E1c = (NO,DK,REF) USE THIS VERSION:  
(NOTE: COMPLEX QUESTION. READ CAREFULLY.) Please look at Card C 
again. People who have periods of losing interest in most things often have other 
problems on this list at the same time. During the time that you lost interest in most 
things, did you also have any of these other problems?  
 
ELSE USE THIS VERSION:  
(IVR: HAND CARD C TO R.) (NOTE: COMPLEX QUESTION. READ 
CAREFULLY.) Please look at Card C. People who have periods of losing interest in 
most things often have other problems on this list at the same time, like changes in 
sleep or energy or appetite or concentration or feelings of low self-worth. During the 
time that you lost interest in most things, did you also have any of these other 
problems?  
 
YES  
5. NO GO TO E2.1  
8. DK GO TO E2.1  
9. REF GO TO E2.1  
 
E2c.1 For the next questions, please think of the two weeks during the past 12 
months when you lost interest in most things and had the largest number of these 
other problems. During that two-week period, did you lack energy or feel tired all 
the time nearly every day, even when you had not been working very hard? (IF R 
SAYS THERE WAS NO SINGLE TWO-WEEK PERIOD THAT STANDS OUT, 
SAY: Then think of the most recent two weeks of this sort.)  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E2d. During that two-week period, did you feel irritable or grouchy or in a bad 
mood most of the time?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
GO TO E3  
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COMMENTS: THE E2.1 SEQUENCE IS THE THIRD AND FINAL STEM 
QUESTION SERIES  
 
E2.1. (READ SLOWLY) In the past 12 months, Did you have a period of two 
weeks or longer when you were irritable or grouchy or in a bad mood most of the 
time?  
 
1. YES  
5. NO GO TO NEXT SECTION  
8. DK GO TO NEXT SECTION  
9. REF GO TO NEXT SECTION  
 
E2.1a. Think of the two weeks when this bad mood was most persistent. During that 
two-week period, did you feel irritable or grouchy or in a bad mood every day, 
nearly every day, most days, about half the days, or less than half the days? 
(PROBE DK: What's your best estimate? REPEAT RESPONSE CATEGORIES).  
 
1. EVERY DAY  
NEARLY EVERY DAY  
MOST DAYS  
4. ABOUT HALF THE DAYS GO TO NEXT SECTION  
5. LESS THAN HALF THE DAYS GO TO NEXT SECTION  
DK GO TO NEXT SECTION  
REF GO TO NEXT SECTION  
 
E2.1b. And did this feeling usually last all day long, most of the day, about half the 
day, or less than half the day? (PROBE DK: What's your best estimate? REPEAT 
RESPONSE CATEGORIES).  
 
1. ALL DAY LONG  
2. MOST OF THE DAY  
3. ABOUT HALF THE DAY  
4. LESS THAN HALF THE DAY GO TO NEXT SECTION  
DK GO TO NEXT SECTION  
REF GO TO NEXT SECTION 
  
E2.1c.  
CAN: IF E1c=(NO,DK,REF) or E2c=(NO, DK, REF), USE THIS VERSION:  
(NOTE: COMPLEX QUESTION. READ CAREFULLY.) Please look at Card C 
again. People who have periods of being irritable or grouchy often have other 
problems on this list at the same time. During the time you were irritable or grouchy, 
did you also have any of these other problems?  
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ELSE USE THIS VERSION:  
(IVR: HAND CARD C TO R.) (NOTE: COMPLEX QUESTION. READ 
CAREFULLY.) Please look at Card C. People who have periods of being irritable 
or grouchy often have other problems on this list at the same time, like changes in 
sleep or energy or appetite or concentration or feelings of low self-worth. During the 
time you were irritable or grouchy, did you also have any of these other problems?  
 
YES  
5. NO GO TO NEXT SECTION  
8. DK GO TO NEXT SECTION  
9. REF GO TO NEXT SECTION  
 
E2.1c.1 For the next questions, please think of the two weeks during the past 12 
months when you were irritable and had the largest number of these other problems. 
During that two-week period, did you lack energy or feel tired all the time nearly 
every day, even when you had not been working very hard? (IF R SAYS THERE 
WAS NO SINGLE TWO-WEEK PERIOD THAT STANDS OUT, SAY: Then 
think of the most recent two weeks of this sort.)  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E3. CHECKPOINT  
 
CAN: DO NOT RANDOMIZE  
 
E4. (During that two-week period,) Did you have less appetite than usual almost 
every day?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E5. (During that two-week period,) Did you lose weight without trying to?  
(IF VOL: "On diet" OR "I tried to lose weight," CODE NO)  
 
1. YES  
5. NO IF E4 EQ YES, GO TO E8. ELSE GO TO E6  
8. DK IF E4 EQ YES, GO TO E8. ELSE GO TO E6  
9. REF IF E4 EQ YES, GO TO E8. ELSE GO TO E6  
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E5a. How much weight did you lose during that two week period? (IF 
RESPONSE > 100, ENTER 100. IF RESPONSE = DK, ENTER 998. IF 
RESPONSE = REF, ENTER 999).  
______ NUMBER OF POUNDS  
 
GO TO E8  
 
E6. Did you have a much larger appetite than is usual for you almost every day 
during that two weeks?  
 
IF VOL: IF ONLY BECAUSE PREGNANT, CODE NO  
IF VOL: ONLY REGAINED WEIGHT LOST, CODE NO  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E7. (During that two-week period,) Did you gain weight?  
 
1. YES  
5. NO GO TO E8  
8. DK GO TO E8  
9. REF GO TO E8  
 
E7a. How much did you gain during that two week period? (IF RESPONSE > 100, 
ENTER 100. IF RESPONSE = DK, ENTER 998. IF RESPONSE = REF, ENTER 
999).  
 
______ NUMBER OF POUNDS  
 
E8. Did you have a lot more trouble than usual sleeping for these two weeks -- 
either trouble falling asleep, waking in the middle of the night, or waking up too 
early?  
 
1. YES  
5. NO GO TO E9  
8. DK GO TO E9  
9. REF GO TO E9  
 
E8.1. Did this happen every night, nearly every night, or less often during those two 
weeks?  
 
1. EVERY NIGHT  
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2. NEARLY EVERY NIGHT GO TO E9  
3. LESS OFTEN GO TO E9  
8. DK GO TO E9  
9. REF GO TO E9  
 
E8a. Did you wake up at least two hours before you wanted to every day during 
these two weeks?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E9. Did you sleep too much almost every day?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E22. (During that two-week period,) Did you feel particularly bad when you first 
got up, but felt better later in the day?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E23. (During that two-week period,) Was your interest in sex a lot less than usual?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E2.4. (During that two-week period,) Did you lose the ability to enjoy having good 
things happen to you, like winning something or being praised or complimented?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E10. Did you talk or move more slowly than is normal for you almost every day 
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during these two weeks?  
 
1. YES  
5. NO GO TO E11  
8. DK GO TO E11  
9. REF GO TO E11  
 
E10a. Did anyone else notice that you were talking or moving slowly?  
 
1. YES  
5. NO  
8. DK  
9. REF  
GO TO E12 
  
E11. (During that two-week period,) Did you have to be moving all the time -- that 
is, you couldn't sit still and paced up and down or couldn't keep your hands still 
when sitting?  
 
1. YES  
5. NO GO TO E12  
8. DK GO TO E12  
9. REF GO TO E12  
 
E11a. Did anyone else notice that you were moving all the time?  
1. YES  
5. NO  
8. DK  
9. REF  
 
E12. (During that two-week period,) Did you feel worthless nearly every day?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E12a. Did you feel guilty?  
 
1. YES  
5. NO  
8. DK  
9. REF  
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IF E12 OR E12a = YES, GO TO E12b. ELSE GO TO E13.  
 
E12b. Was there a particular reason for feeling (worthless/or/guilty)? (PROBE: Any 
other reason?) RECORD OPEN-ENDED RESPONSE  
 
If E12b= DK/REF, GO TO E13.  
 
E12c. INTERVIEWER QUERY: DID R FEEL WORTHLESS OR GUILTY ONLY 
ABOUT BEING IMPAIRED BY DEPRESSION?  
 
1. YES  
NO  
8. DK  
 
E13. Did you feel that you were not as good as other people?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E14. Did you have so little self-confidence that you wouldn't try to have your say 
about anything?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E15. (During that two-week period,) Did you have a lot more trouble concentrating 
than is normal for you?  
 
1. YES GO TO E15a  
5. NO GO TO E16  
8. DK GO TO E15a  
9. REF GO TO E15a  
 
E15a Were you unable to read things that usually interest you or watch television or 
movies you usually like because you couldn't pay attention to them?  
 
1. YES  
5. NO  
8. DK  
9. REF  
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E16. (During that two-week period,) Did your thoughts come much slower than 
usual or seem mixed up?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E17. (During that two-week period,) Were you unable to make up your mind about 
things you ordinarily have no trouble deciding about?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E18. (During that two-week period,) Did you think a lot about death?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E19. Did you feel so low you thought a lot about committing suicide?  
 
1. YES  
5. NO GO TO E20.1  
8. DK  
9. REF  
 
E19a. Did you make a suicide plan?  
 
1. YES  
5. NO  
8. DK  
9. REF  
 
E20. Did you attempt suicide?  
 
1. YES  
5. NO  
8. DK  
9. REF  
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E20.1 CHECKPOINT  
PROGRAMMER: SUM THE FOLLOWING: E1c.1 = YES, E1d = YES, E1e = 
YES, E2c.1 = YES, E2.d = YES. E2.1c.1 = YES, E4 = YES, E5a GT OR EQ 10, E6 
= YES, E7a GT OR EQ 10, E8.1 = 1-2, E9 = YES, E22 = YES, E23 = YES, E2.4 = 
YES, E10 = YES, E11 = YES, E12c = NO, E13 = YES, E14 = YES, E15 = YES, 
E16 = YES, E17 = YES, E18 = YES, E19 = YES.  
 
IF SUM IS 0, GO TO THE NEXT SECTION. IF SUM IS GT 0, GO TO E66.  
 
USE THESE PHRASES IN PADDING  
E1c.1 = E2c.1 = E2.1c.1   felt tired all the time  
E1d        lost interest in most things  
E1e = E2d      felt irritable most of the time  
E4        had less appetite than usual  
E5a       lost weight  
E6        had a larger appetite than usual  
E7a        gained weight  
E8.1        had trouble sleeping  
E9        slept too much  
E23        were less interested in sex than usual  
E2.4        lost the ability to enjoy things  
E10        talked or moved more slowly than usual  
E11        had to be moving all the time  
E12        felt worthless  
E12a        felt guilty  
E13        felt like you weren't as good as other people  
E14        had low self-confidence  
E15        had trouble concentrating  
E16        had your thoughts come much more slowly than 
usual E17        had trouble making up your mind,  
E18        thought a lot about death,  
E19        thought about killing yourself  
E20        attempted suicide  
 
STEM PHRASES FOR PADDING  
 
IF E1b = 1-3     felt sad, depressed or empty most of the time  
ELSE IF E2b = 1-3    lost interest in most things  
ELSE IF E2.1b = 1-3    were irritable most of the time  
 
E66. (NOTE: COMPLEX QUESTION. READ CAREFULLY.) I'm going to review 
what you told me. You had a period of two weeks or longer when you (stem 
phrase)?  
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IF E20.1 SUM = (1,2,3): ? and also (fill with all phrases endorsed on list).  
IF E20.1 SUM > 4: ? . You also had other problems at the same time. For example, 
you (fill with first 3 phrases endorsed on list), and had other problems you 
mentioned.  
 
Think about all the weeks in the past 12 months when you (stem phrase) and also 
had (this/these/some of these) other problem(s) nearly every day. About how many 
weeks of this sort out of 52 did you have in the past 12 months? (IF RESPONSE = 
DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
______ NUMBER OF WEEKS  
 
E66.3 CHECKPOINT:  
 
IF E66 LT 2, GO TO NEXT SECTION. IF E66 EQ 2-3, GO TO E24a. IF E66 GT 3, 
GO TO E24. IF E66 = (DK, REF), GO TO E24.1. IF E66 EQ (51 OR 52), GO TO 
E24a.  
 
E24. Was this one period of ("NUMBER FROM E66 weeks") in a row, or was it 
two or more periods that add up to ("NUMBER FROM E66 weeks").  
1. ONE PERIOD GO TO E24a  
2. TWO OR MORE PERIODS GO TO E25  
DK GO TO E26x  
REF GO TO E26x  
 
E24.1 Was this one period or was it two or more periods?  
 
ONE PERIOD GO TO E24a  
TWO OR MORE PERIODS GO TO E25  
8. DK GO TO E26x  
REF GO TO E26x  
 
COMMENT: THE E24 SERIES IS ONLY FOR PEOPLE WITH EXACTLY ONE 
12-MONTH EPISODE  
 
E24a. Is this period still going on or has it ended?  
 
1. STILL GOING ON  
5. ENDED  
DK  
REF  
 
CHECKPOINT:  
 
 242 
IF E24a = (8,9), SET E24a = 1 FOR THIS CHECKPOINT 
CALCULATION (RETAIN ORIGINAL VALUE IN DATAFILE).  
 
IF E24a = 1 AND E66 = (52 WEEKS, DK, REF), WE KNOW REC = PAST 
MONTH, BUT WE DO NOT KNOW HOW LONG IT HAS BEEN GOING ON. 
THEREFORE, WE NEED TO ASK ABOUT DUR: GO TO E24b.  
 
IF E24a = 1 AND E66 = 2-51 WEEKS, WE KNOW REC = PAST MONTH AND 
WE KNOW DURATION OF EPISODE IS LESS THAN ONE YEAR AND WE 
KNOW EXACT NUMBER OF WEEKS DURATION. THEREFORE, WE DO 
NOT NEED TO ASK ANY MORE DURATION OR RECENCY QUESTIONS 
AND CAN GO TO THE QUESTIONS ABOUT NORMAL BEREAVEMENT 
AND POSTPARTUM: GO TO E24f  
 
IF E24a = 5 AND E66 = 48-52, WE KNOW IT ENDED IN THE PAST MONTH, 
WHICH MEANS THAT REC = PAST MONTH. BUT WE DO NOT KNOW 
HOW LONG IT WENT ON. THEREFORE, WE SHOULD SKIP REC AND GO 
TO THE DUR QUESTION: GO TO E24e.  
 
IF E24a = 5 AND E66 = 27-47, WE DO NOT KNOW REC COMPLETELY, BUT 
WE KNOW IT CANNOT BE MORE THAN SIX MONTHS AGO. THEREFORE, 
WE SHOULD GO TO A TRUNCATED REC QUESTION: GO TO E24c.  
 
IF E24a = 5 AND E66 LT 27, WE DO NOT KNOW REC. THEREFORE, WE 
SHOULD GO TO THE  
REC QUESTION: GO TO E24d.  
 
E24b. How long has this period been going on so far? (IF RESPONSE = DK, 
ENTER 998, IF RESPONSE = REF, ENTER 999).  
 
______# OF MONTHS OR YEARS  
 
GO TO E24f  
 
E24c. When did it end -- in the past month or more than a month ago?  
 
1. PAST MONTH GO TO E24f  
2. MORE THAN A MONTH AGO GO TO E24e  
DK GO TO E24e  
REF GO TO E24e  
 
COMMENT:  
 
IF E24c = 1, WE KNOW DURATION REPORTED IN E66 COULD NOT HAVE 
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BEEN BEYOND THE PAST 12 MONTHS. THEREFORE, WE CAN 
SKIP THE DURATION  
 
QUESTION AND GO TO THE NORMAL BEREAVEMENT AND 
POSTPARTUM QUESTIONS: GO TO E24f  
 
IF E24c = 2, WE HAVE NO WAY OF KNOWING WHETHER DURATION 
WENT BEYOND THE PAST 12 MONTHS. THEREFORE, WE HAVE TO ASK 
DUR: GO TO E24e.  
 
E24d. When did it end -- in the past month, past six months, or more than six 
months ago?  
 
1. MONTH GO TO E24f  
2. SIX MONTHS GO TO E24f  
3. MORE THAN SIX MONTHS AGO GO TO E24e  
DK GO TO E24e  
REF GO TO E24e  
 
COMMENT:  
 
EVERYONE ASKED E24d HAD A RECENCY LT 27 WEEKS. THEREFORE, IF 
E24d = 1-2, WE KNOW THE DURATION IN E66 IS WITHIN THE PAST YEAR. 
THEREFORE, WE CAN SKIP THE DURATION QUESTION: GO TO E24f  
 
IF E24d = 3, WE NEED TO ASK DURATION BECAUSE IT MIGHT HAVE 
BEEN OUTSIDE THE PAST YEAR. GO TO E24e  
 
E24e. How long did this period go on before it ended? (IF RESPONSE = DK, 
ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
______# OF WEEKS OR MONTHS OR YEARS  
 
E24f. Did this period begin just after someone close to you died?  
 
1. YES GO TO E24g  
5. NO IF MALE, GO TO E24i. IF FEMALE AGE 50+, GO TO E24i. IF FEMALE 
LT 50, GO TO E24h  
DK IF MALE, GO TO E24i. IF FEMALE AGE 50+, GO TO E24i. IF FEMALE LT 
50, GO TO E24h  
9. REF IF MALE, GO TO E24i. IF FEMALE AGE 50+, GO TO E24i. IF FEMALE 
LT 50, GO TO E24h  
 
E24g. (IF NEC: Who was it that died?) IF MULTIPLE RESPONSES, RECORD 
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ONLY FIRST MENTION. 
  
1. SPOUSE  
2. CHILD  
3. PARENT/SIBLING  
4. OTHER RELATIVE  
5. NONRELATIVE  
DK  
REF  
 
GO TO E27  
 
E24h. Did this period begin within a month of you having a baby?  
 
1. YES GO TO E27  
5. NO  
DK  
REF  
 
E24i. Did anything else happen shortly before this period began that might have 
caused it to happen?  
 
1. YES  
5. NO GO TO E27  
DK GO TO E27  
REF GO TO E27  
 
E24j. (IF NEC: Briefly, what happened?)  
 
GO TO E27  
 
E25. (IF NEC: How many periods?) (IF RESPONSE = DK, ENTER 98. IF 
RESPONSE = REF, ENTER 99).  
 
______ NUMBER OF PERIODS  
 
IF E25 = 2, GO TO E25a  
IF E25 = 3 OR MORE, GO TO E26x  
IF E25 = (DK,REF), GO TO E26x  
 
COMMENT: THE E25 SERIES IS FOR PEOPLE WITH EXACTLY 2 
12-MONTH EPISODES  
 
E25a. How many weeks, months or years did the first of these periods go on before 
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it ended? (IF RESPONSE = DK, ENTER 98. IF RESPONSE = REF, 
ENTER 99).  
 
______# OF WEEKS OR MONTHS OR YEARS  
 
E25b. Did this first period begin just after someone close to you died?  
 
1. YES GO TO E25c  
NO IF MALE, GO TO E25e. IF FEMALE AGE 50+, GO TO E25e. IF FEMALE 
LT 50, GO TO E25d  
8. DK IF MALE, GO TO E25e. IF FEMALE AGE 50+, GO TO E25e. IF FEMALE 
LT 50, GO TO E25d  
9. REF IF MALE, GO TO E25e. IF FEMALE AGE 50+, GO TO E25e. IF 
FEMALE LT 50, GO TO E25d  
 
E25c. (IF NEC: Who was it that died?) IF MULTIPLE RESPONSES, RECORD 
ONLY FIRST MENTION.  
 
1. SPOUSE  
2. CHILD  
3. PARENT/SIBLING  
4. OTHER RELATIVE  
5. NONRELATIVE  
DK  
REF  
 
GO TO E25g  
 
E25d. Did this period begin within a month of you having a baby?  
 
1. YES GO TO E25g  
5. NO  
DK  
REF  
E25e. Did anything else happen shortly before this period began that might have 
caused it to happen? 
  
1. YES  
5. NO GO TO E25g  
DK GO TO E25g  
REF GO TO E25g  
 
E25f. (IF NEC: Briefly, what happened?)  
 
 246 
E25g. How much time went on between the end of this first period and the 
beginning of the second? (IF RESPONSE = DK, ENTER 998. IF RESPONSE = 
REF, ENTER 999).  
 
______# OF DAYS OR WEEKS OR MONTHS  
 
PROGRAMMER: CONVERT RESPONSE IN E25g TO WEEKS FOR 
PURPOSES OF LATER CALCULATIONS  
 
IF E25g IS LESS THAN 8 WEEKS, GO T0 E25o. ELSE GO TO E25h  
 
E25h. Did you feel OK for at least two months between the two periods?  
 
1. YES  
5. NO  
DK  
REF  
 
E25i. Between these two periods, did you have at least two months when you were 
able to carry out your daily activities and enjoy being with other people as much as 
before the first period began?  
 
1. YES  
5. NO  
DK  
REF  
 
E25o. Is the second period still going on now or has it ended?  
 
1. STILL GOING ON GO TO E25j  
5. ENDED  
DK GO TO E25j  
REF GO TO E25j  
 
E25p. How long did it go on before it ended? (IF RESPONSE = DK, ENTER 998. 
IF RESPONSE = REF, ENTER 999).  
 
______# OF DAYS OR WEEKS OR MONTHS  
 
COMMENT  
 
WE CAN NARROW THE RANGE OF UNCERTAINTY ABOUT REC 
FOR MANY Rs.  
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IF FIRST EPISODE BEGAN MORE THAN 12 MONTHS AGO, 
WE CAN CALCULATE REC EXACTLY BY NOTING THAT # OF WEEKS IN 
EPISODE IN PAST YEAR MINUS DUR OF SECOND EPISODE = DUR OF 
THE PART OF FIRST EPISODE IN THE PAST 12 MONTHS. ADD THE 
LATTER TO TIME BETWEEN EPISODES AND ADD THIS TO DUR OF 
SECOND EPISODE, AND WE KNOW EXACTLY HOW MANY WEEKS AGO 
SECOND EPISODE ENDED. THEREFORE, IF WE KNOW FIRST EPISODE 
STARTED BEFORE 12 MONTHS AGO, WE CAN SKIP THE REC QUESTION. 
THIS CAN BE DONE EXACTLY AS FOLLOWS:  
 
"a". PART OF EPISODE #1 THAT OCCURRED IN PAST 12 MONTHS = 
E66 - E25p. PROGRAMMER: BE SURE TO SET NEGATIVE NUMBERS 
EQUAL TO ZERO AT LEAST STAGE BEFORE CONTINUING BECAUSE 
THERE WILL BE SOME INCONSISTENCY IN REPORTING.  
 
"b". PART OF EPISODE #1 THAT OCCURRED PRIOR TO PAST 12 
MONTHS = E25a - PART THAT OCCURRED IN PAST 12 MONTHS.  
 
IF "b" IS GT 0, THEN RECENCY OF EPISODE #2 IN DEFINED 
EXACTLY IN WEEKS AS [52 - ("a" EXPRESSED IN WEEKS + E25g 
EXPRESSED IN WEEKS + E25p EXPRESSED IN WEEKS). 
THEREFORE, IF "b" IS GT 0, SKIP THE REC QUESTION AND GO TO 
E25j  
 
IF "b" IS 0 (OR NEGATIVE, REMEMBERING TO SET ALL NEGATIVE 
VALUES TO ZERO), AND ("a" EXPRESSED IN WEEKS + E25g 
EXPRESSED IN WEEKS + E25p EXPRESSED IN WEEKS) = "SUM" = 
48 OR MORE, REC = PAST MONTH. IN THIS CASE, SKIP THE REC 
QUESTION AND GO TO E25j  
 
IF "B" IS 0 AND "SUM" = 27-47, REC HAS TO BE EITHER ONE 
MONTH OR SIX MONTHS. IN THI  
 
IF "B" IS 0 AND "SUM" = LESS THAN 27, REC IS UNKNOWN> IN 
THIS CASE, GO TO THE REC QUESTION: GO TO E25r  
 
E25q. When did it end -- in the past month or more than a month ago?  
 
1. PAST MONTH  
2. MORE THAN A MONTH AGO  
DK  
REF  
GO TO E25j  
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E25r. When did it end -- in the past month, past six months, or more than 
six months ago?  
 
1. PAST MONTH  
2. PAST SIX MONTHS  
3. MORE THAN SIX MONTHS AGO  
DK  
REF  
 
E25j. Did this second period begin just after someone close to you died?  
 
1. YES GO TO E25k  
5. NO IF MALE, GO TO E25m. IF FEMALE AGE 50+, GO TO E25m. IF 
FEMALE LT 50, GO TO E25l  
DK IF MALE, GO TO E25m. IF FEMALE AGE 50+, GO TO E25m. IF FEMALE 
LT 50, GO TO E25l  
9. REF IF MALE, GO TO E25m. IF FEMALE AGE 50+, GO TO E25m. IF 
FEMALE LT 50, GO TO E25l  
 
E25k. (IF NEC: Who was it that died?) IF MULTIPLE RESPONSES, RECORD 
ONLY FIRST IN LIST.  
 
1. SPOUSE  
2. CHILD  
3. PARENT/SIBLING  
4. OTHER RELATIVE  
5. NONRELATIVE  
DK  
REF  
 
GO TO E27  
 
E25l. Did this second period begin within a month of you having a baby?  
 
1. YES GO TO E27  
5. NO  
DK  
REF  
 
E25m. Did anything else happen shortly before this second period began that might 
have caused it to happen?  
 
1. YES  
5. NO GO TO E27  
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DK GO TO E27  
REF GO TO E27  
E25n. (IF NEC: Briefly, what happened?)  
 
GO TO E27  
 
COMMENT: THE E26 SERIES IS FOR Rs WITH 3 OR MORE 12-MONTH 
EPISODES  
 
E26x. In the past 12 months, what was the longest number of weeks in a row that 
you felt that way? (IF RESPONSE = DK, ENTER 98. IF RESPONSE = REF, 
ENTER 99).  
(RECORD FRACTIONAL RESPONSE ROUNDED TO LOWEST NUMBER OF 
WEEKS.)  
 
__________ # of weeks  
 
E26. Is the most recent of these (NUMBER FROM E25) periods still going on or 
has it ended?  
 
1. STILL GOING ON  
5. ENDED  
DK  
REF  
 
CHECKPOINT:  
 
IF E26 = 1, WE KNOW REC = PAST MONTH. SO WE CAN GO TO E26c  
 
IF E26 = 5 AND E66 = 48-52, WE KNOW IT ENDED IN THE PAST 4 WEEKS, 
WHICH MEANS THAT REC = PAST MONTH. SO WE CAN GO TO E26c 
  
IF E26 = 5 AND E66 = 27-47, WE DO NOT KNOW REC COMPLETELY, BUT 
WE KNOW IT CANNOT BE MORE THAN SIX MONTHS AGO. THEREFORE, 
WE SHOULD GO TO A TRUNCATED REC QUESTION: GO TO E26a  
 
IF E26 = 5 AND E66 LT 27, WE DO NOT KNOW REC. THEREFORE, WE 
SHOULD GO TO THE REC QUESTION: GO TO E26b  
 
E26a. When did it end -- in the past month or more than a month ago?  
 
1. PAST MONTH  
2. MORE THAN A MONTH AGO  
DK  
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REF  
 
GO TO E26c  
 
E26b. When did it end -- in the past month, past six months, or more than six 
months ago?  
 
1. PAST MONTH  
2. PAST SIX MONTHS  
3. MORE THAN SIX MONTHS AGO  
DK  
REF  
 
E26c. In between any of these (NUMBER FROM E25) periods were you feeling 
OK for at least two months?  
 
1. YES, FELT OK BETWEEN EPISODES GO TO E26e  
2. NO , DID NOT FEEL OK BETWEEN EPISODES GO TO E26g  
DK GO TO E26e  
REF GO TO E26e  
 
E26e. Between these periods, did you have at least two months when you were able 
to carry out your daily activities and enjoy being with other people as much as 
before the first period began?  
 
1. YES  
5. NO  
DK  
REF  
 
E26g. Think about what was going on in your life shortly before each of your (# 
from E25) periods of (being sad, depressed, or empty/losing interest in most 
things/being irritable) in the past 12 months. Did any of these (# from E25) periods 
occur just after someone close to you died?  
 
1. YES  
5. NO FEMALES GO TO E26j, MALES TO E26l  
DK FEMALES GO TO E26j, MALES TO E26l  
REF FEMALES GO TO E26j, MALES TO E26l  
 
E26h. (IF NEC: Who was it that died?) IF MULTIPLE RESPONSES, RECORD 
ONLY FIRST IN LIST.  
 
1. SPOUSE  
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2. CHILD  
3. PARENT/SIBLING  
4. OTHER RELATIVE  
5. NONRELATIVE  
DK  
REF  
 
E26i. Were all these (# from E25) periods shortly after the death of someone close 
to you?  
 
1. YES GO TO E27  
5. NO FEMALES GO TO E26j, MALES TO E26l  
DK FEMALES GO TO E26j, MALES TO E26l  
REF FEMALES GO TO E26j, MALES TO E26l  
 
E26j. Did any of these (#from E25) periods in the past 12 months occur within a 
month of you having a baby?  
 
1. YES  
5. NO  
DK  
REF  
 
E26l. Did anything else happen shortly before any of these periods began that might 
have caused them to happen?  
 
1. YES  
5. NO GO TO E27  
DK GO TO E27  
REF GO TO E27  
 
E26m. (IF NEC: Briefly, what happened?)  
 
COMMENT: THE E27 SERIES IS WHERE ALL Rs COME BACK TOGETHER 
NO MATTER HOW MANY EPISODES THEY HAD IN THE PAST 12 MONTHS 
 
E27. Think about how your life and activities were affected in the past 12 months by 
your (being sad, depressed or empty/losing interest in most things/being irritable) 
and other related problems. Did these problems interfere with your life or activities 
-- a lot, some, a little, or not at all?  
 
1. A LOT  
2. SOME  
3. A LITTLE  
 252 
4. NOT AT ALL GO TO E28  
DK GO TO E27a  
REF GO TO E27a  
 
E27a. About how many days in the past 12 months were you totally unable for the 
whole day to work and carry out your other normal activities because of (being sad, 
depressed or empty/losing interest in most things/being irritable) and other related 
problems? You can answer with any number between 0 and 365. (IF RESPONSE = 
DK, ENTER 998. IF RESPONSE = REF, ENTER 999).  
 
______ NUMBER OF DAYS  
 
E27a.a3 CHECKPOINT:  
 
IF E27a = 0 GO TO E27b. IF E27a = 1, GO TO E27a.1. ELSE GO TO E27a.2  
 
E27a.1. Did that day occur in the past 4 weeks?  
1. YES  
5. NO  
DK  
REF  
GO TO E27b  
 
E27a.2. How many of these (# FROM E27a) days occurred in the past 4 weeks? (IF 
RESPONSE = DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
_____ NUMBER OF DAYS  
 
E27b. [Not counting the day(s) you were totally unable to work,] about how many 
(other) days in the past 12 months did you cut back either on the amount of work 
you got done or on the quality of your work because of these problems? (Again, you 
can use any number between 0 and 365.)(IF RESPONSE = DK, ENTER 998. IF 
RESPONSE = REF, ENTER 999).  
 
______ NUMBER OF DAYS  
 
E27b.b3 CHECKPOINT: IF E27b = 0, GO TO E27x. ELSE GO TO E27c.  
 
E27c. Thinking about (that cutback day/those # FROM 27b cutback days), on a 
scale from 0 to 100 where zero means being totally unable to work and 100 means 
working a full high quality day, what number describes the quantity and quality of 
your work during (that day/those # FROM E27b days)? (IF RESPONSE = DK, 
ENTER 998. IF RESPONSE = REF, ENTER 999).  
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______ RECORD NUMBER BETWEEN 0 AND 100  
 
IF E27b = 1, GO TO E27c.1. ELSE GO TO E27c.2  
 
E27c.1. Did that cutback day occur in the past 4 weeks?  
 
1. YES  
5. NO  
DK  
REF  
GO TO E27x  
 
E27c.2. How many of these (# FROM E27b) cutback days occurred in the past 4 
weeks? (IF RESPONSE = DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
_____ NUMBER OF DAYS  
 
E27x [Not counting the day(s) you were totally unable to work /(or)/(you cut back 
on work,) about how many (other) days in the past 12 months did it take an extreme 
effort to perform up to your usual level at work or at your other normal daily 
activities because of (being sad/losing interest/being irritable)? (Again, you can use 
any number between 0 and 365.)  
 
(IF RESPONSE = DK, ENTER 998. IF RESPONSE = REF, ENTER 999).  
 
______ NUMBER OF DAYS  
 
E27x.x3 CHECKPOINT  
 
IF E27x = 0 GO TO E27d.  
IF E27x = 1, GO TO E27x.1 ELSE GO TO E27x.2  
 
E27x.1 Did that day occur in the past 4 weeks?  
 
YES  
5. NO  
DK  
REF  
 
GO TO E27d  
 
E27x.2 How many of these (#FROM E27x) days occurred in the past 4 weeks? (IF 
RESPONSE = DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
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_______ NUMBER OF DAYS  
 
E27d. And about how many days in the past 12 months did (being sad/losing 
interest/being irritable) and other related problems seriously interfere with your 
personal or social life? (Again, you can use any number between 0 and 365.) (IF 
RESPONSE = DK, ENTER 998. IF RESPONSE = REF, ENTER 999). 
  
_______ NUMBER OF DAYS  
 
E27d.d3 CHECKPOINT  
 
IF E27d = 0, GO TO E28. IF E27d = 1, GO TO E27d.1. ELSE GO TO E27d.2  
E27d.1. Did that day occur in the past 4 weeks?  
 
1. YES  
5. NO  
DK  
REF  
 
GO TO E28  
 
E27d.2. How many of these (# FROM E27d) days occurred in the past 4 weeks? (IF 
RESPONSE = DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
_____ NUMBER OF DAYS  
 
E28. In the past 12 months, did you tell a doctor about (feeling sad, empty, or 
depressed/losing interest in most things/being irritable)?  
 
PFC PRB 2 3 4 5  
 
E29. Can you remember your exact age the very first time in your life you had a 
period lasting two weeks or longer of (being sad, depressed, or empty/losing interest 
in most things/being irritable) and having some of the other problems we reviewed? 
  
1. YES  
5. NO GO TO E29.1  
8. DK GO TO E29.1  
9. REF GO TO E29.1  
 
E29a. (IF NEC: How old were you?) (IF RESPONSE = REF, ENTER 99).  
 
__________ YEARS OF AGE  
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GO TO NEXT SECTION  
 
E29.1. About how old were you the first time you had a period of this sort? (IF 
RESPONSE = DK, ENTER 98. IF RESPONSE = REF, ENTER 99).  
 
__________ YEARS OF AGE  
 
E29.2. What's the earliest age you can clearly remember a particular time when you 
had a period of this sort? (IF RESPONSE = DK, ENTER 98. IF RESPONSE = REF, 
ENTER 99).  
 
__________ YEARS OF AGE  
 
SPLICING RULES  
 
E27b IF E27a = (DK, REF) THEN: INCLUDE OPTIONAL PHRASES USING 
THE PLURAL FORM.  
 
E27c IF E27b = (DK, REF) THEN: ?those cutback days?; ?those days?  
 
E27x IF E27b OR E27c = (DK, REF) THEN: INCLUDE OPTIONAL PHRASES 
USING PLURAL FORM  
 
(Sources: Centers for Disease Control and Prevention (CDC). National Center for 
Health Statistics (NCHS). National Health and Nutrition Examination Survey 
Questionnaire. Hyattsville, MD: U.S. Department of Health and Human Services, 
Center for Disease Control and Prevention. Retrieved November 1, 2010 from:  
http://www.cdc.gov/nchs/data/nhanes/cidi_quex.pdf) 
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DEPRESSION SCREEN – DPQ 
Target Group: SPs 12+ 
05BOX 1 
CHECK ITEM 05DPQ.001: 
 IF INTERVIEW DONE ONLY WITH SURVEY PARTICIPANT (CODED 
„1‟ IN RIQ.005), CONTINUE. 
 OTHERWISE, GO TO NEXT SECTION. 
05DPQ.010 Over the last 2 weeks, how often have you been bothered by the 
following problems: little interest or pleasure in doing things? Would you say . . . 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.020 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] feeling down, depressed, or hopeless? 
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NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.030 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] trouble falling or staying asleep, or sleeping too much? 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.040 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] feeling tired or having little energy? 
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NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.050 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] poor appetite or overeating? 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.060 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] feeling bad about yourself – or that you are a failure or have let 
yourself or your family down? 
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NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.070 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] trouble concentrating on things, such as reading the newspaper 
or watching TV? 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.080 [Over the last 2 weeks, how often have you been bothered by the 
following problems:] moving or speaking so slowly that other people could have 
 261 
noticed? Or the opposite – being so fidgety or restless that you have been 
moving around a lot more than usual? 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
NEARLY EVERY DAY.................................. 3 
REFUSED ....................................................... 7 
DON‟T KNOW ............................................... 9 
05DPQ.090 [Over the last 2 weeks, how often have you been bothered by the 
following problem]: thoughts that you would be better off dead or of hurting yourself 
in some way? 
INTERVIEWER INSTRUCTION: IF DPQ.090 CODED 1, 2, OR 3, PLEASE 
COMPLETE MENTAL HEALTH OBSERVATION FOR PHYSICIAN REVIEW 
AT CONCLUSION OF INTERVIEW. 
NOT AT ALL.................................................. 0 
SEVERAL DAYS ........................................... 1 
MORE THAN HALF THE DAYS.................. 2 
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NEARLY EVERY DAY.................................. 3 
          REFUSED ....................................................... 7 
          DON‟T KNOW ............................................... 9 
05BOX 2 
CHECK ITEM 05DPQ.095: 
 IF RESPONSE TO ANY OF QUESTIONS 05DPQ.010 – 05DPQ.090 = 1, 2, 
OR 3, GO TO 05DPQ.100. 
 OTHERWISE, GO TO NEXT SECTION. 
05DPQ.100  
How difficult have these problems made it for you to do your work, take care of 
things at home, or get along with people? 
Not at all difficult, ........................................... 0 
Somewhat difficult,.......................................... 1 
Very difficult, .................................................. 2 
Extremely difficult?..........................................3 
REFUSED ....................................................... 7 
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   DON‟T KNOW ............................................... 9 
(Sources: Centers for Disease Control and Prevention (CDC). National Center for 
Health Statistics (NCHS). National Health and Nutrition Examination Survey 
Questionnaire. Hyattsville, MD: U.S. Department of Health and Human Services, 
Center for Disease Control and Prevention. Retrieved November 1, 2010 from:  
http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/mi_dpq_d.pdf.) 
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